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ABSTRACT
A quantitative characterisation of phospholipid composition and
biosynthesis in HeLa cells and nuclei - a mass spectrometry study
by Charlotte Victoria Hague
Nuclei from Human cells have been shown to contain a pool of endonuclear phos-
pholipid that is distinct from the nuclear membrane. It has been suggested that
this endonuclear phospholipid is involved in the regulation of nuclear processes
such as transcription.
This study utilised tandem electrospray ionisation mass spectrometry to
determine, quantitatively, the phospholipid content of cultured HeLa (Human cer-
vical carcinoma) cells and their isolated naked nuclei. Endonuclear PC, DAG and
PI was found to be enriched in disaturated molecular species with respect to the
whole cell.
Whole cell and endonuclear phospholipid content was monitored through-
out the cell cycle following treatment with the cell cycle blocking agent mimosine.
The molecular species composition of both whole cell and nuclei was found to diﬀer
to that of cells which had not been treated with mimosine. These compositional
diﬀerences between synchronous and asynchronous cell populations were found to
relate to the saturation level of the molecular species.
Using a combination of ESI-MS and stable isotope labelling, the biosyn-
thesis of PC was monitored in both whole cells and nuclei. The molecular species
composition of newly synthesised PC closely resembled that of endogenous PC.
Biosynthesis of PC was found to continue in nuclei that had been removed from
the cell and stripped of their nuclear envelope.Contents
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Introduction
1.1 Motivation - the neonuclei project
The eukaryotic cell nucleus was the ﬁrst organelle to be discovered and is often
referred to as the control centre of the cell as it contains all the cell’s chromosomal
DNA. The nucleus is separated from the cell cytoplasm by the nuclear envelope, a
double membrane structure, which is contiguous with the endoplasmic reticulum.
Unlike prokaryotic cells, DNA transcription occurs in the nucleus and is separate
to translation which occurs in the cytoplasm [1, 2, 3].
The European Commission funded Neonuclei project was a collaborative research
programme between ﬁve EU Universities. The overall aim of the Neonuclei project
was to produce synthetic analogues of cell nuclei which are transcription-competent
in the presence of the necessary transcription factors. These neonuclei could be in-
terfaced with systems such as cell-free protein expression [4] to synthesise complex
biological molecules on demand. To guide the design and preparation of neonuclei
it was necessary to study and understand the components and biological processes
of real nuclei. It was also important to identify suitable systems for mimicking the
properties of real nuclei. Consequently two approaches were adopted; a top down
approach to better understand nuclear structure and a bottom up approach to
investigate the use of synthetic systems to replicate nuclear function.
The work presented in this thesis formed part of the top down approach to un-
derstanding real nuclei. The aim of this study was to investigate the composition
and role of endonuclear phospholipids in eukaryotic cells. Using HeLa cells as the
11.2 Phospholipids
basis for this work, mass spectrometry was utilised to elucidate and quantify both
whole cell and endonuclear phospholipid content. The remainder of this chapter
introduces some background information which is relevant to this research.
1.2 Phospholipids
Lipids are a large and diverse group of compounds which include classes such
as fatty acids, sterols and eicosanoids. The structure and biological function of
diﬀerent lipid types can vary signiﬁcantly. In this thesis, however, discussion is
limited to phospholipids (also termed glycerophospholipids). The general struc-
ture of phospholipids is shown in Figure 1.1. They consist of a glycerol backbone
to which a polar phosphate headgroup and two non-polar fatty acid chains are
connected. Phospholipids are typically classiﬁed by their headgroup structure, ex-
amples of which are shown in Figure 1.1.
Figure 1.1: Chemical structure of a typical phospholipid and examples of typical head
groups.
The number of possible chain lengths and degree of saturation of the fatty acids
creates a large number of diﬀerent molecular species within each headgroup class.
Within this thesis the following nomenclature is used to denote the structure of
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a phospholipid; PC16:0/18:1 where PC indicates the head group species (in this
example, phosphatidylcholine), 16 represents the number of carbons in the fatty
acid chain and 0 the number of double bonds. The numbers after the forward slash
indicate the number of carbons and double bonds for the second fatty acid chain
if it is present. The letter ‘a’ can be included after the numbers to denote that the
fatty acid chain has an alkyl rather than acyl linkage.
Number of 
double bonds 
in the fatty 
acid chain
PC16:0a/18:1
Headgroup
species
Number of 
carbon atoms in 
the fatty acid 
chain
If this is included, 
the fatty acid 
forms an alkyl 
linkage to the 
glycerol 
backbone
Figure 1.2: Nomenclature for phospholipids
All membrane lipids are amphiphilic and therefore tend to form aggregates in
an aqueous environment. Phospholipids are are essential components of biological
membranes and form a bilayer with the hydrophilic headgroups oriented towards
the aqeous medium and the hydrophobic fatty acid chains towards the centre of
the bilayer [1].
Phospholipids are not, however, simply the building blocks of biological mem-
branes whose main function is cellular compartmentalisation. They are now known
to perform a diverse range of roles within the cell from signal transduction to cy-
toskeletal support [5, 6, 7]. Indeed the biochemical and biophysical properties of
membranes, which are aﬀected by their phospholipid composition, play an impor-
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tant role in the cell. The activity of some proteins for instance can be altered by
interaction with a membrane. CTP:phosphocholine cytidyltransferase (CCT) is a
rate limiting enzyme involved in biosynthesis of phosphatidylcholine and its activ-
ity is mediated by membrane association. CCT membrane binding (and therefore
its activity) is thought to be modulated through a physical feedback signal due to
the stored elastic stress (torque tension) of the bilayer, a property which is related
to its lipid composition [8, 9].
Phospholipids and their derivatives are important signalling molecules involved in
cellular processes such as apoptosis [7]. The phosphoinositide system for example
plays a role in the release of intracellular calcium stores. Although it can not be
described as a phospholipid, DAG (glycerol with two hydroxyl groups esteriﬁed to
a fatty acid) is also discussed throughout this thesis as is is an important interme-
diate in the metabolism of phospholipids. DAG functions as a second messenger
(a molecule that transfers signals from cell surface receptors to target molecules
within the cell) and is involved in many cellular processes through its interaction
with protein kinase C [10].
1.2.1 Phospholipids in the cell nucleus
The presence of phospholipids within the nucleus, but distinct from the nuclear
envelope, has been demonstrated by several histochemical and biochemical tech-
niques. Using gold-conjugated phospholipases, amorphous lipoprotein complexes
were identiﬁed in the interchromatin of the nucleus, co-located with ribonucle-
arproteins [11]. Radioiodination of rat liver nuclear phospholipids demonstrated
that phospholipids extracted from the chromatin were indeed present and not sim-
ply due to contamination from nuclear membranes [12]. More recently lipid mass
spectrometry has been employed to determine the molecular species composition
of certain phospholipids within the nuclear compartment [13].
Membranous structures within the nucleus have yet to be identiﬁed therefore the
precise molecular organisation of these endonuclear phospholipids is still unclear
[13, 14]. Many studies, however, indicate that endonuclear phospholipids are lo-
cated with the chromatin domains and may play important roles in events such
as gene transcription, DNA replication and passage through the cell cycle [13].
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Enzymes necessary for phospholipid metabolism have also been found within the
endonuclear compartment suggesting the presence of a separate nuclear metabolism
[15, 16, 17]. Lipids are known to play an important role in cell signalling by gen-
erating bioactive metabolites in response to stimuli. Endonuclear phospholipid
signalling, independent of that at the plasma membrane is therefore a possibility
[13, 18, 19, 20].
1.3 The cell cycle
The process by which cells reproduce is described by the cell division cycle. In
each cell division cycle a cell divides producing two genetically identical daughter
cells. Figure 1.3 shows the phases of a standard eukaryotic cell cycle. The M phase
(mitosis) is where cell division occurs and usually accounts for only a small fraction
of the cell cycle. The remaining phases are known collectively as interphase during
which the cell grows and prepares for cell division. During G1, the cell grows and
at a certain point commits to transversing the entire cycle. Prior to this restriction
point during the G1 phase, cells can also enter a resting state termed G0 in which
they can remain for an unspeciﬁed time period before resuming their progress
through the cell cycle [21, 22]. DNA replication occurs during the S phase leading
to a doubling of the cellular DNA content. G2 provides additional time for growth
before mitosis [23, 1, 10].
Figure 1.3: The phases of a standard eukaryotic cell cycle. The cell goes through phases
of growth (G1 and G2 phases) and DNA synthesis (S phase) before undergoing mitosis
(M phase) to produce two genetically identical daughter cells.
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Although the cell cycle can be considered simply as four phases, in reality a large
number of complex and coordinated events are required for successfull cell cycle
progression. The transition from one stage to another is regulated by a group
of proteins called the cyclin-dependent kinases. Activation of these kinases by
another group of proteins called cyclins triggers the events which allow the cell to
transverse the cell cycle. Checkpoints monitor events such as DNA replication so
that mutations can be avoided. If a checkpoint is activated it sends a signal that
delays cell cycle progression until the problem has been rectiﬁed [23, 24].
1.3.1 Phospholipids and the cell cycle
The creation of daughter cells during mitosis requires a doubling of the membrane
phospholipid. If this did not occur it would result in cells of abnormal size and
internal membrane surface. Changes in phospholipid metabolism are thought to be
coordinated with events of the cell cycle. In the G1 phase, phospholipids are rapidly
synthesised and degraded (turn over). It is possible that this metabolism, which
can generate lipid second messengers, is required for further cell cycle progression
[25]. Continued phospholipid synthesis coupled with reduced turnover during the
S phase leads to a doubling of the phospholipid mass. Phospholipid metabolisim
is thought to cease during the G2/M phase although this may not be true for all
cell types [26, 27, 28]. It seems that phospholipid metabolism is linked to the cell
cycle but it is unclear whether the phospholipid content can also eﬀect cell cycle
progression [29].
1.3.2 Cell cycle synchronisation
A normal cell population contains cells which are distributed randomly between
all the phases of the cell cycle and is thus termed asynchronous. To investigate a
particular part of the cell cycle, it is therefore necessary to bring the cell popula-
tion into phase. Several methods of synchronisation are commonly used and are
summarised in Table 1.1.
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Method of synchronisation Cell cycle phase Mode of action
Serum starvation G0/G1 Withdrawal of growth
factors
Lovastatin G0/G1 HMG-CoA reductase
Mimosine G1/S Ribonucelase reductase
Thymidine S dNTP synthesis
Aphidicolin S DNA polymerase
Nocodazole G2/M Destabilises micro-
tubules
Mitotic shake oﬀ G2/M Selection of mitotic cells
which detach from cul-
ture substrate
FACS any DNA content
Centrifugal elutriation any Cell size
Table 1.1: Methods of cell cycle synchronisation and the phase during which they act.
Chemical inhibitors such as mimosine or nocodazole reversibly arrest the cell cycle
at a certain point. Cells continue to cycle until they reach this point after which
their progression is halted. On release of the block the cell population resumes pro-
gression through the cell cycle with a high proportion of cells in phase. Application
of these methods tends to be simple and results in a high degree of synchrony [30].
Non-chemical methods such as mitotic shake oﬀ, centrifugal elutriation and FACS
can also be used and oﬀer the advantage that normal progression of the cell through
the cell cycle is not perturbed. Mitotic shake oﬀ relies on the observation that ad-
herant cells become rounded and less ﬁrmly attached to the surface during mitosis
and is thus only applicable to adherant cell lines. Centrifugal elutriation separates
cells based on their size, a characteristic which tends to correlate to position in
the cell cycle [30]. FACS allows cells to be sorted according to their DNA content
after staining with a ﬂuorescent DNA probe. FACS is discussed in more detail in
section 1.4. Although these methods may reduce the risk of unexpected side eﬀects
caused by perturbing the normal cell cycle, they are less convenient when a large
number of cells is required and can yield populations which are not suﬃciently
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synchronous [31].
Serum starvation induces synchronisation by removing a nutrient source which is
required for cell division. The cells stop growing and enter a resting state called G0
phase or quiescence where they can remain until the nutrient source is replenished.
The cells will then resume proliferation and continue cycling synchronously [32, 1].
This method can however alter the rate of progression through the cell cycle and
questions have been raised regarding the entry of cells into a G0 phase [33, 34].
1.4 Flow cytometry
Flow cytometry is a technique which allows certain physical characteristics of par-
ticles, such as cells, to be determined as they ﬂow in a stream of liquid through a
beam of light. The particles are suspended in a ﬂuid called the sheath ﬂuid and
carried through to the illumination point. At this point the particles scatter the
incident laser light and emit ﬂuorescence (if labelled with a ﬂuorescent compound).
Light scattered at small angles is called forward scatter (FSC) and is proportional
to the size of the particle. Side scattered light (SSC) is collected perpendicular to
the laser beam and gives an indication of the internal structure of the cell [35, 36].
Interaction of the laser with a ﬂuorescently labelled particle will lead to emission
of light at a speciﬁc wavelength (ﬂuorescence) which can be detected by the ﬂow
cytometer. This technique can be used to measure the DNA content of a cell and
thus determine the proportion of cells within each cell cycle phase. Fluorescent
dyes such as propidium iodide are allowed to stoichiometrically bind to the DNA.
Cells with more DNA will bind more of the dye and therefore ﬂuoresce more
strongly than those cells with less DNA. As the DNA content varies depending on
the phase of the cell cycle it is therefore possible to determine the proportion of
cells in each phase from the level of ﬂuorescence [37, 38].
Some ﬂow cytometers can also be used to sort particles on the basis of their mea-
sured characteristics. These are termed ﬂuorescence activated cell sorters (FACS)
however this term is often applied to ﬂow cytometers that do not have this capa-
bility.
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1.5 Mass spectrometry
A mass spectrometer allows the mass of a chemical compound to be determined
by separating molecular ions according to their mass to charge ratio. Although
many diﬀerent types of mass spectrometer exist they all consist of three basic
components; an ion source, a mass analyser and a detector [39].
The advent of ‘soft ionisation’ techniques such as electrospray and matrix-assisted
laser desorption/ionisation have greatly improved the analysis of biological samples
by mass spectrometry. These techniques avoid the problem of sample decompos-
tion which can occur with electron ionisation. Electrospray ionisation (ESI) forms
a spray of charged droplets from the tip of a needle to which a potential diﬀerence
has been applied. The droplets undergo desolvation at atmospheric pressure until
the ions are released and transferred into the mass analyser [39, 40, 41]. Two mech-
anisms by which ions are released from the droplet have been proposed - ‘Coulomb
explosion’ and ‘Ion evaporation’. This remains a topic for further research but is
beyond the scope of this study [42, 43].
A mass analyser measures the mass to charge ratio of the gas phase ion produced
by the ion source. Quadrupole mass analysers are made up of four parallel rods
to which a ﬁxed DC potential and an alternating radio frequency (RF) is applied.
Opposite rods have a potential of
φ0 = +(U − V cosωt) and −φ0 = −(U − V cosωt)
where ‘U’ is the applied direct potential and ‘V cosωt’ is the applied RF with
frequency ω and amplitude ‘V ’. Ions entering along the z axis of the quadrupole
will be subject to the electric ﬁeld of the rods. Certain combinations of the direct
and alternating potentials will allow speciﬁc ions to maintain a stable trajectory
through the centre of the quadrapole. Other ions will be unstable in the electric
ﬁeld, hit the rods and therefore not be detected [44].
Quadrupoles can be placed in series to perform tandem mass analysis. An in-
strument consisting of three quadrupoles is depicted in ﬁgure 1.4. The second
quadrupole acts as a collision cell producing fragments by colliding the ions with
an inert gas such as argon. Several possible scan types are shown.
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Figure 1.4: In the full scan mode ions are scanned in the ﬁrst quadrupole (Q1) and
allowed to pass through the remaining quardrupoles without fragmentation. This allows
detection of all molecular ion species. If Q3 is set to detect a certain ion and Q1 scans all
masses, all the ions that produce the selected ion after fragmentaion (CID) are detected
- this is called a precursor scan. If Q1 and Q3 are scanned together but with a constant
mass offset this is called a neutral loss scan. An ion is detected if it has given a fragment
of mass equal to the mass offset between the two quadrupoles.
1.5.1 Mass spectrometry of phospholipids
Analysis of phospholipids has conventionally relied mainly on techniques such as
thin layer chromatography (TLC) and gas chromatography. These techniques can
be time consuming and require a large amount of sample [7, 5, 45]. Only since
the advent of soft ionisation techniques (section 1.5) has mass spectrometry been
widely used for the study of lipids. Mass spectrometry (ESI triple quadrupole
MS) oﬀers a good alternative to traditional methods due to its sensitivity and
ability to identify diﬀerent lipid species without prior separation by chromatogra-
phy [46, 47]. The precursor and neutral loss scanning ability of triple quadrupole
mass spectrometers enables detection of molecular species for each phospholipid
class from a crude mixture thus allowing direct analysis of a cellular extract.
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In addition to the relative abundance of molecular species for a certain phospho-
lipid class, inclusion of internal standards allows quantitative analysis. Internal
standards are phospholipid species of a known quantity that are not normally
found in the cell line of interest. Comparision of the relative intensity of the species
of interest to that of the internal standard allows absolute quantiﬁcation [5].
The use of stable isotope labelling also allows dynamic studies of lipid synthesis
to be undertaken [48]. In this study choline-d9 is used to follow the synthesis of
PC. An excess of the deuterated choline causes the phosphocholine-d9 headgroup
to be incorporated in any newly synthesised PC. This newly synthesised PC can
then be distinguished from endogenous PC by ESI-MS as it produces an analo-
gous fragment nine mass units higher. The same method can be applied to other
phospholipid species [49].
1.6 HeLa cell culture
The culture of human cells in vitro has been invaluable to the research of funda-
mental cellular processess as it oﬀers a relatively easy system for such research.
One of the most widely used and well-known immortalised cell lines is HeLa. This
cell line was derived from the cervical cancer cells of Henrietta Lacks and ﬁrst
cultured by George Gey in 1951. HeLa cells grow extremely well under cell culture
conditions and are surprisingly resilient. This has, in many cases, led to cross-
contamination of other cell lines with HeLa [50, 51, 52].
In this study we use a stably transfected HeLa cell line in which the histone H2B
gene has been fused to the gene encoding for green ﬂuorescent protein (GFP) from
the jellyﬁsh Aequorea victoria. This oﬀers an alternative to DNA stains such as
DAPI for live microscopy of nuclear chromatin structure [53, 54]. This cell line
was used as a basis for the work described in this study as it was decided that
a standard cell line should be used for studies by all members of the neonuclei
project.
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1.7 Thesis aims and overview
As described in section 1.1, the work presented in this thesis is an investigation
into the composition and role of endonuclear phospholipids in eukaryotic cells. The
purpose of this work was to further the understanding of components and processes
present in real nuclei and thus contribute to the overall neonuclei project aim of
producing synthetic analogues of cell nuclei.
Previous studies have provided strong evidence for the presence of endonuclear
phospholipids in several cell lines (see section 1.2.1). The molecular species com-
position of some endonuclear phospholipid classes has also previously been deter-
mined by mass spectrometry [48]. The work presented in this thesis considerably
extends these mass spectrometry studies by providing a quantitative determina-
tion of the endonuclear molecular species composition for all phospholipid classes
and DAG in HeLa cells. Furthermore this work aims to determine any link be-
tween whole cell and endonuclear phospholipid composition and the cell cycle. This
extends both the scope of previous mass spectrometry studies and also provides
additional information to that obtained from previous studies using techniques
such as chromatography [26].
As described in section 1.5.1 the biosynthesis of phospholipids can be followed by
stable isotope labelling. Previous studies have determined the molecular species
composition of newly synthesised endonuclear PC [55, 56]. In this study PC syn-
thesis is followed using both stable and radio-isotope methods throughout the cell
cycle. In addition, this study aimed to determine if naked nuclei (nuclei stripped
of their nuclear envelope) are capable PC synthesis.
Although previously reported methods and protocols were initially followed, this
thesis describes the process of modiﬁcation and optimisation applied to these pro-
tocols to best address the requirements of the study. Method developments were
applied to both sample preparation and data analysis protocols for mass spec-
trometry.
Chapter 2 describes the development and optimisation of experimental techniques
used in this study. The compositional analysis of whole cell and endonuclear phos-
pholipids, in relation to the cell cycle, is detailed in chapters 3 and 4 respectively.
Chapter 5 describes the use of stable and radio-isotope methods to determine
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the biosynthetic dynamics of phosphatidylcholine. Conclusions and experimental
details are presented in chapters 6 and 7.
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18Chapter 2
Method development
2.1 Introduction
Experimental and analytical techniques descibed in this thesis have been optimised
to best address the requirements of this study. The development of these methods
is detailed in this chapter.
2.2 Development of Biological methods
Before analysis of phospholipid composition by mass spectrometry can take place,
the biological sample must be prepared. Figure 2.1 shows the process followed to
obtain a phospholipid sample from cells in culture (a synchronised population).
To assess the endonuclear phospholipid composition, it is ﬁrst necessary to isolate
nuclei that are free from nuclear envelope. The method of isolating these nuclei
is discussed in detail in section 2.2.1. Quantitative analysis of both whole cells
and nuclei requires an assessment of cell/nuclei number. Section 2.2.2 describes
the current technique for this analysis and proposes an alternative method. The
process of cell cycle synchronisation is discussed in Chapter 3.
2.2.1 Isolation of naked nuclei
As introduced in section 1.2.1, endonuclear phospholipids are distinct from those
in the nuclear envelope. Complete removal of the nuclear envelope is therefore es-
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HeLa cells in 
culture 
Add cell cycle block 
to synchronise 
Remove cell cycle block and 
allow cells to reach appropriate 
point of cell cycle 
Count cells 
Phospholipid 
extraction 
ready for mass 
spec analysis 
Isolate naked 
nuclei 
Count nuclei 
Figure 2.1: Process of preparing cells for analysis. Once the synchronised cell population
has reached an appropriate cell cycle point, the culture medium is removed and the cells
counted before phospholipid extraction. If nuclei are required, these are extracted prior
to counting and phospholipid extraction.
sential to avoid contamination of the endonuclear phospholipid pool and thus allow
accurate compositional analysis. Detergents can be used to solubilise membranes
and release cellular components. Section 7.3 describes the protocol whereby these
cellular components are separated through a sucrose density gradient. The nuclear
fraction forms a pellet which is easily separated from the other less dense cellular
components. The resultant nuclei are free from nuclear envelope and are therefore
termed ‘naked nuclei’.
Previous studies have indicated that complete nuclear envelope removal can be
achieved with the detergent Triton-X-100 [1]. Unfortunately residual detergent
contamination of the naked nuclei can be carried through during phospholipid
extraction. Triton-X-100 is easily detected by mass spectrometry under positive
ionisation conditions and fragmentaion of the molecule leads to peaks at 44 mass
unit intervals in the P193 spectra (Table 7.2) as shown in Figure 2.2. These peaks
can obscure those of the species of interest and lead to signal reduction through
ion supression [2].
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Figure 2.2: A typical P193 spectrum with detergent contamination. Peaks marked with
arrows arise from the Triton-X-100 contamination.
Solid phase extraction cartridges can be used to separate the phospholipid into
neutral, acidic, PC and PE fractions (section 7.7.1) [1, 3]. Triton-X-100 contami-
nant is eluted with the neutral fraction, removing the problem of detergent peaks
in the P193 spectrum. Although this method can be used to remove Triton-X-100,
some loss of sample during the procedure is likely. This is signiﬁcant due to the
small quantity of phospholipid which can be extracted from the endonuclear com-
partment.
Alternative surfactants to Triton-X-100 were investigated with the aim of suc-
cessfully isolating naked nuclei whilst removing the problem of artefactual mass
spectrometry results. Table 2.1 summarises the results from several detergents. Use
of the ionic detergents (SDS and CTAB) did not result in intact nuclei even at
low concentrations. The non-ionic detergents all gave intact nuclei, however, only
n-Decyl β-D-Maltopyranoside allowed extraction of the nuclear fraction without
causing experimental or analytical diﬃculties.
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Detergent Comments
SDS Caused complete cell lysis. No nuclei obtained.
CTAB Caused complete cell lysis. No nuclei obtained.
n-Decyl β-D-Maltopyranoside Nuclei were isolated. No detergent peaks visible
when analysed by mass spectrometry.
Nonidet P-40 Nuclei were isolated. Detergent peaks detected
when analysed by mass spectrometry.
n-Octyl α-D-Glucopyranoside Nuclei were extracted. Detergent easily crys-
tallised out of solution, limiting the viability of
the extraction procedure.
Table 2.1: Detergents investigated as alternatives to Triton-X-100 for the isolation of
naked nuclei. Initially the same concentration as used for Triton-X-100 was used in each
case (section 7.3). The procedure was repeated with a reduced concentration of deter-
gent but the results remained the same.
Transmission electron microscopy (TEM) was used to assess the eﬀectiveness of n-
Decyl β-D-Maltopyranoside for nuclear envelope removal. Figure 2.3 shows TEM
pictures of a whole cell, a n-Decyl β-D-Maltopyranoside extracted nucleus and a
Triton-X-100 extracted nucleus. The double membrane, ‘track-like’, morphology
of the nuclear envelope is visible in the whole cell however there is no evidence of
this structure in either of the nuclear samples. These results strongly indicate that
n-Decyl β-D-Maltopyranoside is a suitable alternative to Triton-X-100 for naked
nuclei preparation.
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Triton X-100 
extracted nucleus 
Maltopyranoside 
extracted nucleus 
Nucleus 
Nucleus 
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Figure 2.3: TEM image of whole cells and nuclei isolated with n-Decyl β-D-
Maltopyranoside and Triton-X-100. The double membrane of the nuclear envelope is
visible in the the whole cell but not in either nuclei sample. In this ﬁgure n-Decyl β-D-
Maltopyranoside has been shortened to ‘maltopyranoside’.
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2.2.2 Cell counting
Phospholipid quantiﬁcation requires an accurate estimate of the number of cells
per sample. Haemocytometer counting was used (section 7.4.2) as this is simple,
relatively quick and requires very little sample. Assessment of the number of naked
nuclei by this method is however more challenging than for intact cells. Rather
than forming a uniform suspension in buﬀer, naked nuclei can become clumped
making it extremely diﬃcult to obtain an accurate count.
The feasablility of using DNA content per sample as an indicator of naked nuclei
number was investigated. When phospholipid is extracted using the Bligh Dyer
protocol the DNA content of the cells remains in the aqueous layer. This DNA
can be isolated and quantiﬁed as described in section 7.10. The DNA from several
whole cell samples was quantiﬁed and compared to the haemocytometer count
(Figure 2.4). As DNA content is dependent on cell cycle position, synchronised
cell populations were used (discussed in more detail in section 3.3). The 6hr and
9hr synchronised cells show a clear increase in DNA content with cell number but
this is not apparent for those at 3hrs and 12hrs. A clear trend is not obvious for all
data sets indicating that the DNA method does not oﬀer a signiﬁcant improvement
on haemocytometer counting. This data is however preliminary and with further
improvement could provide a valuable alternative.
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Figure 2.4: The DNA content of whole cells at various cell cycle points compared to the
cell count obtained by haemocytometer counting.
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2.3 Development of data analysis protocols for mass
spectrometry
To produce a ﬁnal data set from ESI-MS measurements, a number of processes are
applied in sequence to the raw results. These processes, as summarised in Figure
2.5, correct for instrumental noise, isotope eﬀects and measurement errors.
Smooth data, 
centre peaks and 
subtract baseline 
Input internal 
standard amount 
Percentage of 
total ion count 
Absolute 
amounts 
Selected absolute 
amounts 
Threshold value – 
arbitrary or 
defined 
Selected 
percentages 
Optional CID 
correction 
Raw data 
Input cell count  Amount per cell 
Correction for 
13C effects 
Figure 2.5: Process of analysing mass spectrometry data. The raw data is smoothed to
remove noise and converted to centroid format following baseline subtraction. The data
is then corrected for isotope effects and collision induced dissociation (CID) error. The
species are expressed as a percentage of the total ion count. The absolute amount of
each species is determined by comparison with the internal standard ion count. Species
above a chosen threshold value (below which data can not be distinguished from noise)
are selected and presented as a percentage of the total ion count of the selected species.
The same threshold is applied to the absolute amounts and following input of cell count,
the amount of each species per cell is determined.
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The CID correction and threshold value can be aﬀected by instrument settings,
enviromental conditions and the nature of the sample. To avoid arbitrary assign-
ment of correction values, a method to assess these processes was adopted and is
discussed further in sections 2.3.2 and 2.3.3.
The reproducibility of the ﬁnal results are dependent not only on the accuracy
of the data processing but also on the stability of the mass spectrometer. Section
2.3.5 provides a detailed assessment of spectrometer reproducibility and its eﬀect.
2.3.1 Standard mixture
Natural variations and small diﬀerences in the method of collection, preparation
and storage can lead to inconsistencies between biological samples. An accurate
assessment of instrument stability and also the corrections applied to mass spec-
trometry results however requires measurement of identical samples. Any incon-
sistencies between measurements are thus not attributable to the sample being
measured. A standard mixture of known phospholipids at known concentrations
was therefore prepared. Table 2.2 shows the constituents of this standard mixture
and their concentrations. Section 7.4.5 details the preparation of the standard mix-
ture and how it was aliquoted to give identical samples. The use of this standard
mixture is discussed further in sections 2.3.3 and 2.3.5.
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Phospholipid class Molecular species Concentration
PC 18:1/18:1 10 nM
PC 16:0/16:0 10 nM
PC 16:0/14:0 10 nM
PC 20:0/20:0 10 nM
DG 16:0/18:1 2 nM
DG 12:0/12:0 2 nM
PS 16:0/16:0 2 nM
PS 18:1/18:1 2 nM
PS 14:0/14:0 2 nM
PA 18:1/18:1 2 nM
PA 16:0/16:0 2 nM
PA 14:0/14:0 2 nM
PE 18:1/18:1 2 nM
PE 14:0/14:0 2 nM
Table 2.2: Standard mixture compostition. This mixture was prepared accurately to give
many identical samples which could be run to assess instrument stability and the effect
of applied corrections.
2.3.2 Error due to CID
In the collision cell of the mass spectrometer sample molecules collide with argon
gas and are fragmented (collision induced dissociation or CID). The energy re-
quired to break up these molecules is related to their size with larger molecules
requiring more energy. Lighter molecules tend to scatter more following collision
and are often lost outside the quadrupole ﬁeld. The eﬃciency at which fragments
are transferred through the mass spectrometer is related to the combination of
both these eﬀects [4]. The mass spectrometer is optimised to produce a maximum
transfer eﬃciency at a particular m/z value, usually in the middle of the chosen
range. The further away the molecule of interest is from the optimised mass, the
less the transfer eﬃciency. A correction for this eﬀect has been previously reported
on, however the value is dependent on the instrument settings at that time [1]. A
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full scan allows all ions to pass through the mass spectrometer without collision
and is therefore not aﬀected by this transfer eﬃciency. Comparision of the break-
down scan with the full scan therefore allows the magnitude of this eﬀect to be
assessed. Figure 2.6 shows an example of this assessment under current settings.
The ratio of precursor scan values to full positive scan values is constant across
the mass range indicating that the correction needed is minimal.
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Figure 2.6: Ratio of P184 scan to the full positive scan. This comparison indicates that
the response is very similar across the mass range for this species under current set-
tings.
2.3.3 Peak selection
All peaks from a mass spectrum are expressed as a percentage of the total ion
count, however some of these peaks are a result of background ﬂuctuations. Dur-
ing the analysis of mass spectrometry data it is important to select only sample
peaks and not those that are due to this background noise. A threshold value is
therefore chosen below which sample peaks are not distinguishable from noise. Any
data points which fall below this threshold value are not included in any further
analysis steps. The remaining ‘selected’ species are expressed as a percentage of
the total ion count for those selected species.
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Figure 2.7: Peak selections with different threshold values. The species shown in red
are those present in the standard mixture. The lyso PC species which remain at 1.5 %
threshold are probably due to breakdown of the species in the collision cell. Error bars
represent the ﬁrst standard deviation of 58 independent measurements and therefore
include instrument instability.
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As the standard mixture composition is known (section 2.3.1), it was used to
provide an estimate of this threshold value. If species which are not present in
the mixture remain following the selection process then the threshold value is too
low. If however species known to be present are removed then the threshold is
too high. Figure 2.7 shows the result of three diﬀerent threshold values for the
PC headgroup species in the standard mixture. A similar analysis was performed
for all headgroup classes and the results are summarised in Table 2.3. PI was not
included in the standard mixture as this was not readily available therefore the
threshold for this species was estimated to be 1.5%.
Phospholipid class Threshold value (%)
PC 1.5
PE 1.5
DG 4.0
PA 2.5
PS 2.0
Table 2.3: Threshold values below which sample peaks are not distinguishable from
noise
2.3.4 Accuracy of internal standards
Inclusion of internal standards allows the amount (moles) of phospholipid in a sam-
ple to be quantiﬁed (section 1.5.1). The intensity of the signal from the species of
interest is compared to that of the internal standard to provide an estimate of the
amount of the sample species. The internal standard must be prepared carefully
to allow an accurate quantiﬁcation of the sample species (section 7.4.4).
A colorimetric method based on the formation of a complex between phospho-
lipids and ammonium ferrothiocyantate was used to assess the accuracy of pre-
pared internal standards [5]. For each phospholipid species a calibration curve of
concentration versus optical density was prepared, an example of which is shown
in Figure 2.8 (see also section 7.5).
Following the same method, the absorbance of the internal standard was deter-
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mined and compared to the calibration curve to determine its concentration. The
concentration of the internal standards found by this method agreed well with
their expected value from calculation indicating that they were accurately pre-
pared.
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Figure 2.8: A colorimetric method based on the formation of a complex between phos-
pholipids and ammonium ferrothiocyantate used to assess the accuracy of prepared
internal standards. This ﬁgure represents a calibration curve of absorbance at 488nm
versus the amount of PE species.
2.3.5 Instrument stability
Mass spectrometric analysis of a complete sample set can require data acquisition
over a number of hours or days. As described in section 2.3.2, the eﬃciency at
which fragments are transferred through the mass spectrometer following CID is
dependent on the quadrupole ﬁeld and the pressure of the collision cell. Variations
in instrument settings, source conditions and collision cell gas pressure which may
arise between measurements can therefore lead to changes in the resultant spec-
trum [6]. A distinction must therefore be made between real results and artefacts
resulting from spectrometer instability.
The standard mixture of known phospholipids (sections 2.3.1 and 7.4.5) was used
to assess inter-session reproducibility of mass spectrometry results. Figure 2.9A
shows the percentage composition of PC molecular species in the standard mixture
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when measured by mass spectrometry on three separate occasions over a period
of three months. Results from the same day incur a very small error (represented
by the error bars) however there is a noticeable variation between measurements.
The PC20:0/20:0 (m/z 846) species was used as an internal standard and the
resulting quantiﬁed data is shown in Figure 2.9B. The error in percentage compo-
sition of the internal standard molecular species is carried through for this analysis,
therefore the variation between data sets is greater.
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Figure 2.9: A: Percentage composition of PC molecular species in the standard mixture,
measured on three occasions over a period of three months. B: The amount per cell of
the PC molecular species in the standard mixture determined by using PC20:0/20:0 as
the internal standard. Error bars represent the ﬁrst standard deviation of three measure-
ments on the same day.
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The coeﬃcient of variance is deﬁned as the ratio of the standard deviation to
the mean. It allows variability to be determined even when comparing between
datasets with markedly diﬀerent means. Figure 2.10 shows the coeﬃcient of vari-
ance (CV) for percentage composition measurements of the PC standard mixture.
The CV for data obtained over a long period of time is indeed larger than that of
data obtained during the same session.
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Figure 2.10: Coefﬁcient of variance for the standard mixture PC percentage composi-
tion results. The CV for each time point in ﬁgure 2.9, the total CV for these points and
the overall CV for every standard mixture measurement (spanning from May 2007 to
December 2008) is shown.
The same analysis was applied to the standard mixture data for PA and is shown
in Figure 2.11. In this case, the CV for data obtained during the same session is
not signiﬁcantly smaller than that obtained over a longer period of time. Similar
analysis was applied to all phospholipid species in the standard mixture and is
presented in Appendix A (ﬁgures A.1 to A.3). The CV of percentage composition
measurements for each phospholipid species is summarised in Table 2.4.
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Figure 2.11: A: Percentage composition of PA molecular species in the standard mixture
measured on three occasions over a period of three months. B: Coefﬁcient of variance
for the standard mixture PA percentage composition results
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Maximum coeﬃcient of variance/ %
Phospholipid
class
Molecular
species
Day 3 months All measurements
PC
14:0/16:0 2.4 4.5 8.5
16:0/16:0 4.1 3.8 5.7
18:1/18:1 3.2 4.6 6.8
20:0/20:0 5.3 9.4 10.3
PE
14:0/14:0 7.2 19.3 15.2
18:1/18:1 3.7 9.6 8.9
PS
14:0/14:0 20.4 25.0 19.7
16:0/16:0 13.0 10.3 9.5
18:1/18:1 19.2 14.8 20.5
PA
14:0/14:0 27.8 20.2 28.8
16:0/16:0 14.3 15.2 14.0
18:1/18:1 12.0 9.9 12.7
DG
12:0/12:0 9.6 11.1 22.8
16:0/18:1 7.1 10.3 12.4
Table 2.4: Maximum CV for percentage composition measurements of each phospholipid
species in the standard mixture
To minimise the eﬀect of this instrument variability, data sets should be as far as
possible collected on the same day. When comparing between data sets measured
on diﬀerent occasions the possibility of instrument instability must be noted. Al-
though a direct comparison of values may be aﬀected by such instability, consistent
patterns between data sets can still be considered as real.
2.3.6 Q-TOF
Time of ﬂight mass spectrometry can also be used to characterise lipid species. In
a time of ﬂight analyser, ions are accelerated into a tube which is ﬁeld free. Ions
of lower m/z reach a higher velocity than those of higher m/z therefore the time it
takes for ions to travel a set distance is a measure of m/z. In this study the time
of ﬂight analyser is used in tandem with a quadrupole to allow species selection.
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Ions are introduced into the quadrupole where a particular mass is selected. These
ions are then fragmented in the collision cell and all possible fragments are de-
tected in the time of ﬂight analyser. This procedure is repeated for other masses
until a spectrum of all the possible fragments for each species is acquired. This
information could be obtained by running a series of product ion (daughter) scans
on the triple quadrupole ESI-MS however this would be a long process. The ad-
vantage of using the TOF-MS is that all the possible fragments are detected at
one time [7].
Normally the peaks from the ESI triple quadrupole MS spectrum are assigned
according to the most likely molecular species for each mass. Several diﬀerent
molecular species can however have the same mass therefore making correct as-
signments diﬃcult. Q-TOF allows the complete fatty acid chain composition of
each phospholipid class to be determined and thus allows a more accurate assign-
ment of molecular species. Figure 2.12 shows the PC molecular species of whole
cells and nuclei which were found to be present by Q-TOF for each mass. The
same analysis was applied to the other phospholipid species and is presented in
Appendix A, Figures A.4 to A.8.
Mass Originally assigned species
706 PC14:0/16:0 16:0/14:0 16:0/14:0
718 PC16:0a/16:1 16:0a/16:1 16:1a/16:0 16:0a/16:1 16:1a/16:0 14:0a/18:1
720 PC16:0a/16:0 16:0a/16:0 18:0a/14:0 16:0a/16:0 18:0a/14:0
732 PC16:0/16:1 16:0/16:1 14:0/18:1 16:0/16:1 14:0/18:1
734 PC16:0/16:0 16:0/16:0 16:0/16:0
744 PC16:0a/18:2 16:1a/18:1 16:0a/18:2 18:1a/16:1 16:1a/18:1 16:0a/18:2 16:1/18:1a
746 PC16:0a/18:1 16:0a/18:1 18:1a/16:0 16:1a/18:0 16:0a/18:1 18:1a/16:0 18:0a/16:1
748 PC16:0a/18:0 18:0a/16:0 16:0a/18:0 18:0a/16:0 16:0a/18:0
758 PC16:0/18:2 16:0/18:2 16:1/18:1 16:1/18:1 16:0/18:2
760 PC16:0/18:1 16:0/18:1 16:1/18:0 16:0/18:1
772 PC18:0a/18:2 18:1a/18:1 18:0a/18:2 18:1a/18:1 18:0a/18:2
774 PC18:0a/18:1 18:0a/18:1 18:1a/18:0 18:0a/18:1 18:1a/18:0
782 PC16:0/20:4 20:4/16:0 18:1/18:3 16:0/20:4 18:1/18:3
784 PC18:1/18:2 18:1/18:2 20:3/16:0 18:1/18:2 16:0/20:3 18:0/18:3 16:1/20:2
786 PC18:1/18:1 18:1/18:1 18:0/18:2 16:0/20:2 18:1/18:1 16:0/20:2 18:0/18:2 16:1/20:1
788 PC18:0/18:1 18:0/18:1 20:1/16:0 18:0/18:1 16:0/20:1
794 PC18:1a/20:4 18:1a/20:4 20:4a/18:1 18:1a/20:4 20:4a/18:1
808 PC18:1/20:4 18:1/20:4 22:5/16:0 20:5/18:0 20:4/18:1 16:0/22:5 18:0/20:5 20:3/18:2
810 PC18:0/20:4 18:0/20:4 20:3/18:1 18:1/20:3 18:0/20:4 16:0/22:4
812 PC18:0/20:3 20:2/18:1 18:2/20:1 20:2/18:1 20:1/18:2 18:0/20:3
814 PC18:0/20:2 20:1/18:1 16:0/22:2 18:0/20:2 20:1/18:1 16:0/22:2 18:0/20:2
848 PC20:0a/22:6 24:5a/18:1 24:6a/18:0 24:5a/18:1 22.5a/20:1
whole cells nuclei
Species found to be present by TOF analysis. In order of intensity (most intense first)
Figure 2.12: The PC molecular species assignment for whole cells and nuclei determined
by Q-TOF. The species are presented in order of decreasing intensity. The proportion of
each species for a particular mass cannot be quantiﬁed.
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2.4 Summary
This chapter has described the development of experimental and analytical tech-
niques used in this study including the process of preparing biological samples and
the process of analysing mass spectrometry data.
The preparation of nuclei free from nuclear envelope contamination is essential
for the accurate analysis of endonuclear phospholipid composition by mass spec-
trometry. Complete nuclear envelope removal can be achieved with the detergent
Triton-X-100, however, residual contamination of the resulting naked nuclei can
lead to artefactual peaks arising in the P193 spectrum. Alternatives to Triton-X-
100 were investigated and n-Decyl β-D-Maltopyranoside was found to successfully
isolate naked nuclei without leading to diﬃculties with mass spectrometry analysis
(section 2.2.1).
Preliminary experiments to determine the feasability of using DNA content as
an indicator of naked nuclei number were described. Naked nuclei can become
clumped, rather than forming a uniform suspension, thus making an accurate as-
sessment of their number challenging. The amount of DNA isolated from the aque-
ous layer following Bligh Dyer phospholipid extraction of synchronised cell popula-
tions was compared to the count obtained from the haemocytometer method. The
DNA method did not oﬀer an improvement on haemocytometer counting, how-
ever further development of the method could provide a viable alternative (section
2.2.2).
The mass spectrometer is optimised to produce a maximum transfer eﬃciency of
fragments at a particular m/z. The transfer eﬃciency is reduced the further away
the molecule of interest is from the optimised mass. A method to assess the mag-
nitude of this eﬀect was described and it was found to be minimal under current
settings (section 2.3.2).
A method to determine threshold values below which sample peaks are not distin-
guishable from noise was described. Using a carefully prepared mixture of phos-
pholipids at a known concentration, termed the ‘standard mixture’, the threshold
value was set to only allow selection of molecular species which were present in
the standard mixture (section 2.3.3).
Accurate preparation of internal standards is required for an accurate assessment
372.4 Summary
of the absolute amount of each phospholipid species. A colorimetric method based
on the formation of a complex between phospholipids and ammonium ferroth-
iocyanate was described to assess the accuracy of prepared internal standards
(section 2.3.4).
Using the standard mixture, an assessment of mass spectrometer stability over
time was described. Variations in the results for identical samples can occur be-
tween diﬀerent measurement sessions. It was noted that data sets should be, as
far as possible, collected on the same day (section 2.3.5).
Several molecular species of a particular phospholipid class can have the same
mass. Q-TOF mass spectrometry was used to allow the correct assignment of
molecular species for each mass. The method and results of this analysis were
described (section 2.3.6).
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39Chapter 3
Phospholipid composition of
intact HeLa cells - an analysis
by ESI-MS
3.1 Introduction
This chapter describes the use of ESI-MS to analyse and quantify the phospholipid
composition of intact, also termed whole, HeLa cells. Section 3.2 details the molec-
ular species composition and overall composition of the main phospholipid classes
in the whole cells. This composition is then monitored over the cell cycle using a
population of synchronised cells, the results of which are presented in section 3.3.
The ﬁndings of this analysis not only give a detailed description of the phospho-
lipid composition of HeLa-GFP cells but also provide a control for comparison
with the nuclei data described in Chapter 4.
3.2 Non-synchronised whole cells
Non-synchronised whole cells are representative of a normal cell population when
grown under standard cell culture conditions. As introduced in section 1.3.2,
the cells of a non-synchronised population are distributed randomly between the
phases of the cell cycle and are therefore termed asynchronous. As such they pro-
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vide a basis for comparison to populations which have been partially synchronised
by the addition of agents such as mimosine that lead to cell cycle inhibition. The
cells were prepared for analysis by mass spectrometry following the techniques
described in sections 7.1, 7.4.2, 7.4.3 and 7.6.
3.2.1 Molecular species percentage composition
The results presented in this section (Figures 3.1 to 3.6) show the molecular species
composition of each headgroup class in intact HeLa-GFP cells. The molecular
species composition presented is an average of measurements obtained over six
diﬀerent days. On each day the composition of phospholipid extracted from three
separate ﬂasks of cells was measured. The error bars shown on the data represent
the ﬁrst standard deviation of all these measurements (18 samples in total). The
reported stardard deviation therefore includes error resulting from both biological
variability and instrument instability.
The molecular species composition of the PC headgroup class is shown in Figure
3.1. PC is composed mainly of monounsaturated molecular species, the most abun-
dant of which are 16:0/18:1 (m/z 760) at 28.2% of the total and 18:1/18:1 (m/z
786) at 16.5% of the total. Species 16:0a/18:1 (m/z 746), 16:0/16:1 (m/z 732) and
18:0/18:1 (m/z 788) comprise 8.7%, 6.8% and 6.4% respectively. The remaining
species comprise between 2% and 5% each.
Although a similar study of HeLa cell phospholipid composition was not found
in the literature, these results are comparable with previous studies by ESI-MS
of the Human neuroblastoma cell line IMR-32 [1] and the Human promyelocytic
leukemia cell line HL-60 [2]. In the IMR-32 cell line 16:0/18:1 is also the most
abundant molecular species, comprising approximately 23% of the total. Unlike
HeLa cells however, species 18:1/18:1 only comprises approximately 6% of the to-
tal and species containing polyunsaturated chains were also detected in IMR-32
cells. HL-60 cells show a very similar composition to that of the HeLa cells with the
most abundant species, 16:0/18:1 (m/z 760), 18:1/18:1 (m/z 786), 18:0/18:1 (m/z
788), 16:0a/18:1 (m/z 746) and 16:0/16:1 (m/z 732) comprising approximately
20%, 16%, 8%, 7% and 6% respectively. The diﬀerences between these cell lines
most probably reﬂects the diﬀerent roles of each cell type.
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Figure 3.1: Molecular species percentage composition of PC for asynchronous whole
cells (average of 6 triplicate measurements of phospholipid composition). The error bars
represent the ﬁrst standard deviation of this data and include errors arising from biologi-
cal variability and instrument instability.
The most abundant molecular species of the PE headgroup class are 18:1/18:1
(m/z 744), 18:0/18:1 (m/z 746) and 16:0/18:1 (m/z 718) which comprise 23.8%,
15.7% and 10.8% respectively (Figure 3.2). Despite the high abundance of these
monounsaturated species, there is also a large proportion of highly unsaturated
molecular species such as 18:1/20:4 (m/z 766) at 7.5% of the total and 18:0/22:6
(m/z 792) at 5.6% of the total.
The PE of IMR-32 cells [1] was also found to contain a large proportion of highly
unsaturated species. Molecular species containing polyunsaturated chains were
however found to contribute to approximately 80% of the total in contrast to 37%
in the HeLa cells. For IMR-32 cells 18:0/20:4 and 18:1/20:4 were the most abun-
dant molecular species. The two most abundant molecular species in HL-60 cells
were, as described for HeLa, 18:1/18:1 and 18:0/18:1 although these were found
to comprise only 7.6% and 7% of the total respectively [2].
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Figure 3.2: Molecular species percentage composition of PE for asynchronous whole
cells (average of 6 triplicate measurements of phospholipid composition). The error bars
represent the ﬁrst standard deviation of this data and include errors arising from biologi-
cal variability and instrument instability.
DAG is composed mainly of molecular species with saturated or monounsaturated
chains, the most abundant of which are 16:0/18:1 (m/z 612) at 31.3% of the total
and 18:1/18:1 (m/z 638) at 18% of the total (Figure 3.3). This molecular species
composition closely resembles that of PC which is probably due to the intercon-
version between PC and DAG (ﬁgure A.9). DAG is synthesised from PC by the
action of phospholipase C (PLC) and PC can be generated from DAG by the en-
zyme DAG-cholinephosphotransferase [3].
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Figure 3.3: Molecular species percentage composition of DAG for asynchronous whole
cells (average of 6 triplicate measurements of phospholipid composition). The error bars
represent the ﬁrst standard deviation of this data and include errors arising from biologi-
cal variability and instrument instability.
The whole cell PI contains molecular species with both monounsaturated and
polyunsaturated chains. The molecular species with monounsaturated chains con-
tribute to > 63% of the total whereas the species with polyunsaturated chains con-
tribute approximately half that value. The most abundant species are 18:0/18:1
(m/z 863), 16:0/18:1 (m/z 835), 18:1/18:1 (m/z 861) and 18:0/20:2 (m/z 889),
comprising 24.8%, 17.5%, 14.2% and 12.3% of the total respectively.
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Figure 3.4: Molecular species percentage composition of PI for asynchronous whole
cells (average of 6 triplicate measurements of phospholipid composition). The error bars
represent the ﬁrst standard deviation of this data and include errors arising from biologi-
cal variability and instrument instability.
As described for PE and PI, whole cell PS contains molecular species with both mo-
nounsaturated and polyunsaturated fatty acid chains. The most abundant species
are 18:0/18:1 (m/z 788) at 36.2%, 18:1/18:1 (m/z 786) at 12.9% and 16:0/18:1
(m/z 760) at 9.8% of the total. Molecular species containing monounsaturated
chains contribute to 78% of the total whereas those containing polyunsaturated
chains contribute 22%.
PS can be synthesised from either PC or PE by two diﬀerent phosphatidylserine
synthases [4] which may account for the mixture of monounsaturated and polyun-
saturated molecular species. A potential reason for the apparent similarity to PI
is however less clear.
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Figure 3.5: Molecular species percentage composition of PS for asynchronous whole
cells (average of 6 triplicate measurements of phospholipid composition). The error bars
represent the ﬁrst standard deviation of this data and include errors arising from biologi-
cal variability and instrument instability.
PG is visible on a P153 scan in addition to PA (table 7.2) and is therefore shown
in Figure 3.6. The most abundant PA species is 18:0/18:1 (m/z 701) at 17% of
the total and the most abundant PG molecular species is 16:0/18:1 (m/z 747) at
32.8% of the total. PA isolated from IMR-32 cells was also found to be composed
mainly of monounsaturated molecular species [1].
In addition to the synthetic route from glycerol-3-phosphate, PA can also be gen-
erated from PC through the action of the enzyme phospholipase-D or from DAG
by the action of diacylglycerol kinase. Conversely, DAG can also be generated from
PA by the enzyme phosphatidate phosphatase. Both PG and PI are synthesised
from PA via the precursor CDP-diacylglycerol [5]. The interconversion between
these phospholipid classes may account for some similarities in the most abundant
molecular species in each case.
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Figure 3.6: Molecular species percentage composition of PA and PG for asynchronous
whole cells (average of 6 triplicate measurements of phospholipid composition). The
error bars represent the ﬁrst standard deviation of this data and include errors arising
from biological variability and instrument instability.
It is clear that similarities exist between the molecular species composition of the
HeLa, IMR-32 and HL-60 cell lines. Several diﬀerences were however noted and
these are probably indicative of the diﬀerent functions of each cell type. There also
appears to be some consistency between the most abundant molecular species in
each headgroup class. As discussed above this is possibly due to the interconversion
of diﬀerent phospholipid classes as shown in Figure A.9.
3.2.2 Quantiﬁed data
The absolute amount per cell of each phospholipid was determined by the inclusion
of internal standards as described in section 7.4.4. The results of this analysis are
shown in Figure 3.7. This data provides a control for the comparison of quantiﬁed
data from synchronised whole cells and nuclei.
Addition of the amounts of each phospholipid class (Figure 3.7) gives a total phos-
pholipid content per cell of 1.17 × 10−4 ± 7.72 × 10−5 nmoles. Newly synthesised
PC is shown as this is included in the total however further discussion regarding
this species can be found in Chapter 5.
The values presented in Figure 3.7 are an average of measurements taken on four
separate days. On each of these days the phospholipid from three diﬀerent ﬂasks
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of cells was analysed giving 12 samples in total. The error bars in Figure 3.7 rep-
resent the ﬁrst standard deviation of this data. As described in section 3.2.1 this
standard deviation includes instrument instability (see also section 2.3.5) and bio-
logical variability. As this is quantiﬁed data, the standard deviation also includes
errors arising from cell counting and internal standard addition.
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Figure 3.7: Absolute amount per cell of each phospholipid class determined from an
average of 12 samples. Newly synthesised PC (d9) is also displayed as this is included in
the total. The error includes biological variability, instrument instability and errors arising
from cell counting and internal standard addition.
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Figure 3.8: Each phospholipid class as a percentage of total phospholipid content per
cell. The error includes biological variability, instrument instability and errors arising from
cell counting and internal standard addition.
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PC and PE are the most abundant classes of phospholipid in the cell forming 44%
and 29% of the total respectively (Figure 3.8) with the other species accounting
for the remaining 27%. PI and PS are the most abundant of the remaining species
totaling 22%, with DAG and PA accounting for less than 2% of the total.
The exact proportions of each phospholipid class vary depending on the cell type
however the high proportion of PC and PE is typical of a eukaryotic cell [6, 7].
The Human erythrocyte membrane for example contains choline phospholipids
(including PC, lyso-PC and sphingomyelin) at 55.8%, PE at 27.6% and acidic
phospholipids (PS, PI and PA) at 16.6% of the total [8, 9].
3.3 The phospholipid composition of synchronised whole
cells
Membrane phospholipid synthesis is required for cell division and is thought to
be coordinated with the cell cycle as described in section 1.3.1. It has also been
suggested that phospholipids might in turn be an important element in the reg-
ulation of the cell cycle [10]. Indeed, it has been found that a PC deﬁciency can
arrest C3H/10T1/2 ﬁbroblasts before the S phase [11].
Within a normal cell culture the cells are distributed between the phases of the
cell cycle. To study a particular phase, it is therefore necessary to synchronise the
population so that the majority of cells are within the same phase of the cycle.
Several methods exist to synchronise cell populations and are introduced in sec-
tion 1.3.2. In this study a cell cycle blocking agent, L-mimosine, is used. This is a
plant amino acid derived from Mimosa and blocks cell cycle progression near the
G1/S boundary. It is thought to prevent replicative chain elongation by inhibiting
the enzyme ribonucleotide reductase, thereby arresting cell cycle progression [12].
The exact point at which mimosine arrests the cell cycle, either before or after the
onset of the S phase, is still a topic of debate [13, 14, 15]. A large proportion of
the cell population reach the arrest point and on release from the block progress
through the cell cycle with a greater synchronicity than prior to the block.
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3.3.1 Cell cycle determination by FACS
As introduced in section 1.4, ﬂow cytometry enables the DNA content of a cell to
be determined by measuring the ﬂuorescence of a dye that has been allowed to
bind to the DNA. Cells containing more DNA will take up more of the dye and
therefore ﬂuoresce brighter than those with less DNA.
For a cell to undergo mitosis its DNA content must be double that of cells in the
G1 phase of the cell cycle. DNA synthesis occurs during the S phase leading to
a doubling of DNA content in the G2 and M phases. Cells in the S phase of the
cell cycle therefore contain a variable amount of DNA depending on their stage
of DNA synthesis. Flow cytometry can be used to assess the cell cycle phase by
determining the DNA content of a cell although it is not possible to distinguish
between the G2 and M phase and between the G1 and G0 phase as these contain
the same amount of DNA [16].
The cell cycle of the HeLa-GFP cells was analysed by ﬂow cytometry following
staining with propidium iodide [17]. Figure 3.9 shows a typical result for an asyn-
chronous population of HeLa cells. The x-axis indicates the DNA content (ﬂuo-
rescence intensity) and the y-axis the number of cells.
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Figure 3.9: A typical FACS plot for asynchronous HeLa cells. The phases of the cell cycle
represented by each peak are labelled
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Flow cytometry was used to assess the DNA content of HeLa cells following treat-
ment with mimosine (synchronised cells). The cells were synchronised and prepared
for analysis by ﬂow cytometry following the protocol described in sections 7.2 and
7.8. The proportion of the cell population within each phase following release from
the cell cycle block was estimated using BD FACS Diva software (Figure A.10).
Figure 3.10 shows the percentage of the cell population in each phase following
release of the cell cycle block. At 12 hours post removal of the mimosine block 4
samples were measured and at 15 hours 6 samples were measured. At all other
time points, 3 samples were measured. The values presented are the average of
these samples and the error bars represent the ﬁrst order standard deviation of
this data. With the exception of 12 hours and 15 hours, the three samples per
data point were prepared from the same ﬂask of cells. The standard deviation on
these data points therefore represents the error in the measurement and subse-
quent analysis. As described in section 7.8 the percentage of cells in each phase of
the cell cycle is determined by estimating the area of each peak (see Figure 3.9).
The standard deviation of this data will therefore include error from this analysis
process. The results for 12 hours and 15 hours include samples from two diﬀerent
ﬂasks of cells. The standard deviation for these data points therefore also includes
any biological variation between ﬂasks. The standard deviation of the 12 hour data
point is the largest. This is most likely due to variation in DNA content of cells in
a population undergoing cell division.
The data presented in Figure 3.10 is summarised in Table 3.1. On release of the
cell cycle block (0 hours) the majority of the cell population is in the G1 phase
and this is also true 3 hours post removal of the block. This indicates that the
cell cycle is arrested prior to the onset of DNA replication. After 21 hours the
phase distribution of the cell population resembles that at 0 hours and 3 hours,
indicating that the cell cycle length is approximately 21hrs. This value is similar
to previously reported estimates of HeLa cell cycle length which range from 18
hours to 23 hours [18, 19, 20]. The proportion of cells in the G1 phase at 21 hours
is however more than 10% less than at 0 hours and 4% less than at 3 hours post
block removal which may be indicative of cell cycle synchronicity being lost.
At 0 hours, 3 hours, 15 hours, 18 hours and 21 hours post removal of the mi-
mosine block, the majority of the cell population is in the G1 phase. At 6 hours
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the S phase becomes predominant although it is possible that this change occurs
between the 3 hour and 6 hour time points. The S phase remains the predominant
phase until 12 hours post block removal. Assuming that the majority of the cell
population enter the S phase at approximately 4 hours following release of the
mimosine block then the G1 phase is approximately 10 hours and the S phase
approximately 8 hours. The highest proportion of cells in the G2/M phases occurs
between 12 hours and 15 hours post block removal, indicating that these phases
last approximately 3 hours. The comparatively short length of the G2/M phases
and the lack of 100% synchronicity (see discussion below) may account for them
not appearing as the predominant phases at any of the measured time points.
These cell cycle phase lengths are similar to those reported for HeLa cells follow-
ing a thymidine-nocodazole block (arrest at mitosis) [18].
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Figure 3.10: The proportion of the cell population in each phase following release from
the mimosine block. The standard deviation on these data points represents the error in
the measurement and subsequent analysis.
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Percentage of cell popula-
tion in each phase / %
Time following re-
lease of mimosine
block (hours)
Predominant phase
of cell cycle
G1 S G2/M
0 G1 83 13 4
3 G1 74 16 10
6 S 9 80 11
9 S 20 62 17
12 S and G2/M 20 51 29
15 G1 41 37 22
18 G1 50 38 12
21 G1 70 17 13
Table 3.1: The cell cycle phase occupied by the largest proportion of the cell population
following release from the mimosine block
The proportion of cells in each phase of an asynchronous and a blocked population
is shown in Figure 3.11. On release from the cell cycle block approximately 80% of
the cell population is in the G1 phase. This indicates that blocking the cells with
mimosine results in an enrichment of over 20% in the proportion of cells in the G1
phase relative to the distribution of the asynchronous population. The consecutive
use of mimosine over two cell cycles (double block), as shown in Figure 3.11, did
not appear to increase the degree of synchronicity instead resulting in only a 10%
enrichment in the proportion of cells in the G1 phase.
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Figure 3.11: The proportion of the cell population in each phase of an asynchronous
population and immediately following release from the cell cycle block. The double block
represents the proportion of cells in each phase following the consecutive use of mimo-
sine over two cell cycles.
3.3.2 Molecular species percentage composition
The data acquired from ESI-MS analysis of synchronous HeLa cell populations is
summarised in this section. The fatty acid molecular species are expressed as a
percentage of the total for each head group class. The molecular species compo-
sition of each head group is measured at time intervals following release from the
cell cycle block, allowing the phospholipid composition to be monitored through-
out the cell cycle. Throughout this section, hour has been abbreviated to ‘hr’. As
described in section 2.3.5 variation can occur between measurements obtained on
separate occasions therefore a second independent measurement of each species is
presented in the Appendix (Section B, Figures B.1 to B.7). These two independent
measurements are referred to as set 1 and set 2 so that it is possible to distinguish
between them in subsequent analysis.
The molecular species composition of PC at three hourly intervals following release
from the cell cycle block is shown in Figures 3.12 (data set 2) and B.1 (data set 1).
As found for asynchronous whole cells, species 16:0/18:1 (m/z 760) and 18:1/18:1
(m/z 786) are the most abundant. The data presented for each time point is an
average of the results from three phospholipid samples. The error bars on this data
represent the ﬁrst standard deviation of the three measurements. Each sample was
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obtained from separate ﬂasks of cells, therefore, the reported standard deviation
includes biological variability in addition to systematic errors.
The data for asynchronous cells was used as a control to allow direct compari-
son of the two data-sets and a detailed analysis of the compositional variation.
As the asynchronous data represents an average of the phospholipid composition
over the cell cycle it is possible to assess which species have changed relative to
this. Figure 3.13 shows the result of subtracting the asynchronous PC data from
the synchronised. The error bars represent the combined standard deviation of
the synchronised and asynchronous results. This combined standard deviation is
determined by calculating the square root of the sum of the squared standard devi-
ations for each equivalent data point. This combined standard deviation therefore
includes the error of instrument instability from the asynchronous data (see sec-
tion 3.2.1) and the biological variability and systematic errors from both data sets.
Species which show a signiﬁcant change relative to the asynchronous control are
deﬁned as those which show a diﬀerence which is greater that the combined stan-
dard deviation. This method provides a good indication of likely changes. The use
of more thorough statistical measures of this signiﬁcance (such as a t-test) was
investigated however a much larger number of measurements would be required
for an accurate assessment.
Several of the PC molecular species show a signiﬁcant (change greater than the
combined standard deviation) increase or decrease relative to the control. It ap-
pears that this change, relative to the control, may depend on the degree of satura-
tion of the species. Figures 3.14 to 3.17 therefore show this data with the molecular
species grouped according to their level of saturation.
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Figure 3.12: Molecular species percentage composition of PC for synchronised whole
cells (data set 2). This data is an average of three separate samples. The error bars
represent the ﬁrst standard deviation of these measurements and include systematic
errors and biological variability.
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Figure 3.13: Difference between the synchronised and non-synchronised PC molecular
species percentage composition (The asynchronous data subtracted from set 1 of the
synchronised data). The error bars represent the combined standard deviation of the
synchronised and asynchronous data. This standard deviation includes systematic er-
rors and biological variability from both data sets. It aslo includes instrument instability
from the asynchronous data set. 573.3 The phospholipid composition of synchronised whole cells
The saturated species (Figure 3.14) generally show no change or a small increase
relative to the asynchronous data. The increase is most obvious in set 1 for species
16:0/18:0a (m/z 748), however, only two of the time points show an increase in
set 2. Interestingly, the time points which show some increase in set 2 (3hrs and
15hrs) are not the ones which show the greatest increase in set 1 (6, 9 and 18hrs).
Some signiﬁcant changes are also seen for species 16:0/16:0 (m/z 734) at the 3hr,
9hr and 18hr time points in set 1. The 9hr time point in set 2 also shows an
increase, however, this is not the case for the other time points. At the 9hr time
point, the majority of the cell population is in the S phase (Table 3.1) during
which the cell normally doubles its phospholipid mass ready for division [21].
Set one shows a wave-like pattern over the time points for every species. A rise in
the value until 9hrs accompanies the S phase of the cell cycle. A sudden decrease
in the value occurs at 12hrs followed by a second gradual increase until 18hrs.
These time points coincide with the G2/M phase where cell division occurs fol-
lowed by the G1 phase during which cell growth resumes (section 1.3 and 3.3). A
small decrease in the value is seen for the 21hr time point where the cells have
completed the cell cycle. Figure 3.10 shows that a signiﬁcant proportion of the
cell population is still in the S phase at 18hrs which is not the case at 21hrs. This
occurs as a result of the cell population not being 100% synchronised and may lead
to the diﬀerence between the two time points. The obvious discrepancies between
the two data-sets make it impossible to determine with any certainty whether the
observed variations over the time points are linked to cell cycle position.
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Figure 3.14: Difference between synchronised and non-synchronised percentage com-
position for saturated PC species. Set 1 is shown at the top followed by set 2. The error
bars represent the combined standard deviation of the synchronised and asynchronous
data.
The monounsaturated species (Figure 3.15) also show a similar trend to the sat-
urated species with most molecular species remaining unchanged or increasing
relative to the asynchronous control. Species 16:0/18:1 (m/z 760) and 18:0/18:1
(m/z 788) show the most signiﬁcant increases relative to the asynchronous control.
For species 18:0/18:1 the 3hr and 12hr time points show a consistent increase over
both data sets. The 9hr time point shows a signiﬁcant increase in set 2 but not in
set one. For species 16:0/18:1 there appears to be an increase particularly of the
later time points (12hrs onwards) in both data sets.
As for the saturated data, the cell cycle phase of the population may aﬀect the
magnitude of variation relative to the non synchronised control but the diﬀerences
between the data sets preclude an accurate assessment. Contrary to the general
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trend there is one species, 16:0a/18:1 (m/z 746), which shows a small decrease
relative to the asynchronous data. This indicates that the saturation level of the
species may not be the only factor which determines whether the species is in-
creased or decreased relative to the control.
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Figure 3.15: Difference between synchronised and non-synchronised percentage com-
position for monounsaturated PC molecular species. Set 1 is shown at the top followed
by set 2
The di-monounsaturated species (Figure 3.16) all show a reduction when compared
to the asynchronous data except species 18:1a/18:1 (m/z 772) which remains un-
changed apart from a decrease in the 6hr time point of set 1. Species 18:1/18:1
(m/z 786) shows the largest decrease in both data sets. The 15hr, 18hr and 21hr
time points of data set 2 however, remain unchanged within error.
The highly unsaturated species (Figure 3.17) generally remain very similar to the
non-synchronised control. There is a small decrease at 3hrs and 18hrs of species
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16:0/18:2 (m/z 758) and at 3hrs of species 18:1/18:2 (m/z 784) in set 1 but this is
not observed in set 2.
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Figure 3.16: Difference between synchronised and non-synchronised percentage com-
position for di-monounsaturated PC molecular species. Set 1 is shown at the top followed
by set 2
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Figure 3.17: Difference between synchronised and non-synchronised percentage com-
position for highly unsaturated PC molecular species. Set 1 is shown at the top followed
by set 2
The changes in molecular species composition for PC, relative to the asynchronous
control, appear to be related mainly to the saturation level of the species. Discrep-
ancies between the two data sets make it very diﬃcult to determine any trends
over the cell cycle although cell cycle position may inﬂuence the magnitude of this
change. The discrepancies between the two data sets however, may also indicate
that the cell cycle phase is not linked to any observed changes and that an alter-
native explanation such as measurement error may account for variation over the
time points. Whatever the role of cell cycle position, these results indicate that
the synchronisation procedure itself leads to a change in PC molecular species
composition. The resulting change in saturation level may therefore be an artefact
of mimosine addition.
Certain species, such as 18:1/18:1 (m/z 786) (Figure 3.16), appear to show a
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greater change relative to the non synchronised control than other species of the
same saturation level. It is possible that these species are preferentially altered
during the remodelling of the molecular species composition which occurs at some
point during or after synchronisation. The molecular species which show the largest
changes, at one or more time points in both data sets, are 16:0/18:1 (m/z 760),
18:0/18:1 (m/z 788), and 18:1/18:1 (m/z 786). These molecular species are also
the most abundant in the cell (Figure 3.12).
Figures 3.18 and B.2 show the molecular species composition of the PE headgroup.
The composition is very similar to that of the asynchronous whole cells (Figure
3.2) with species 18:1/18:1 (m/z 744), 18:0/18:1 (m/z 746) and 16:0/18:1 (m/z
718) the most abundant. In both data sets however, species 18:1/20:4 (m/z 766)
is less than species 18:0/20:4 (m/z 768) although they are almost identical in the
non synchronised data. Species 16:0/20:4 (m/z 740) and 20:4/22:5 (m/z 814) are
also not visible on the synchronised data.
Figure 3.19 shows the result of subtracting the non synchronised data from the
synchronised data. Unlike the PC molecular species, PE species remain the same,
within error, as the non synchronised control. It is important to note however
that the error is very large and may mask changes and patterns. Species 18:0/18:1
(m/z 746), for instance, shows a small increase relative to the control in set 1
however this is not mirrored in set 2 (Figure B.8). It should also be noted that PE
is composed of several highly unsaturated molecular species and it was found that
highly unsaturated PC species remain very similar to the asynchronous control.
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Figure 3.18: Molecular species percentage composition of PE for synchronised whole
cells (data set 2)
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Figure 3.19: Difference between synchronised and non-synchronised percentage com-
position of PE molecular species (data set 1)
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Figures 3.20 (data set 2) and B.3 (data set 1) show the molecular species com-
position of DAG in whole cells at three hourly intervals following removal of the
mimosine block. Like the asynchronous whole cells (Figure 3.3) species 16:0/18:1
(m/z 612) is the most abundant, however, there are also some noticable diﬀer-
ences. Species 16:0a/16:0 (m/z 572), 16:0a/18:1 (m/z 598) and 16:0a/18:0 (m/z
600), which each comprise approximately 10% in the synchronised data, are below
the selection threshold (section 2.3.3) in the asynchronous data. Conversely species
16:0/16:1 (m/z 584) and 18:0/20:2 (m/z 666) are present in the asynchronous data
but not in the synchronised.
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Figure 3.20: Molecular species percentage composition of DAG for synchronised whole
cells (data set 2)
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Figure 3.21: Difference between synchronised and non-synchronised percentage com-
position of DAG molecular species. Set 1 is shown at the top followed by set 2
When compared to the asynchronous control, DAG species show a general increase
in saturated molecular species and a decrease in unsaturated species in both data
sets. This is similar to the ﬁndings for PC although there is also a decrease in the
monounsaturated species 16:0/18:1 (m/z 612) and 18:0/18:1 (m/z 640) which is
diﬀerent to the trend for PC. As described above, all species with an alkyl link
(see section 1.2) are increased relative to the control, including one species which is
monounsaturated (16:0a/18:1). The saturated species 16:0/16:0 (m/z 586) shows a
small decrease in set 1 between time points 6hrs and 15hrs. Species 16:0/18:0 (m/z
614) also shows a small decrease relative to the asynchronous control at the 6hr,
12hr and 18hr time points of set 2. This decrease in saturated species which do
not have an alkyl link may indicate that this characteristic has a greater inﬂuence
than saturation level on the change relative to the asynchronous control for DAG
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molecular species. It is possible that DAG species containing an alkyl link may be
involved in signalling through the regulation of Protein Kinase C (PKC) [22, 23].
In set 1 the 3hr time points of species 16:0a/16:0 (m/z 572) and 16:0a/18:0 (m/z
600) are increased, relative to the asynchronous control, by approximately twice
that of the other time points. This pattern is mirrored by species 16:0/18:1 (m/z
612) and 18:0/18:1 (m/z 640) which show a larger decrease at 3hrs. A similar trend
occurs in set 2 where the 3hr and 9hr time points show a greater change relative
to the asynchronous data. This indicates that the increase in species 16:0a/16:0
and 16:0a/18:0 may be achieved from the remodelling of species 16:0/18:1 and
18:0/18:1. It is not however clear from this data where the fatty acid 16:0a is ob-
tained from. Species 18:1/18:1 (m/z 638) also shows this greater decrease at 3hrs
in set 1 and at 3hrs and 9hrs in set 2. The increase in species 16:0a/18:1 (m/z 598)
does not however follow this pattern.
Figures 3.22 (data set 2) and B.4 (data set 1) show the molecular species composi-
tion of PI in whole cells at three hourly intervals following removal of the mimosine
block. As for asynchronous cells, species 18:0/18:1 (m/z 863) is the most abundant
and species 18:1/20:4 (m/z 883), 18:1/20:2 (m/z 887) and 18:0/20:1 (m/z 891) are
the least abundant at most time points. Species 16:1/18:1 (m/z 833) is visible in
the asynchronous data but is below the selection threshold in the synchronised
data.
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Figure 3.22: Molecular species percentage composition of PI for synchronised whole
cells (data set 2)
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PI species broadly remain very similar to the asynchronous control although the
large error makes a detailed assessment of trends diﬃcult. The three hour time
point for species 16:0/18:0 (m/z 837), however, shows a signiﬁcant increase relative
to the control in both data sets (Figures 3.23 and 3.24). There is also a consistent
decrease over both data sets in the 3hr time point of species 18:1/18:1 (m/z 861).
In set 1 a change relative to the asynchronous control occurs for species 16:0/18:0
(m/z 837), 18:1/18:1 (m/z 861) and and 18:0/20:4 (m/z 885) at 12hrs, 12hrs and
9hrs respectively. The same species in set 2 also show a change but at time points
9hrs, 9hrs and 6hrs respectively.
The shift in time points at which changes occur may arise due to variations in
the cell cycle position of the cell population. As discussed in section 3.3.1, cell
populations are not 100% synchronised following treatment with mimosine. It is
possible that variations in the level of synchronisation could occur between dif-
ferent cell populations. Even if the cell populations are in the same phase, there
could also be variations in what stage of that phase the majority cells have reached.
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Figure 3.23: Difference between synchronised and non-synchronised percentage com-
position of PI molecular species (data set 1)
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Figure 3.24: Difference between synchronised and non-synchronised percentage com-
position of PI molecular species (data set 2)
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The PS molecular species composition of synchronised whole cells is shown in
Figures 3.25 and B.5. The composition is very similar to that of asynchronous
whole cells (Figure 3.5) with species 18:0/18:1 (m/z 788), 18:1/18:1 (m/z 786) and
16:0/18:1 (m/z 760) the most abundant. Species 18:0/18:0 (m/z 790), 18:0/20:1a
(m/z 802) and 18:0/20:4 (m/z 810) are visible in both data sets of the synchronised
whole cell results but below the selection threshold of the asynchronous data.
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Figure 3.25: Molecular species percentage composition of PS for synchronised whole
cells (data set 2)
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Figures 3.26 and 3.27 show the percentage composition of PS relative to the asyn-
chronous control for set 1 and 2 respectively. There does not appear to be a
consistent trend between these two data sets. Set 1 shows a decrease in species
18:1/20:1 (m/z 814) whereas set 2 shows no change. Similarly set 2 shows an in-
crease across all time points in species 18:0/18:0 (m/z 790) and a decrease in all
but the 18hr time point of species 18:0/18:1 (m/z 788) which is not apparent in set
1. All except the 15hr and 21hr time points of species 18:0/20:4 (m/z 810) show
an increase relative to the non synchronised control, as do the 6hr and 12hr time
points of species 18:0/20:3 (m/z 812) in set 2. Only the 9hr time point of species
18:0/20:3 shows a small increase in set 1. Species 18:0/20:1a (m/z 802) shows an
increase relative to the non synchronised at most time points in both data sets,
with the exception of 3hrs and 9hrs in set 1 and 3hrs and 15hrs in set 2.
The large error on the data should be taken into account as this may lead to
some of the discrepancies between the two data sets. As described above, species
18:0/18:0 (m/z 790), 18:0/20:1a (m/z 802) and 18:0/20:4 (m/z 810) are visible on
both sets of the synchronised data but not in the asynchronous data. Despite this,
only data set 2 (Figure 3.27) shows a signiﬁcant increase in all these species due
to the error.
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Figure 3.26: Difference between synchronised and non-synchronised percentage com-
position of PS molecular species. (data set 1)
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Figure 3.27: Difference between synchronised and non-synchronised percentage com-
position of PS molecular species (data set 2)
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In addition to PA species, PG is also visible on the P153 scan and is therefore
shown in Figures 3.28 and B.6. Unlike the asynchronous whole cells (Figure 3.6)
the most abundant species in both sets of the synchronised data is PA16:0/18:1
(m/z 673) rather than PG 16:0/18:1 (m/z 747). Species 18:1/18:1 (m/z 773) which
is present at almost 20% in the asynchronous data is below the selection threshold
in both sets of the synchronised data.
The diﬀerence between synchronised and asynchronous PA molecular species is
shown in Figure 3.29. As described above, the PG species (PG16:0/18:1) is de-
creased relative to the non-synchronised data in both data sets. This is in contrast
to the PA16:0/18:1 (m/z 673) species which shows a slight increase. The saturated
species PA16:0/18:0 (m/z 675) is also increased relative to the non-synchronised
control in both data sets.
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Figure 3.28: Molecular species percentage composition of PA for synchronised whole
cells (data set 2)
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Figure 3.29: Difference between synchronised and non-synchronised PA molecular
species percentage composition. Set 1 is shown at the top followed by set 2
The results presented in this section indicate that the phospholipid composition of
synchronised HeLa cells diﬀers to that of asynchronous populations, usually in a
saturation level dependent fashion. It was not possible to determine many changes
that were consistently linked to particular time points over both data-sets. These
two observations strongly suggest that these diﬀerences between the synchronised
and non-synchronised populations are mainly artefacts of the synchronisation with
mimosine rather than simply the eﬀect of cell cycle phase. This does not, however,
preclude the possibility of changes that are related to the cell cycle phase of the
population as these may have been masked by the error of the technique or indeed
the eﬀect of cell cycle synchronisation. Some evidence, however, was presented
which suggests a possible link between the cell cycle position and the magnitude
of the change relative to the asynchronous control.
Mimosine and other chemicals that lead to cell cycle inhibition, such as hydrox-
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yurea, have been shown to cause DNA damage and in the HL-60 cell line mimosine
is known to cause apoptosis [24, 25, 26, 27]. It is possible that the use of mimosine
causes cellular changes that may correlate with the apoptotic process. Iron deple-
tion by chelation with mimosine has been shown to activate the hypoxia response
pathway and hypoxia can lead to apoptosis [24, 28]. A study of the neuronal cell
line HN2-5 found an increase in saturated fatty acid containing phospholipids as-
sociated with apoptosis. This increase in saturated species was attributed to the
changes in membrane morphology such as shrinkage and ﬂuidity that occur dur-
ing apoptosis [29, 30]. The changes observed in certain species could therefore be
linked to alterations in the membrane structure as a result of treatment with mi-
mosine.
Synchronisation methods are widely used to study the cell cycle and are presumed
to represent the events occuring during an unperturbed cycle. Although these cells
may have certain properties in common, it has been proposed that that they are
not truely synchronised. The inhibition of DNA synthesis for example may not
inhibit protein synthesis or mass increase. Cell cycle studies using whole-culture
methods of synchronisation, such as cell cycle arrest with mimosine, may therefore
not completely reﬂect the normal cell cycle [31, 32, 33, 34]. If the phospholipid is
not truely synchronised with the DNA synthesis following treatment with mimo-
sine, this may account for the discrepancies between data sets.
3.3.3 Quantiﬁed data
Inclusion of internal standards during phospholipid extraction also allowed the ab-
solute amount per cell of each phospholipid class to be determined by ESI-MS. The
data sets 1 and 2 referred to in this section correspond to those in section 3.3.2.
Figures 3.30 to 3.35 show the total amount per cell of each phospholipid class over
the cell cycle and also the value for non-synchronised cells. As described in section
3.3.2, the data presented for each time point is an average of the results from three
phospholipid samples. The error bars on this data represent the ﬁrst standard de-
viation of the three measurements. Each sample was obtained from separate ﬂasks
of cells, therefore, the reported standard deviation includes biological variability
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in addition to systematic errors. This is quantiﬁed data and therefore includes any
error resulting from cell counting and internal standard addition. For a discussion
of the errors on the non-synchronised data see section 3.2.2.
There is a signiﬁcant diﬀerence between the two PC data-sets (Figure 3.30) with
the set 2 values up to nine times greater than those of set 1. The set 1 3hr value is
however larger than the other time points and thus very similar to the set 2 value.
The set 1 values remain quite stable over the cell cycle, with the exception of the
3hr time point, and are also very similar to the result for non-synchronised cells.
Set 2 however follows a wave-like pattern across the time points and is consistently
higher than the non-synchronised result.
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Figure 3.30: Absolute amount per cell of PC for synchronised whole cells. The error
bars represent the ﬁrst standard deviation of this data and includes error arising from
biological variability and systematic errors.
Over the 6hr-15hr time points the amount per cell of PE in each data sets remains
very similar. The value of data set 1 is almost twice that of data set 2 in each
case. At the 3hr, 18hr and 21hr time points, however, the values are, within error,
the same for each data set. Although the non-synchronised value is larger than
either data set, the standard deviation is very large and therefore encompasses the
values of both data sets at all time points.
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Figure 3.31: Absolute amount per cell of PE for synchronised whole cells. The error
bars represent the ﬁrst standard deviation of this data and includes error arising from
biological variability and systematic errors.
The set 1 data for DAG (Figure 3.32) shows a similar trend to that of set 1 PC
with a high 3hr time point and smaller consistent values from 6hrs to 21hrs. There
is a wave-like pattern in the 6-21hr time points but this is less pronounced than
that of PC data-set 2. Unlike the PC results, the DAG set 2 values are generally
less than those of set 1. At the 18hr and 21hr time point though, the values are
the same within error. In all cases the amount of DAG per cell is higher for the
synchronised populations than the non-synchronised.
Within error the values for set 1 and 2 of PI (Figure 3.33) are the same for the
3hr, 6hr, 9hr and 21hr time points. At 15hrs the set 1 value is almost three times
larger than the set 2 value however this pattern is reversed at the 18hr time point
with the set 2 value more than four times larger. At 3hrs and 21hrs both data sets
are similar to the non-synchronised result. From 6hrs to 15hrs the set 2 results are
within error similar to the non-synchronised value although the standard deviation
is large therefore precluding a more detailed assessment. At 15hrs the set 2 time
point is similar to the non-synchronised value whereas it is the set 1 result which
is most similar at the 18hr time point.
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Figure 3.32: Absolute amount per cell of DAG for synchronised whole cells. The error
bars represent the ﬁrst standard deviation of this data and includes error arising from
biological variability and systematic errors.
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Figure 3.33: Absolute amount per cell of PI for synchronised whole cells. The error bars
represent the ﬁrst standard deviation of this data and includes error arising from biologi-
cal variability and systematic errors.
The values of both PS data sets and the non synchronised result are very similar
at the 3hr, 6hr and 15hr time points (Figure 3.34). At 12hrs the set 1 value is
similar to the non-synchronised but the set 2 value is four times larger than the
non-synchronised value. At 18hrs the set 1 value is again similar to that of the
non-synchronised but the set 2 value is almost three times as large. At 9hrs the
pattern is very similar to that at 12hrs and 18hrs, however, within error the set 2
value is not signiﬁcantly diﬀerent to either the non-synchronised or set 1 value. At
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21hrs the set 2 value is very similar to the non-synchronised but the set 1 value is
less than half that of set 2.
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Figure 3.34: Absolute amount per cell of PS for synchronised whole cells. The error
bars represent the ﬁrst standard deviation of this data and includes error arising from
biological variability and systematic errors.
As for PC and DAG the PA/PG 3hr time point is the largest in set 1 and is,
within error, the same as the set 2 value. The set 2 value is more than twice that
of the set 1 value at the 6hr, 9hr and 21hr time points and more than four times
larger at the 18hr time point. At 12hrs and 15hrs the values are very similar for
both data sets. In all cases the non-synchronised result is smaller than that of the
synchronised.
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Figure 3.35: Absolute amount per cell of PA and PG for synchronised whole cells.The
error bars represent the ﬁrst standard deviation of this data and includes error arising
from biological variability and systematic errors.
The total amount of phospholipid per cell is shown in Figure 3.36. The pattern
is very similar to that of the total PC per cell, however this is unsurprising as
PC forms the greatest proportion of cellular phospholipid content. There does not
appear to be a doubling of phospholipid before mitosis as would be expected for
the formation of two daughter cells [10]. There are several possible explanations
for this observation. It was suggested in section 3.3.2 that some alterations in the
phospholipid composition of synchronised populations relative to asynchronous
populations was an artefact of treatment with mimosine. It is therefore possible
that artefacts in total lipid content may arise from mimosine treatment thereby
masking any contribution from the cell cycle position. It is also possible that the
phospholipids are not fully synchronised with DNA synthesis following the cell
cycle block. The ﬂow cytometry analysis presented in section 3.3.1 indicated that
the cell population was not 100% synchronised. A proportion of the cell population
may therefore be halving their mass whilst others are doubling leading to only a
small net increase in the total phospholipid that is not visible by this technique.
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Figure 3.36: Total amount of phospholipid per cell
The composition of each phospholipid class as a percentage of the total content
is shown in Figure 3.37. The proportion of PC in set 1 is similar to the non syn-
chronised data (Figure 3.8) except for the 3hr, 18hr and 21hr time points which
are at least 10% greater. Set 2 however shows a higher proportion of PC than the
non synchronised data over all time points, ranging from more than 20% greater
at the 3hr, 9hr and 15hr time points to more than 30% greater at the 6hr time
point.
In both data sets the percentage of PE per cell is less than the 27% of non syn-
chronised cells, comprising less than 20% of the total in set 1 and less than 10%
of the total in set 2. As described in section 3.3.2, there seems to be an increase
in saturated phospholipid molecular species and a decrease in unsaturated species
which accompanies synchronisation of the cell population with mimosine. The PE
phospholipid class has a higher proportion of unsaturated molecular species than
PC which contains mainly saturated or monounsaturated molecular species. It is
possible that the larger proportion of PC and lower proportion of PE in synchro-
nised cells relates to this apparent alteration in the saturation level.
The percentage of DAG in set 1 of the synchronised data ranges between 7% and
15.5% of the total in contrast to only 1% in non-synchronised data. The percentage
of DAG in set 2 of the synchronised data, however, is very similar to that of the
non-synchronised data. The percentage of PI in set 1 ranges from 17.6% to 26.4%
over the 6hr-15hr time points compared to only 6.8% in the non-synchronised
data. The 3hr, 18hr and 21hr PI time points however range between 5% and 9.6%,
probably corresponding to the increase in PC at those times. DAG and PI act as
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lipid second messengers which control many aspects of cellular function such as
proliferation and apoptosis [35, 36]. It is therefore possible that these species are
increased in synchronised cell populations as a response to the eﬀect of mimosine.
Unlike set 1, however, the proportion of DAG and PI in set 2 is very similar to
that of non-synchronsied whole cells.
The proportion of PA/PG in set 1 of the synchronised data is approximately twice
that of the non-synchronised. The set 2 value is however very similar to that of
the non-synchronised data. The deuterated PC will be discussed in Chapter 5.
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Figure 3.37: Each phospholipid species as a percentage of total phospholipid content
per cell. Set 1 and 2 respectively from top. (In this case DAG is labelled as DG)
893.4 Summary
The results presented in this section indicate that the amount per cell of each phos-
pholipid species is variable over diﬀerent data-sets. This might be expected due
to natural variations in cell size however the changes in the absolute amounts also
translate into a diﬀerent overall composition of phospholipid classes. It is possible
that variations could arise from incorrect internal standard addition, however, this
seems improbable as such a mistake is unlikely to aﬀect the whole set. Although
further investigation would be required for a more detailed assessment, these re-
sults indicate that the overall phospholipid content can vary. It has previously
been suggested that membrane torque tension is under homeostatic control as this
parameter is intrinsically linked to properties such as membrane ﬂuidity and per-
miability which are in turn linked to the functional properties of the membrane
[37]. It is possible that several diﬀerent membrane compositions may achieve a
similar value of membrane torque tension. The variations between data sets de-
scribed in this chapter may therefore reﬂect diﬀerent phospholipid compositions
which maintain a similar value of membrane torque tension.
3.4 Summary
This chapter described the use of ESI-MS to determine the phospholipid compo-
sition of whole HeLa cells. Section 3.2 detailed the analysis of non-synchronised
whole cells. These asynchronous cell populations were found to contain a large
proportion of PC and PE (44% and 29% respectively) which is typical of eukary-
otic cells. The total phospholipid content per cell was found to be 1.17 × 10−4 ±
7.72 × 10−5 nmoles.
The molecular species composition of each phospholipid class was also determined.
PC was found to be comprised mainly of monounsaturated molecular species, the
most abundant of which is 16:0/18:1 at 28.2% of the total. This composition is
similar to that previously reported for HL-60 and IMR-32 cells although molecu-
lar species containing polyunsaturated chains were also found in IMR-32 cells. PE
comprised a mixture of monounsaturated molecular species (63% of the total) and
polyunsaturated molecular species (37% of the total). The most abundant species
was 18:1/18:1 at 23.8% of the total. The molecular species composition of DAG
was very similar to that of PC. Interconversion of PC and DAG was discussed
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as a possible explanation for this similarity. As found for PE, PI and PS were
composed of both monounsaturated and polyunsaturated molecular species with
monounsaturated species comprising over 60% of the total in each case. As found
for PC and DAG, PA/PG was composed mainly of monounsaturated molecular
species. The biosynthetic pathways between PC, PA, PG and DAG were discussed
as this could account for some of the similarities in the composition of the phos-
pholipid classes.
Flow cytometry was used to assess the DNA content of HeLa cells at regular in-
tervals following treatment with mimosine (section 3.3.1). Mimosine was found
to arrest the cell cycle prior to the onset of DNA replication. An enrichment of
over 20% in the proportion of cells in the G1 phase relative to an asynchronous
population was found on removal of the mimosine cell cycle block. The G1 phase
was estimated to last for approximately 10 hours, the S phase for 8 hours and the
G2/M phases for 3 hours giving a total cell cycle length of 21 hours. These times
are similar to previously reported results for HeLa cells.
Section 3.3.2 detailed the molecular species composition of synchronised HeLa cell
populations at three hour intervals following removal of the cell cycle block. The
non-synchronised data was used as a control to allow direct comparison of the
two synchronised data sets and a detailed analysis of the compositional variation
between time points. Saturated and monounsaturated PC molecular species were
found to show no change or increase relative to the non-synchronised data. Di-
monounsaturated species showed the opposite trend with a signiﬁcant reduction
compared to the non-synchronised data. Highly unsaturated PC molecular species,
however, showed little change relative to the control. It was noted that certain PC
molecular species showed a greater change relative to the non-synchronised con-
trol. These species were also the most abundant molecular species in the cell. PE
molecular species, within error, remained the same as the non-synchronised con-
trol and it was suggested that this may be due to the high proportion of highly
unsaturated molecular species in this phospholipid class. DAG molecular species
containing an alkyl link were found to be increased relative to the control. There
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were some indications that the increase in certain DAG molecular species may
be achieved by the remodelling of other DAG molecular species, however further
investigation would be required to determine this with any certainty. PI molecu-
lar species remained very similar to the non-synchronised data however the large
error precluded a detailed assessment. The PS molecular species did not show any
consistent trend across both data sets although again the large error precluded
a detailed assessment. In the synchronised data, species PA16:0/18:1 became the
most dominant instead of PG16:0/18:1.
The molecular species composition of synchronised cells was found to diﬀer to
that of non-synchronised cells usually in a saturation dependant manner. It was
suggested that this arose as a consequence of the synchronisation technique. A pos-
sible link between the synchronisation procedure and cell apoptosis was proposed
to account for this change in composition. Two independent measurements were
presented for each result, however, diﬀerences between these measurements made
an accurate assessment of the eﬀect of cell cycle position very diﬃcult. There were
however some indications that the cell cycle position may alter the magnitude of
changes relative to the non-synchronised control.
The total amount of each phospholipid class per cell was determined (section 3.3.3).
A doubling of phospholipid prior to mitosis, as would be expected for the formation
of two daughter cells, was not observed. It was suggested that the phospholipids
were not synchronised with DNA synthesis following treatment with mimosine. It
was also noted that the population was not 100% synchronised and this could lead
to no net increase in phospholipid content as some cells would be dividing whilst
others are doubling their mass.
The proportion of each phospholipid class was also found to change relative to
the non-synchronised. The proportion of PC was found to be greater in the syn-
chonised data at three time points in set 1 and over all time points in set 2. The
proportion of PE was less than in the non-synchronised data at all time points
in both data sets. The proportion of DAG and PI was higher in set 2 than in
the non-synchronised data. It was suggested that DAG and PI might be involved
in signalling which controls cellular functions such as apoptosis. The amount per
cell of each phospholipid class was found to be variable over the two data sets.
923.4 Summary
It was suggested that membrane torque tension was under homeostatic control
but that diﬀerent phospholipid compositions may maintain a similar value of this
parameter.
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97Chapter 4
Endonuclear phospholipid
composition
4.1 Introduction
As introduced in section 1.2.1 phospholipids, distinct from those in the nuclear
envelope are found within the endonuclear compartment. Following nuclear isola-
tion and nuclear envelope removal (see sections 7.3 and 2.2.1), ESI-MS was used
to probe the endonuclear phospholipid content of HeLa cells. The results of this
analysis are detailed in this chapter. For simplicity the detergent n-Decyl β-D-
Maltopyranoside is referred to as maltopyranoside during this chapter.
4.2 The phospholipid composition of non-synchronised
naked nuclei
The results presented in this section are from cells which have not been treated
with a cell cycle inhibitor. They therefore represent the phospholipid composition
of a population of cells that is distributed throughout the cell cycle (an asyn-
chronous population).
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4.2.1 Molecular species percentage composition
The molecular species composition of endonuclear phospholipid is compared to
that of whole cells in Figures 4.1 to 4.6. Additionally the molecular species com-
position of nuclei extracted with Triton-X-100 is compared to that of nuclei ex-
tracted with maltopyranoside. The molecular species composition of the nuclei
extracted with Triton-X-100 is an average of measurements obtained over four dif-
ferent days. For nuclei extracted with matopyranoside, the result presented is an
average of measurements taken over three diﬀerent days. On each day the compo-
sition of phospholipid extracted from three separate ﬂasks of cells was measured.
The error bars on the data represent the ﬁrst standard deviation of all these mea-
surements (12 samples in total for Triton-X-100 and 9 for maltopyranoside). The
reported standard deviation therefore includes error resulting from both biological
variability and instrument instability. The reader is referred to section 3.2.1 for a
discussion of the errors associated with the whole cell data.
For all phospholipid classes, the molecular species composition is essentially the
same for nuclei extracted with either detergent. This observation gives further
evidence to that presented in section 2.2.1 that maltopyranoside is a suitable al-
ternative to Triton-X-100. In addition, this ﬁnding also suggests that the molecular
species composition observed is not simply an artefact of the detergent used.
Analysis of the PC fraction (Figure 4.1) shows that endonuclear PC is enriched,
with respect to whole cell PC, in species where both fatty acid chains are sat-
urated. Disaturated PC molecular species total 34.4% in nuclei extracted with
Triton-X-100 and 22% in nuclei extracted with maltopyranoside. This is in con-
trast to a total of 12.3% in whole cells. Species where both fatty acid chains are
unsaturated are found in a higher proportion in the whole cell. Diunsaturated PC
molecular species total 32.7% in the whole cell. In nuclei extracted with maltopy-
ranoside this value is 14.1% and in nuclei extracted with Triton-X-100 it is 21.6%.
Monounsaturated species, however, remain at a very similar value between the
whole cell and nucleus.
The ﬁnding that endonuclear PC is enriched in saturated molecular species agrees
with previous study of IMR-32 cells [1] and gives further evidence that this is a
generalised phenomenon across a variety of Human cell lines [2]. The precise role
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of this saturated endonuclear PC is currently unknown although several ideas have
been put forward including structural, signalling and antioxidant [2].
Unlike PC, the molecular species compositions of PE (Figure 4.2), PS (Figure 4.5)
and PA/PG (Figure 4.6) remain the same between the whole cell and endonuclear
compartments. This also agrees with the previous analysis of PA and PE compo-
sition for IMR-32 cells [1].
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Figure 4.1: Molecular species percentage composition of PC in nuclei. Endonuclear PC
is enriched in molecular species where both fatty acid chains are saturated. The error
bars represent the ﬁrst standard deviation of this data and include errors arising from
biological variability and instrument instability.
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Figure 4.2: Molecular species percentage composition of PE in nuclei. The composition
of endonuclear PE remains the same as whole cell PE. The error bars represent the ﬁrst
standard deviation of this data and include errors arising from biological variability and
instrument instability.
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Assessment of DAG and PI indicates that the diﬀerence between whole cell and
nuclear molecular species composition is not restricted to PC. The most abun-
dant molecular species of DAG in the whole cells is 16:0/18:1 (m/z 612) but this
is replaced by 16:0/18:0 (m/z 614) in the nucleus. There also appears to be an
increase relative to the whole cells in the other saturated species, 16:0/16:0 (m/z
586) and 18:0/18:0 (m/z 642), although the large standard deviation precludes an
accurate assessment. Similarly there is a greater proportion of PI16:0/18:0 (m/z
837) in the nucleus to that in the whole cell. Although the endonuclear PI is en-
riched in 16:0/18:0 when compared to the whole cell, it is important to note that
PI isolated from both fractions is mainly unsaturated with a high proportion of
species containing polyunsaturated chains.
Nuclear DAG can be generated by the hydrolysis of PC or by the hydrolysis of
PI. It has been shown that DAG derived from PI is mainly unsaturated whereas
that derived from PC is predominantly disaturated and monounsaturated [3]. It
was suggested that nuclei contain two independently regulated pools of DAG, one
that is highly polyunsaturated (derived from PI) and one that is mainly disatu-
rated and monounsaturated (derived from PC). Analysis of the PA composition
showed that this was highly polyunsaturated indicating that it was generated from
polyunsaturated DAG [4].
Our ESI-MS study indicates that the endonuclear DAG present in HeLa cells is
most likely derived from PC as it is composed mainly of disaturated and monoun-
saturated species (Figure 4.3). Endonuclear PA however is composed mainly of
polyunsaturated molecular species (Figure 4.6) although the standard deviation
of this data prevents a detailed analysis. This would indicate that PA is being
generated from a pool of polyunsaturated DAG which forms a smaller fraction of
the endonuclear DAG content.
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Figure 4.3: Molecular species percentage composition of DAG in nuclei. Endonuclear
DAG is enriched in molecular species where both fatty acid chains are saturated. The
error bars represent the ﬁrst standard deviation of this data and include errors arising
from biological variability and instrument instability.
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Figure 4.4: Molecular species percentage composition of PI in nuclei. Endonuclear PI is
enriched in molecular species where both fatty acid chains are saturated although both
whole cell and nuclear fractions contain a high proportion of unsaturated species. The
error bars represent the ﬁrst standard deviation of this data and include errors arising
from biological variability and instrument instability.
1054.2 The phospholipid composition of non-synchronised naked nuclei
-10 0 10 20 30 40 50 60
PS16:0/18:1
PS18:0a/18:1
PS18:1/18:1
PS18:0/18:1
PS18:0/20:3
PS18:1/20:1
PS18:0/20:1
PS18:0/22:6
PS18:0/22:5
PS20:0/20:4
PS18:1/22:2
PS18:0/22:2
PS18:1/22:0
7
6
0
7
7
4
7
8
6
7
8
8
8
1
2
8
1
4
8
1
6
8
3
4
8
3
6
8
3
8
8
4
0
8
4
2
8
4
4
M
o
l
e
c
u
l
a
r
 
s
p
e
c
i
e
s
 
a
n
d
 
m
/
z
Percentage composition %
Whole cells
Nuclei extracted with Maltopyranoside
Nuclei extracted with Triton-X-100
Figure 4.5: Molecular species percentage composition of PS in nuclei. The composition
of endonuclear PS remains the same as whole cell PS. The error bars represent the ﬁrst
standard deviation of this data and include errors arising from biological variability and
instrument instability.
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Figure 4.6: Molecular species percentage composition of PA and PG in nuclei. The com-
position of endonuclear PA/PG remains the same as whole cell PA/PG. The error bars
represent the ﬁrst standard deviation of this data and include errors arising from biologi-
cal variability and instrument instability.
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4.2.2 Quantiﬁed data
Inclusion of internal standards enabled the concentration of endonuclear phospho-
lipids to be determined. The total amount of endonuclear phospholipid for nuclei
extracted with maltopyranoside is 1.39 × 10−5 ± 1.3 × 10−5 nmoles which is ap-
proximately 12% of that in the whole cell. For nuclei extracted with Triton-X-100
the total amount of phospholipid per cell is 1.59×10−5±2.41×10−5 nmoles which
is approximately 14% that in the whole cell.
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Figure 4.7: Absolute amount per nucleus of each phospholipid class. The error includes
biological variability, instrument instability and errors arising from cell counting and inter-
nal standard addition.
Figure 4.7 shows the amount in nmoles of each phospholipid class per nucleus.
The values presented are an average of measurements taken over diﬀerent days
as detailed in section 4.2.1. In addition to instrument instability and biological
variability, the reported ﬁrst standard deviation also inlcudes errors arising from
cell counting and internal standard addition. The error on this measurement is
very large, probably due to the problems in counting nuclei as described in sec-
tion 2.2.2. The proportion of phospholipid classes in the nucleus is within error
the same as that in the whole cell (Figure 4.8). This suggests that although the
molecular species composition (section 4.2.1) of PC, DAG and PI is found to vary
between the whole cell and nucleus, the overall amount of each phospholipid class
is maintained. The values, within error, are comparable for nuclei extracted with
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either Triton-X-100 or maltopyranoside giving further evidence that the results
are not an artefact of the detergent.
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Figure 4.8: Each phospholipid class as a percentage of total phospholipid content per
cell or nucleus
4.3 Endonuclear phospholipid composition of synchro-
nised cells
As described in section 3.3, L-mimosine was used to synchronise cell populations.
After removal of the cell cycle block, the cells were allowed to progress through
the cell cycle to an appropriate point before isolation of the naked nuclei. The
phospholipid content of these nuclei was then assessed by ESI-MS. Throughout
this section, hour has been abbreviated to ‘hr’.
4.3.1 Molecular species percentage composition
The phospholipid molecular species composition of naked nuclei, extracted from
synchronised populations of HeLa cells, was determined by ESI-MS and is sum-
marised in this section. The molecular species are expressed as a percentage of the
total for each head group class. The molecular species composition was monitored
at time intervals throughout the cell cycle as described for whole cells in section
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3.3.2. For each class of phospholipid, the molecular species composition of nuclei
extracted both with Triton-X-100 and maltopyranoside is shown. A second inde-
pendent measurement from nuclei extracted with maltopyranoside is also shown.
Figures 4.9 to 4.11 show the molecular species composition of PC in HeLa cell
nuclei at three hourly intervals following removal of the cell cycle block. The data
presented for each time point is an average of the results from three phospholipid
samples. The error bars on this data represent the ﬁrst standard deviation of the
three measurements. Each sample was obtained from separate ﬂasks of cells, there-
fore, the reported standard deviation includes biological variability in addition to
systematic errors.
As described for non-synchronised cells (section 4.2), endonuclear PC is enriched
in saturated PC molecular species with respect to the whole cell. In the whole cells
(section 3.3.2) the most abundant PC molecular species were found to be 16:0/18:1
(m/z 760) and 18:1/18:1 (m/z 786), however, in the nuclei species 18:1/18:1 (m/z
786) is below 10% of the total in all three data sets. The most abundant species
in the nuclei are 16:0/18:1 (m/z 760) and 16:0/16:0 (m/z 734). Species 16:0/16:0
is, however, at or below 5% of the total in whole cells. The saturated molecular
species 16:0/18:0(m/z 762) is present in all three synchronised nuclei data sets but
below the selection threshold (section 2.3.3) for whole cells. Conversely, species
16:1a/18:1 (m/z 744), 16:0/20:4 (m/z 782), 18:1/18:2 (m/z 784), 18:1/20:4 (m/z
808), 18:0/20:4 (m/z 810) and 18:1/20:1 (m/z 814) are above the selection thresh-
old in the whole cells but not in the nuclei.
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Figure 4.9: Molecular species percentage composition of PC for synchronised nuclei
extracted with Triton-X-100. The error bars represent the ﬁrst standard deviation of these
measuremtns and include systematic errors and biological variability.
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Figure 4.10: Molecular species percentage composition of PC for synchronised nuclei
extracted with maltopyranoside. The error bars represent the ﬁrst standard deviation of
these measuremtns and include systematic errors and biological variability.
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Figure 4.11: Molecular species percentage composition of PC for synchronised nuclei
extracted with maltopyranoside repeat. The error bars represent the ﬁrst standard devi-
ation of these measuremtns and include systematic errors and biological variability.
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For whole cells (section 3.3.2), the non-synchronised data was used as a control
to allow detailed analysis of compositional variation. This same method was also
applied to the nuclei. The species which show a signiﬁcant change relative to the
non-synchronised control are again deﬁned as those which show a diﬀerence greater
than the combined standard deviation of the synchronised and asynchronous re-
sults.
Figures 4.12 to 4.14 show the result of subtracting the asynchronous PC data from
the synchronised. Set 1 corresponds to the nuclei extracted with Triton-X-100, set
2 to the nuclei extracted with maltopyranoside and set 3 to the second independent
measurement of nuclei extracted with maltopyranoside. The error bars represent
the combined standard deviation of the synchronised and asynchronous results.
This combined standard deviation is determined by calculating the square root of
the sum of the squared standard deviations for each equivalent data point. This
combined standard deviation therefore includes the error of instrument instability
from the asynchronous data (see section 4.2.1) and the biological variability and
systematic errors from both data sets.
The saturated PC species (Figure 4.12) show a general increase relative to the
non synchronised control with the 18hr time point of species 16:0/16:0 (m/z 734)
consistently showing the greatest increase over all three data-sets. At the 18 hour
time point a large proportion of the cell population is in the G1 phase of the cell
cycle (Table 3.1). During the G1 phase cells are thought to ‘commit’ to undergo
mitosis and it is possible that a change in nuclear phospholipid composition may
be linked to this [5].
Although whole cells (Figure 3.14) also showed a general increase in saturated
molecular species relative to the non-synchronised control, the trend was less con-
sistent between data sets. In the whole cells, species 16:0/18:0a (m/z 748) shows
an increase relative to the non-synchronised over all time points in set 1 but only
the 3hr and 15hr time points are increased in set 2. This contrasts with the nuclei
data in which there is an increase over all time points in all data sets, with the
exception of 6hrs in set 3. Species 14:0/16:0 (m/z 706) and 16:0a/16:0 (m/z 720)
show an increase at most time points in all data sets in the nuclei data. These
species only show an increase at 12hrs and 18hrs respectively in set 1 of the whole
cell data. The magnitude of changes in the whole cell data are also less than that
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of nuclei with a maximum diﬀerence of approximatly 1.5% compared to almost
25% for species 16:0/16:0 (m/z 734) in set 2 of the nuclei data.
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Figure 4.12: Difference between synchronised and non-synchronised percentage com-
position for saturated PC molecular species. Set 1 (nuclei extracted with Triton-X-100)
is shown at the top followed by set 2 (nuclei extracted with maltopyranoside) and set 3
(independent repeat of nuclei extracted with maltopyranoside). The error bars represent
the combined ﬁrst standard deviation of the synchronised and asynchronous data.
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The monounsaturated PC molecular species (Figure 4.13) generally show no change
or a decrease relative to the non-synchronised control although a slight increase of
species 18:0/18:1 (m/z 788) is seen at 12hrs in set 3. The 6hr time point of species
16:0/18:1 (m/z 760) shows the most signiﬁcant decrease in set 1 and 2 however
no change is seen at this time point in set 3. The 15hr and 18hr time points also
show a signiﬁcant decrease in sets 1 and 3 for species 16:0a/18:1 (m/z 746) and
16:0/18:1 (m/z 760) although the 15hr time point shows no change in set 2 for
either species.
This decrease in monounsaturated PC molecular species contrasts with the ﬁnd-
ings for whole cells (Figure 3.15) which show no change or an increase relative to
the non-synchronised control. The small increase of species 18:0/18:1 (m/z 788)
at 12hrs in data set 3 agrees with the whole cell results but this is not consistent
with the other two data sets.
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Figure 4.13: Difference between synchronised and non-synchronised percentage com-
position for monounsaturated PC molecular species. Set 1 (nuclei extracted with Triton-
X-100) is shown at the top followed by set 2 (nuclei extracted with maltopyranoside) and
set 3 (independent repeat of nuclei extracted with maltopyranoside)
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The di-monounsaturated species (Figure 4.14) generally show no change or a de-
crease relative to the non-synchronised control with species 18:1/18:1 (m/z 786)
showing the most signiﬁcant change. The highly unsaturated 18:1/24:5a (m/z 848)
species shows no change over most time points, however, in both set 1 and 2 the
6hr time point shows a signiﬁcant increase relative to the non-synchronised data.
At 6hrs, the majority of the cell population have entered the S phase of the cell
cycle (section 3.3.1) It is possible that this molecular species is involved in the
regulation of progression into this phase.
The di-monounsaturated and highly unsaturated PC species of the whole cells
(Figures 3.16 and 3.17) also showed similar results except for the increase at 6hrs.
As mentioned earlier, however, the highly unsaturated species such as 16:0/20:4
(m/z 782) which are present in the whole cell data are below the selection thresh-
old in the nuclei data.
As described for whole cells (section 3.3.2) certain molecular species show more
change relative to the non-synchronised control than others. The largest changes,
at one or more time points, are in species 16:0/16:0 (m/z 734) and 16:0/18:1 (m/z
760). This again correlates with the most abundant endonuclear PC molecular
species (Figures 4.9 to 4.11).
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Figure 4.14: Difference between synchronised and non-synchronised percentage com-
position for unsaturated PC molecular species. Set 1 (nuclei extracted with Triton-X-100)
is shown at the top followed by set 2 (nuclei extracted with maltopyranoside) and set 3
(independent repeat of nuclei extracted with maltopyranoside)
1204.3 Endonuclear phospholipid composition of synchronised cells
Figures 4.15 to 4.17 show the molecular species composition of PE in HeLa cell nu-
clei at three hourly intervals following removal of the cell cycle block. As described
for whole cells and nuclei from non-synchronised cells, the most abundant species
are 18:0/18:1 (m/z 746) and 18:1/18:1 (m/z 744). Species 14:0/16:0 (m/z 664),
16:0/16:0 (m/z 692), 16:0/18:0 (m/z 720), 18:0a/18:1 (m/z 732), 18:0/18:0 (m/z
748), 18:0/22:0 (m/z 804) and 20:3/22:0 (m/z 826) are shown in the synchronised
nuclei data but are below the selection threshold in the whole cell data and non-
synchronised nuclei data. It should be noted, however, that the standard deviation
on these species is very large. A more detailed comparison to the non-synchronised
data is shown below (Figures 4.18 to 4.21).
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Figure 4.15: Molecular species percentage composition of PE for synchronised nuclei
extracted with Triton-X-100
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Figure 4.16: Molecular species percentage composition of PE for synchronised nuclei
extracted with Maltopyranoside
1234.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.17: Molecular species percentage composition of PE for synchronised nuclei
extracted with Maltopyranoside repeat
1244.3 Endonuclear phospholipid composition of synchronised cells
The saturated PE species (Figure 4.18) show very little consistent change relative
to the asynchronous control. There is an increase in species 14:0/16:0 (m/z 664)
at 6hrs in set 2 however this does not occur in set 1 or 3. Species 16:0/16:0 (m/z
692) also shows an increase at the 3hr, 6hr and 9hr time points in set 1 and the
3hr and 18hr time points in set 2. There is a small increase at 12hrs, 15hrs and
18hrs in set 3 for species 18:0/18:0 (m/z 748), however, only the 12hr time point in
set 2 shows a similar increase. The 15hr and 18hr time points of species 18:0/22:0
(m/z 804) show a small increase in data set 3 but this is not seen in data set 1
or 2. These ﬁndings agree well with those for whole cells (Figure 3.19) which also
showed very little change, within error, relative to the asynchronous control.
1254.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.18: Difference between synchronised and non-synchronised percentage com-
position for saturated PE molecular species. Set 1 (nuclei extracted with Triton-X-100)
is shown at the top followed by set 2 (nuclei extracted with maltopyranoside) and set 3
(independent repeat of nuclei extracted with maltopyranoside)
1264.3 Endonuclear phospholipid composition of synchronised cells
The monounsaturated species tend to show a decrease or very little change rela-
tive to the asynchronous control. Species 16:0/18:1 (m/z 718) shows a signiﬁcant
decrease in set 1 at 6hrs, 9hrs and 15hrs. In set 2 all time points show a signiﬁcant
decrease except 15hrs which remains the same as the asynchronous control. In
set 3 it is the 12hr, 15hr and 18hr time points which show a decrease. No such
decrease in this species was found in the whole cell data (Figure 3.19).
Species 18:0/18:1 (m/z 746) shows a decrease at the 6hr time point in set 1 and
2 and a decrease in the 15hr time point in set 3. This contrasts with the small
increase seen in this species in set 1 of the whole cell data (Figure 3.19). There
are some indications of small increases relative to the asynchronous control for
species 18:0a/18:1 (m/z 732), 18:1/20:0 (m/z 774) and 18:1/22:0a (m/z 788) but
these changes are not consistent over all three data sets.
1274.3 Endonuclear phospholipid composition of synchronised cells
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Molecular species and m/z 
Figure 4.19: Difference between synchronised and non-synchronised percentage com-
position for monounsaturated PE molecular species. Set 1 (nuclei extracted with Triton-
X-100) is shown at the top followed by set 2 (nuclei extracted with maltopyranoside) and
set 3 (independent repeat of nuclei extracted with maltopyranoside)
1284.3 Endonuclear phospholipid composition of synchronised cells
The di-monounsaturated species 16:1/18:1 (m/z 716) and 18:1/22:1 (m/z 800)
show no change relative to the asynchronous control, however, species 18:1/18:1
(m/z 744) shows a signiﬁcant decrease (Figure 4.20). Although a decrease of this
species is seen in all three data-sets the pattern over the time points is not the
same in each case. In set 1 the 3hr time point shows the largest decrease whereas
this occurs at 18hrs in set 2 and 15hrs in set 3. In set 3 all time points are de-
creased relative to the asynchronous control however at 15hrs there is no change
in set 2 and at 9hrs, 12hrs and 21hrs there is no signiﬁcant change in set 1. No
signiﬁcant change in this species, relative to the non-synchronised control, is seen
in the whole cell data (Figure 3.19).
1294.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.20: Difference between synchronised and non-synchronised percentage com-
position for di-monounsaturated PE molecular species. Set 1 (nuclei extracted with
Triton-X-100) is shown at the top followed by set 2 (nuclei extracted with maltopyra-
noside) and set 3 (independent repeat of nuclei extracted with maltopyranoside)
1304.3 Endonuclear phospholipid composition of synchronised cells
Very little consistent change relative to the asynchronous data is seen for the highly
unsaturated species (Figure 4.21). Species 20:3/22:0 (m/z 826) is increased at the
3hr, 6hr, 9hr and 12hr time points in set 1 and the 6hr, 9hr, 12hr and 18hr time
points in set 2 however no change is seen in set 3. An increase is also apparent at
the 12hr-21hr time points for species 18:0/20:4 (m/z 768) but only in set 1. There
is some indication of a decrease in species 18:0/20:2 (m/z 772) in set 2 however
this is not the case for set 1 and 3. The whole cell data (Figure 3.19) also showed
very little change, relative to the non-synchronised control, for highly unsaturated
molecular species.
As described for PC (Figures 4.12 to 4.14), the molecular species which show the
greatest change relative to the asynchronous control are those which are most
abundant (16:0/18:1, 18:0/18:1 and 18:1/18:1).
1314.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.21: Difference between synchronised and non-synchronised percentage com-
position for unsaturated PE molecular species. Set 1 (nuclei extracted with Triton-X-100)
is shown at the top followed by set 2 (nuclei extracted with maltopyranoside) and set 3
(independent repeat of nuclei extracted with maltopyranoside)
1324.3 Endonuclear phospholipid composition of synchronised cells
The molecular species composition of DAG in HeLa cell nuclei at three hourly in-
tervals following removal of the cell cycle block is shown in Figures 4.22 to 4.24. In
data set 1 (Triton-X-100 extracted nuclei) and 2 (maltopyranoside extracted nu-
clei), species 16:0/18:0 (m/z 614) is the most abundant. In set 3 (maltopyranoside
extracted nuclei repeat), however, all species are approximately equal, within error,
except 16:0/18:1 (m/z 612) and 18:0/18:0 (m/z 642) which are less. This contrasts
with the ﬁndings from whole cells which indicated that species 16:0/18:1 (m/z
612) was the most abundant over the majority of time points (ﬁgure 3.20).
At most time points in the synchronised nuclei data, species 18:0/18:0 (m/z 642)
comprises more than 10% of the total, however, this species is below the selec-
tion threshold in the whole cell data. Conversely, species 18:1/18:1 (m/z 638) and
18:0/18:1 (m/z 640) are present at more than 5% in the whole cell data but below
the selection threshold in the synchronised nuclei data. This data also suggests
that, as described for nuclei from asynchronous cells (section 4.2.1), endonuclear
DAG is enriched in saturated molecular species.
1334.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.22: Molecular species percentage composition of DAG for synchronised nuclei
extracted with Triton-X-100
1344.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.23: Molecular species percentage composition of DAG for synchronised nuclei
extracted with maltopyranoside
1354.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.24: Molecular species percentage composition of DAG for synchronised nuclei
extracted with maltopyranoside repeat
1364.3 Endonuclear phospholipid composition of synchronised cells
Data sets 1 and 2 show an increase in most saturated DAG species and a decrease
in unsaturated DAG species relative to the asynchronous control (Figure 4.25),
which is a very similar trend to that of PC. Set 3, however, only shows an in-
crease in species containing an alkyl link (16:0a/16:0 and 16:0a/18:0) and either
no change or a decrease in the remaining species. This is similar to that found for
DAG species in the whole cell data (Figure 3.21). Species 16:0a/16:0 (m/z 572)
shows very little change in set 1 except for a very small increase at the 3hr time
point. In set 2 there is also very little change in this species except for the 15hr
time point which shows an increase of over 10%. In set 3 however, all time points
are signiﬁcantly increased relative to the asynchronous control. Species 16:0a/18:0
(m/z 600) again shows a similar increase in set 3 but little change except for the
3hr and 18hr time points in set 1 and the 15hr time point in set 2.
In set 1 there is an increase in species 16:0/18:0 (m/z 614) at 6hrs, 9hrs, and 12hrs
but no signiﬁcant change in the remaining time points. In set 2 there is an increase
in all time points except 15hrs and 21hrs. In set 3 however, there is a decrease at
15hrs and 21hrs and no change at the other time points. Species 18:0/18:0 (m/z
642) shows little change relative to the asynchronous control in set 3. In set 2
however there is an increase at all time points except 15hrs and 21hrs and in set 1
the 6hr, 9hr and 12hr time points are increased. For set 1 and 2, the time points
which show a change or no change are the same for species 16:0/18:0 (m/z 614)
and 18:0/18:0 (m/z 642) possibly indicating a link to the cell cycle position.
A previous study of intact nuclei from U937 promonocytic cells found an increase
in tetraunsaturated DAG species during G2/M associated with the activation of
PKC-βII [6]. No such tetraunsaturated species were detected in the endonuclear
compartment, most likely reﬂecting the requirement of membrane association for
enzyme activation.
1374.3 Endonuclear phospholipid composition of synchronised cells
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Molecular species and m/z 
Figure 4.25: Difference between synchronised and non-synchronised DAG molecular
species percentage composition. Set 1 (nuclei extracted with Triton-X-100) is shown at
the top followed by set 2 (nuclei extracted with maltopyranoside) and set 3 (independent
repeat of nuclei extracted with maltopyranoside)
1384.3 Endonuclear phospholipid composition of synchronised cells
For the whole cell data (section 3.3.2) it was suggested that the increase in certain
DAG molecular species, relative to the asynchronous control, may be achieved
by the remodeling of other DAG molecular species. It is possible that the in-
crease in set 1 of species 16:0/18:0 (m/z 614) at the 6hr, 9hr and 12hr time points
corresponds to the decrease of species 16:0/18:1 (m/z 612) at those time points.
Similarly the changes in these species in set 2 may also correlate. In both set 1
and 2 the decrease in species 18:0/18:1 (m/z 640) may be linked to the increase
in species 18:0/18:0 (m/z 642) although the magnitude of the decrease is approx-
imately half that of the increase in species 18:0/18:0 (m/z 642). In set 2 there is
an increase of approximately 10% in species 16:0a/16:0 (m/z 572) and 16:0a/18:0
(m/z 600) at 15hrs and a very small increase at 21hrs but very little change at the
other time points. At the 15hrs and 21hrs there is no change, relative to the asyn-
chronous control, in species 16:0/18:0 (m/z 614) and 18:0/18:0 (m/z 642) which
contrasts with the increase at all other time points. In set 3 there is an increase
of species 16:0a/18:0 (m/z 600) over all time points but only a decrease at 15hrs,
18hrs and 21hrs in species 16:0/18:0 (m/z 614). Similarly there is an increase of
species 16:0a/16:0 (m/z 572) over all time points, however, species 16:0/16:0 (m/z
586) is only decreased at the 15hr and 18hr time points and species 16:0/18:1 (m/z
612) at the 6hr and 9hr time points. As for whole cells, the origin of the increase
in species containing the 16:0a fatty acid is unclear from this data.
The molecular species composition of PI in nuclei following synchronisation with
mimosine is shown in Figures 4.26 to 4.28. The most abundant species are 16:0/18:0
(m/z 837) and 18:0/18:1 (m/z 863). Species 18:1/20:4 (m/z 883) is present in the
whole cell (ﬁgure 3.22) data but below the selection threshold in the nuclei data.
Conversely, species 16:0a/18:0 (m/z 823), 14:0a/22:6 (m/z 839), 18:0/18:0 (m/z
865), 16:0a/22:6 (m/z 867) and 18:1a/20:4 (m/z 869) are present in the nuclei data
but below the selection threshold in the whole cell data.
1394.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.26: Molecular species percentage composition of PI for synchronised nuclei
extracted with Triton-X-100
1404.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.27: Molecular species percentage composition of PI for synchronised nuclei
extracted with maltopyranoside
1414.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.28: Molecular species percentage composition of PI for synchronised nuclei
extracted with maltopyranoside repeat
1424.3 Endonuclear phospholipid composition of synchronised cells
As found for the whole cells (Figure 3.23), the PI molecular species generally show
little change relative to the asynchronous data. The most signiﬁcant change in the
saturated species (Figure 4.29) is seen in set 3 for species 16:0/18:0 (m/z 837) in
which all time points are increased except 18hrs which shows no change. In set
1 and 2, however, only the 3hr time point is increased and there is also a small
decrease in the 6hr time point of set 2.
Species 16:0/18:1 (m/z 835) (Figure 4.30) shows a signiﬁcant decrease over all
time points in set 3. In set 2 it is decreased at all time points except 12hrs, 15hrs
and 21hrs and in set 1 it is decreased at all time points except 3hrs and 21hrs.
Species 18:1.18:1 (m/z 861) shows a small decrease at 3hrs and 15hrs in set 1 and
a decrease at 3hrs, 6hrs, 18hrs and 21hrs in set 2. In set 3, there is a decrease for
every time point except 3hrs and 18hrs. In set 3, species 18:0/18:1 (m/z 863) is
decreased at all time points except 21hrs and in set 2 it is decreased at the 3hr,
6hr, 12hrs and 18hr time points. In set 1, however, this species shows no signiﬁ-
cant change relative to the asynchronous control. Species 18:0/20:2 (m/z 889) is
decreased at all time points except 3hrs and 21hrs in set 3 and decreased at the
3hr, 6hr and 21hr time points in set 2. In set 1 most time points show no change
and there is only a small decrease at the 3hr and 18hr time points.
Species 14:0a/22:6 (m/z 839) shows a small increase in the 12hr time point in set 1
and an increase at the 9hr, 12hr and 18hr time points of set 3 but no change in set
2. In set 1, species 16:0a/22:6 (m/z 867) is increased relative to the asynchronous
control at the 6hr, 9hr and 15hr time points and in set 2 at the 3hr, 6hr, 12hr
and 18hr time points. In both cases the most signiﬁcant change occurs at 6hrs.
This species shows no change relative to the asynchronous control in set 3. Species
18:1a/20:4 (m/z 869) again shows no change in set 3 but an increase in the 6hr
and 18hr time points of set 2 and an increase in the 6hr time point of set 1. Species
18:0/20:4 (m/z 885) is increased at the 15hr time point in set 1, at 12hrs, 18hrs
and 21hrs in set 2 and at the 15hr and 18hr time points of set 3.
1434.3 Endonuclear phospholipid composition of synchronised cells
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Molecular species and m/z 
Figure 4.29: Difference between synchronised and non-synchronised percentage com-
position for saturated PI molecular species. Set 1 (nuclei extracted with Triton-X-100)
is shown at the top followed by set 2 (nuclei extracted with maltopyranoside) and set 3
(independent repeat of nuclei extracted with maltopyranoside)
1444.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.30: Difference between synchronised and non-synchronised percentage com-
position for saturated PI molecular species. Set 1 (nuclei extracted with Triton-X-100)
is shown at the top followed by set 2 (nuclei extracted with maltopyranoside) and set 3
(independent repeat of nuclei extracted with maltopyranoside)
1454.3 Endonuclear phospholipid composition of synchronised cells
The molecular species composition of PS in nuclei extracted from a population
of synchronised cells is shown in Figures 4.31 to 4.33. As found for whole cells
(Figure 3.25), species 18:0/18:1 (m/z 788) is the most abundant. The majority of
the other species are at or below 10% of the total. Species 18:1a/18:2 (m/z 770)
and 18:0/20:0 (m/z 818) are shown in the nuclei data but are below the selection
threshold in the whole cell data (Figure 3.25). Species 18:0/20:1a (m/z 802) and
18:1/22:0 (m/z 844) are shown in the whole cell data but not in the nuclei data.
1464.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.31: Molecular species percentage composition of PS for synchronised nuclei
extracted with Triton-X-100
1474.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.32: Molecular species percentage composition of PS for synchronised nuclei
extracted with maltopyranoside
1484.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.33: Molecular species percentage composition of PS for synchronised nuclei
extracted with maltopyranoside repeat
1494.3 Endonuclear phospholipid composition of synchronised cells
Most PS molecular species (Figure 4.34) show very little diﬀerence to the non syn-
chronised data, however, there are indications of some changes. Species 18:1a/18:2
(m/z 770) is increased at the 3hr and 6hr time points in set 1, at the 6hr, 9hr
and 18hr time points in set 2 and at 12hrs in set 3. In set 1 and 2 there is an
increase at the 6hr time point for species 18:0a/18:1 (m/z 774) but no change in
set 3. There is a signiﬁcant decrease for species 18:0/18:1 (m/z 788) at the 3hr
time point in set 1, at 3hrs, 9hrs, 12hrs and 18hrs in set 2 and 12-21hrs inclusive
in set 3. A decrease of this species was also observed in set 2 of the whole cell
results (Figure 3.27). All time points of species 18:0/18:0 (m/z 790) are increased
relative to the asynchronous control in set 3. This is again similar to set 2 of the
whole cell results. In set 2, however, it is only increased at 18hrs and 21hrs and no
change is seen in set 1. The 12hr, 15hr and 18hr time points of species 18:0/20:3
(m/z 812) are increased relative to the asynchronous control in set 3. In set 2 the
6hr and 18hr time points are increased but in set 1 the only increase is at 3hrs.
1504.3 Endonuclear phospholipid composition of synchronised cells
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Molecular species and m/z 
Figure 4.34: Difference between synchronised and non-synchronised percentage com-
position. Set 1 (nuclei extracted with Triton-X-100) is shown at the top followed by set 2
(nuclei extracted with maltopyranoside) and set 3 (independent repeat of nuclei extracted
with maltopyranoside)
1514.3 Endonuclear phospholipid composition of synchronised cells
The molecular species composition of PA in nuclei extracted from a synchronised
cell population is shown in Figures 4.35 to 4.37. At most time points, species
16:0/18:1 (m/z 673) is the most abundant species in the whole cell data (Figure
3.28), however, this species is below the selection threshold in the nuclei data.
Species PG16:0/18:1 (m/z 747) which comprises more than 10% of the total in
whole cell PA is also below the selection threshold in the nuclei data.
1524.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.35: Molecular species percentage composition of PA for synchronised nuclei
extracted with Triton-X-100
1534.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.36: Molecular species percentage composition of PA for synchronised nuclei
extracted with Maltopyranoside
1544.3 Endonuclear phospholipid composition of synchronised cells
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Figure 4.37: Molecular species percentage composition of PA for synchronised nuclei
extracted with Maltopyranoside repeat
1554.3 Endonuclear phospholipid composition of synchronised cells
Figure 4.38 shows the diﬀerence between the PA molecular species composition of
nuclei from synchronised and non-synchronised cells. In set 1 there is an increase
in the 3hr and 12hr time points of species 16:0/16:0 (m/z 647) relative to the asyn-
chronous control. In set 3 there is an increase at 3hrs and 6hrs, however, there is
no signiﬁcant change in set 2. Species 16:0/18:0 (m/z 675) is increased at all time
points except 6hrs and 15hrs in set 1, at the 21hrs time point in set 2 and at the
3hr-12hr time points of set 3. This agrees with the result for whole cells which also
showed an increase of this species (Figure 3.29).
A small decrease is seen at the 3hr time point of species 18:0/18:1 (m/z 701) in
set 2 and the 6hr time point of both set 1 and 3. In set 3 there is a decrease in
the 3hr and 6hr time points of species 18:1/26:2 (m/z 809), however, there is no
signiﬁcant change in either set 1 or 2.
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Figure 4.38: Difference between synchronised and non-synchronised PA molecular
species percentage composition. Set 1 (nuclei extracted with Triton-X-100) is shown at
the top followed by set 2 (nuclei extracted with maltopyranoside) and set 3 (independent
repeat of nuclei extracted with maltopyranoside)
1574.3 Endonuclear phospholipid composition of synchronised cells
As described for whole cells, the endonuclear phospholipid composition of synchro-
nised HeLa cells diﬀers to that of non-synchronised cells in a saturation dependent
fashion. There is, however, a distinction between the compositional changes of
certain molecular species in whole cells and nuclei following synchronisation. The
saturated endonuclear PC molecular species showed a larger and more consistent
change, relative to the asynchronous control, than the whole cell saturated PC. The
endonuclear monounsaturated PC molecular species showed a decrease which con-
trasts with the increase or no change of the whole cell monounsaturated PC molec-
ular species. The decreases in certain monounsaturated and di-monounsaturated
endonuclear PE species is also not seen in the whole cell data. It was suggested
in section 3.3.2 that the use of mimosine may cause cellular changes that cor-
relate with the apoptotic process. It is possible that endonuclear lipid may be
eﬀected in a diﬀerent way to whole cell phospholipid during apoptosis, leading to
the discrepancies noted above. Previous studies have indicated that endonuclear
phospholipids may interact with DNA and be involved with DNA synthesis [7, 8].
The process of synchronisation with mimosine may interfere with this lipid-DNA
interaction and thus lead to alterations in endonuclear phospholipid composition
that are diﬀerent to the whole cell.
Three data sets were presented for each phospholipid class in this section. Although
the general trend is very similar across all three data sets for most phospholipid
molecular species, some variations were observed. The diﬀerences do not, however,
seem to be linked to the detergent as no greater variation was observed between
the results for Triton-X-100 and maltopyranoside than between the two maltopy-
ranoside data sets. It is perhaps more likely that these diﬀerences are attributable
to variations between the cell populations such as their exact position in the cell
cycle.
4.3.2 Quantiﬁed data
Internal standards were included during phospholipid extraction to allow quantiﬁ-
cation of the phospholipid species. Figures 4.40 to 4.45 show the amount of each
species per nucleus over the cell cycle. The results for non-synchronised cells are
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also included again here for easy reference (Figure 4.39). As described in section
4.3.1, the data presented for each time point is an average of the results from three
phospholipid samples. The error bars on this data represent the ﬁrst standard de-
viation of the three measurements. Each sample was obtained from separate ﬂasks
of cells, therefore, the reported standard deviation includes biological variability
in addition to systematic errors. This is quantiﬁed data and therefore also includes
any error resulting from cell counting and internal standard addition. For a dis-
cussion of the errors on the non-synchronised data see section 4.2.1.
The amount of PC per nucleus is very similar for all three data sets except at
the 12hr and 15hr time points (Figure 4.40). At 12hrs the value of data set 3
(‘maltopyranoside repeat’ data) is more than four times larger than the other two
data sets and at 15hrs it is less than half the value. The amount of PC per nucleus
decreases in all three data sets from the 3hr time point to the 9hr time point. This
coincides with the S-phase of the cell cycle (Table 3.1) during which a reduction
in nuclear phospholipid has been reported for rat liver cells [9]. The value at 12hrs
is approximately the same as at 9hrs with the exception of data set 3. At 15hrs
the amount per nucleus reaches a value slightly greater than at 3hrs, again with
the exception of data set 3. At 18hrs data set 3 appears to be almost twice the
value of set 1 and 2, however, within the reported error they are the same. The
non-synchronised value is very similar to that of the 3hr time point, however, the
standard deviation on the non-synchronised results is very large and encompasses
all the synchronised results.
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Figure 4.39: Absolute amount per nucleus of each phospholipid species for nuclei ex-
tracted from an asynchronous cell population
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Figure 4.40: Absolute amount per cell of endonuclear PC for synchronised cells. Data is
shown for nuclei extracted with Triton-X-100 (data set 1), nuclei extracted with n-Decyl
β-D-Maltopyranoside (data set 2) and a second independent measurement of nuclei
extracted with n-Decyl β-D-Maltopyranoside (data set 3). The error bars represent the
ﬁrst standard deviation of this data and include error arising from biological variability
and systematic errors.
The total amount of PE per nucleus is mainly consistent across the three data
sets and across the time points (Figure 4.41). This pattern is very similar to that
described for whole cells in section 3.3.3. At the 15hr time point, however, the set
2 value is more than twice that of either set 1 or 3. There is also some indication
that the set 3, 12hr time point may be larger than set 1 and 2 but the standard
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deviation on this result is very large. Although the non-synchronised value is gen-
erally larger than either data set, the standard deviation is very large and therefore
encompasses the values of both data sets at all time points.
The 3hr, 6hr and 15hr time points of the set 1 DAG data (Figure 4.42) are all
approximately twice the value of the 9hr, 12hr, 18hr and 21hr time points. From
6hrs to 18hrs, the set 2 values are, within error, consistent with those of data set
1. At both 3hrs and 21hrs however, the set 2 value is more than twice that of
the set 1. Data set 3 appears to be consistently larger than set 1 or 2 however its
standard deviation is very large and encompasses the set 1 and 2 values at 3hrs,
9hrs and 21hrs. This data set also shows a wave-like pattern similar to that of
the whole cell, set 1 data for DAG. The minimum amount of DAG per nucleus
from synchronised cells is 1.25×10−6 nmoles which is larger than the 4.09×10−7
nmoles in non-synchronised cells.
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Figure 4.41: Absolute amount per cell of endonuclear PE for synchronised cells. Data is
shown for nuclei extracted with Triton-X-100 (data set 1), nuclei extracted with n-Decyl
β-D-Maltopyranoside (data set 2) and a second independent measurement of nuclei
extracted with n-Decyl β-D-Maltopyranoside (data set 3). The error bars represent the
ﬁrst standard deviation of this data and include error arising from biological variability
and systematic errors.
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Figure 4.42: Absolute amount per cell of endonuclear DAG for synchronised cells. Data
is shown for nuclei extracted with Triton-X-100 (data set 1), nuclei extracted with n-Decyl
β-D-Maltopyranoside (data set 2) and a second independent measurement of nuclei
extracted with n-Decyl β-D-Maltopyranoside (data set 3). The error bars represent the
ﬁrst standard deviation of this data and include error arising from biological variability
and systematic errors.
The amount of PI per nucleus (Figure 4.43) is very similar, within error, over
most time points. When compared to the asynchronous PI data (Figure 4.39), the
values are also similar to this at most time points. Data set 1 and 2 closely resem-
ble the non-synchronised results at 12hrs, however, as also found for PC (Figure
4.40), the value of data set 3 is more than ﬁve times larger. At 3hrs, data sets 1
and 3 are approximately twice and four times as large as the asynchronous data
respectively. Data set 3 of the 18hr time point is more than twice the asynchronous
value, as is data set 2 of the 21hr time point. At 18hrs and 21hrs, data sets 2 and
3 respectively are also larger than the asynchronous data, however, the error on
these data points are large and encompass the asynchronous values.
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Figure 4.43: Absolute amount per cell of endonuclear PI for synchronised cells. Data is
shown for nuclei extracted with Triton-X-100 (data set 1), nuclei extracted with n-Decyl
β-D-Maltopyranoside (data set 2) and a second independent measurement of nuclei
extracted with n-Decyl β-D-Maltopyranoside (data set 3). The error bars represent the
ﬁrst standard deviation of this data and include error arising from biological variability
and systematic errors.
With the exception of 12hrs, the amount per nucleus of PS (Figure 4.44) is, within
error, very similar in both data sets 1 and 2. The value of data set 3 is, however,
consistently less than set 1 or 2 at all time points except 12hrs. The large standard
deviation on the asynchronous data (Figure 4.39) precludes a detailed analysis,
however, the values of data set 1 and 2 are similar to that of nuclei extracted
from an asynchronous population with maltopyranoside. The value of data set 3
is very similar to that of nuclei extracted from an asynchronous population by
Triton-X-100.
At 9hrs, 18hrs and 21hrs the amount per nucleus of PA (Figure 4.45) is very sim-
ilar between data set 3 and the non-synchronised results. Set 1 and 2, however,
are at least twice as large at these time points. The value for all three data sets
is very similar at the 6hr and 12hr time points but more than three times that of
the non-synchronised data. At 3hrs and 15hrs all data sets are, within error, the
same as the non-synchronised results although the standard deviation of data set
3 at 3hrs is very large.
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Figure 4.44: Absolute amount per cell of endonuclear PS for synchronised cells. Data is
shown for nuclei extracted with Triton-X-100 (data set 1), nuclei extracted with n-Decyl
β-D-Maltopyranoside (data set 2) and a second independent measurement of nuclei
extracted with n-Decyl β-D-Maltopyranoside (data set 3). The error bars represent the
ﬁrst standard deviation of this data and include error arising from biological variability
and systematic errors.
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Figure 4.45: Absolute amount per cell of endonuclear PA for synchronised cells. Data is
shown for nuclei extracted with Triton-X-100 (data set 1), nuclei extracted with n-Decyl
β-D-Maltopyranoside (data set 2) and a second independent measurement of nuclei
extracted with n-Decyl β-D-Maltopyranoside (data set 3). The error bars represent the
ﬁrst standard deviation of this data and include error arising from biological variability
and systematic errors.
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The total amount of phospholipid per nucleus is shown in Figure 4.46. As found
for whole cells (section 3.3.3) there does not appear to be a doubling of the phos-
pholipid content as would be expected prior to mitosis in either set 1 or set 2.
Instead, the value remains, within error, constant across the time points. There is
an increase in set 3 at 12hrs which gives a value approximately twice that of the
6hr, 15hrs and 21hrs time points. Within error, however, the 12hr time point is
not signiﬁcantly diﬀerent to set 3 of the 18hr or 3hr time points or set 2 of the
15hrs time point.
The large value of total phospholipid at 12hrs in set 3 is mainly due to the large
amount of PC at this time point. It is possible that this is an artefact due to
incorrect internal standard addition or error within the cell count however this
seems unlikely. If the PC internal standard was added incorrectly this would not
eﬀect the quantitation of other species, however, the 12hr time point of PI in set
3 is also very high. An incorrect cell count would lead to a comparably high value
at the 12hr time point in all species but this is not the case.
-2.0E-05
-1.0E-05
0.0E+00
1.0E-05
2.0E-05
3.0E-05
4.0E-05
5.0E-05
6.0E-05
7.0E-05
8.0E-05
3 6 9 12 15 18 21
Time past G1/S boundary / hours
T
o
t
a
l
 
a
m
o
u
n
t
 
o
f
 
p
h
o
s
p
h
o
l
i
p
i
d
 
p
e
r
 
n
u
c
l
e
u
s
 
/
 
n
m
o
l
e
s
Nuclei extracted with Triton-X-100
Nuclei extracted with Maltopyranoside
Nuclei extracted with Maltopyranoside
repeat
Figure 4.46: Total amount of phospholipid per nucleus
Figure 4.47 shows each phospholipid species as a percentage of the total phos-
pholipid content per nucleus. When compared to the same analysis for nuclei of
an asynchronous cell population (Figure 4.8) it is obvious that DAG comprises a
larger proportion of the total. In an asynchronous cell population, DAG was found
to comprise less than 5% of the total endonuclear phospholipid content. The pro-
portion of total endonuclear DAG was, however, more than 5% and at most time
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points greater that 10% for nuclei extracted from synchronised populations (Fig-
ure 4.47). It has been suggested that accumulation of endonuclear DAG may be
a pro-apoptotic signal [10, 11]. This observation is consistent with the idea dis-
cussed in sections 3.3.2 and 4.3.1 that some diﬀerences between the phospholipid
composition of synchronous and asynchronous cell populations may be an artefact
attributable to synchronisation with mimosine. Set 1 of the synchronised whole
cell data (Figure 3.37) shows a comparable proportion of DAG to set 1 and 2 of the
nuclei data. The percentage of DAG per whole cell in data set 2 is, however, more
similar to the results for nuclei from asynchronous populations than synchronised.
At most time points, within error, there is no signiﬁcant diﬀerence between the
endonuclear proportion of PC, d9PC and PE in nuclei of synchronised cell pop-
ulations (Figure 4.47) with respect to those of asynchronous populations (Figure
4.8). The 9hr and 15hr time points of data set 2 PC are however approximately
half the value of maltopyranoside extracted nuclei from asynchronous cells and
less than half that of Triton-X-100 extracted nuclei from asynchronous cells. The
proportion of PC in set 2 of synchronised whole cell data (Figure 3.37) is at least
20% higher than endonuclear PC and in set 1 at least 10% larger than most time
points of the nuclei data.
The proportion of PI is at most time points, within error, not signiﬁcantly diﬀer-
ent to the data for nuclei of asynchronous populations. The 12hr, 15hr and 21hr
time points of set 3 are, however, more than twice the value of the asynchronous
data. The proportion of PS in data set 1 and 2 is also, within error, similar to the
asynchronous data, however, in set 3 all time points are less than half the value of
either asynchronous data set. With the exception of the 9hr, 12hr and 15hr time
points in set 1 and the 9hr and 18hr time points in set 2, the proportion of PA
in nuclei of synchronised cells is not signiﬁcantly diﬀerent to that of nuclei from
asynchronous populations.
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Figure 4.47: Each phospholipid class as a percentage of total phospholipid content per
nucleus. Set 1 (Triton-X-100) is shown at the top followed by set 2 (maltopyranoside) and
set 3 (maltopyranoside repeat)
1674.4 Summary
The amount per nucleus of each phospholipid class and the resulting overall com-
position are found to vary between data sets. As described for whole cells it is
plausible that these variations may relate to diﬀerent phospholipid compositions
which maintain the same value of membrane torque tension. As discussed in sec-
tion 1.2.1 though, endonuclear membrane structures have not yet been found.
These variations may also be linked to population diﬀerences due to lack of 100%
synchronicity.
4.4 Summary
This chapter described the use of ESI-MS to determine the endonuclear phos-
pholipid composition of HeLa cells. Section 4.2 described the analysis of nuclei
extracted from asynchronous cell populations. The molecular species composition
of nuclei extracted with both Triton-X-100 and maltopyranoside was found to be,
within error, the same. This indicated that maltopyranoside is a suitable alter-
native to Triton-X-100 and that the phospholipid composition is not an artefact
of the detergent used. Endonuclear PC, DAG and PI was found to be enriched
in saturated molecular species with respect to the whole cell composition. Disat-
urated PC molecular species were found to total 34.4% in nuclei extracted with
Triton-X-100 and 22% in nuclei extracted with maltopyranoside. This contrasts
with only 12.3% in whole cells. The molecular species composition of PE, PS and
PA/PG, however, was found to remain the same between the whole cell and en-
donuclear compartment. It was noted that endonuclear DAG was most likely to
be derived from PC as it is composed mainly of disaturated and monounsaturated
molecular species. Endonuclear PA was however, found to be composed mainly of
polyunsaturated molecular species indicating that it was generated from a pool of
polyunsaturated DAG.
The total amount of endonuclear phospholipid was approximately 12% and 14% of
that in the whole cell for nuclei extracted with maltopyranoside and Triton-X-100
respectively. The amount per nucleus of each phospholipid class was very similar
for nuclei extracted with each detergent, giving further evidence that the results
are not an artefact of the detergent used. The proportion of each phospholipid
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class within the nucleus was found to be the same as that within the whole cell.
Section 4.3 described the analysis of nuclei extracted from cell populations which
had been treated with mimosine to increase cell cycle synchronicity. As descibed
for non-synchronised cells, endonuclear PC is enriched in saturated PC molecular
species. Saturated molecular PC species were also found to increase relative to the
non-synchronised control. The consistency and magnitude of these changes were
greater in the nuclei than the whole cell. The monounsaturated PC molecular
species showed either no change or a decrease relative to the non-synchronised
control. This contrasted with the whole cell results which showed an increase in
some species. The unsaturated PC molecular species showed either no change or
a decrease relative to the control which agrees with the whole cell results. As de-
scribed for whole cells, certain molecular species show more change relative to the
non-synchronised control. The largest changes are in species which are also the
most abundant.
Saturated and highly unsaturated PE molecular species showed little consistent
change relative to the non-synchronised control which agrees with the whole cell
ﬁndings. Monounsaturated and di-monounsaturated PE species showed either no
change or a decrease. As found for PC, most saturated DAG molecular species
were increased relative to the non-synchronised control and most unsaturated
DAG molecular species were decreased. Set 3, however, showed an increase in
molecular species containing an alkyl link but no change in the other species. This
result is similar to the ﬁndings for whole cell DAG molecular species. As described
for whole cells, it was suggested that the increase in certain molecular species
may be achieved by the remodelling of other DAG molecular species. The satu-
rated and highly unsaturated PI molecular species showed either no change or an
increase relative to the non-synchronised control. The monounsaturated species,
however, tend to show a decrease. The PS molecular species show very little consis-
tent change relative to the non-synchronised control. The most signiﬁcant changes
were in species 18:0/18:1 which was decreased and species 18:0/18:0 which was
increased. The PA molecular species also showed very little consistent change over
the three data sets. Species 16:0/18:0 and 16:0/16:0, however, showed an increase
at some time points and species 18:0/18:1 showed a decrease.
1694.4 Summary
The compositional changes of certain molecular species, following synchronisation,
diﬀer between the whole cell and nucleus. It was suggested that this may be caused
by diﬀerences in the way that mimosine interacts with phospholipid of the whole
cell and nucleus.
The total amount of each phospholipid class per nucleus was determined (section
4.3.2). As found for whole cells there did not appear to be a doubling of the phos-
pholipid content as would be expected prior to mitosis. There was an increase of
the 12 hour time point in set 3, however, within error this was not signiﬁcantly
diﬀerent to the 3 hour or 15 hour values. DAG was found to comprise a larger
proportion of the total phospholipid content in nuclei from synchronised cell com-
pared to nuclei from non-synchronised cells. It was suggested that this increase in
endonuclear DAG may be acting as a pro-apoptotic signal.
As described for whole cells, the variations between data sets may reﬂect diﬀerent
molecular species compositions that maintain the same value of membrane torque
tension. The variation may also be due to population diﬀerences arising from a
lack of 100% synchronicity.
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172Chapter 5
Phosphatidylcholine
biosynthetic dynamics
5.1 Introduction
Phosphatidylcholine (PC) accounts for a large proportion of both whole cell and
endonuclear lipids (Chapters 3 and 4). Biosynthesis of PC is thought to regulate the
accumulation of diacylglycerol (DAG) which is involved in cell signalling [1, 2, 3].
In eukaryotic cells, synthesis of PC proceeds principally via the Kennedy pathway
in which choline is converted to phosphatidylcholine following a three step process
(Figure 5.1).
Several isoforms of the Kennedy pathway enzymes exist and are distributed within
spatially distinct areas of the cell [4]. A study of IMR-32 cells indicated that these
enzymes retained activity in isolated nuclei and may therefore represent an intact
pathway for the synthesis of endonuclear PC, separate to that of the whole cell
[2].
Deuterium enriched choline-d9 can be used as a substrate to allow PC biosynthesis
to be analysed by ESI-MS. The deuterated label is added to the culture medium in
excess as described in section 7.4.1. Newly synthesised PC incorporates the choline-
d9 and can be identiﬁed by ESI-MS by scanning for the parents of m/z 193 [5].
This method was used to determine the relationship between cell cycle progression
and PC biosynthesis within the whole cell and endonuclear compartment.
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Figure 5.1: Phosphatidylcholine synthesis by the Kennedy pathway. This is the principal
pathway for phosphatidylcholine synthesis in eukaryotic cells.
5.2 Whole cell PC synthesis
The molecular species composition of newly synthesised PC in non-synchronised
whole cells is shown in Figure 5.2. As described in section 3.2.1, the molecular
species composition presented is an average of measurements obtained over six
diﬀerent days. On each day the composition of phospholipid extracted from three
separate ﬂasks of cells was measured. The error bars shown on the data represent
the ﬁrst standard deviation of all these measurements (18 samples in total). The
reported stardard deviation therefore includes error resulting from both biological
variability and instrument instability.
The composition is very similar to that of the endogeonous PC shown in Figure
3.1, with species 16:0/18:1 and 18:1/18:1 the most abundant. This observation
agrees well with a previous study of IMR-32 cells [2]. As described for endogenous
PC (section 3.2.1), the molecular species composition is similar to that of DAG
(Figure 3.3). Figures 5.1 and A.9 show that DAG is required for the synthesis of
PC via the Kennedy pathway and this may explain the similarity in composition
to newly synthesised PC.
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Figure 5.2: Molecular species percentage composition of d9PC for whole cells. The error
bars represent the ﬁrst standard deviation of this data and inlclude errors arising from
biological variability and instrument instability.
Table 5.1 summarises the total amount of endogenous and newly synthesised PC
per cell. As described in section 3.2.2, the values presented are an average of
measurements taken on four separate days. The reported ﬁrst standard deviation
therefore includes instrument instability, biological variability and errors arising
from cell counting and internal standard addition. The newly synthesised PC is
found to account for approximately 5.7% of the total PC in the cell. When the
error on the measurement is taken into account, this value is quite similar to the
8.6% newly synthesised PC found for IMR-32 cells [2].
1755.2 Whole cell PC synthesis
Total amount of PC per cell /nmoles
Type of PC Average Standard deviation Coeﬃcient of
Variation (%)
Endogenous 4.9 × 10−5 2.9 × 10−5 59.3
Newly synthesised 2.5 × 10−6 9.2 × 10−7 36.8
Total 5.2 × 10−5 2.9 × 10−5 57.6
Newly synthesised
PC as percentage of
total PC
5.7 2.8 50.2
Table 5.1: Total amount of endogenous and newly synthesised PC per non-synchronised
whole cell following a three hour incubation with d9-choline. The reported ﬁrst standard
deviation includes instrument instability, biological variability and errors arising from cell
counting and internal standard addition.
The molecular species composition of newly synthesised PC over the cell cycle is
shown in Figures 5.3 and B.7. Data set 1 and 2 refer to those described in section
3.3.2. The data presented for each time point is an average of the results from three
phospholipid samples. The error bars on this data represent the ﬁrst standard de-
viation of the three measurements. Each sample was obtained from separate ﬂasks
of cells, therefore, the reported standard deviation includes biological variability
in addition to systematic errors.
The composition is very similar to that of endogenous PC (Figure 3.12) and newly
synthesised PC in non-synchronised cells (Figure 5.2), with species 16:0/18:1 and
18:1/18:1 the most abundant. Species 16:0a/16:1, 16:1a/18:1 and 16:0/18:0a are
present in the endogenous PC data (Figure 3.12) but not in the newly synthesised
data. Species 16:0/18:0, 18:1a/20:4 and 16:0/22:6 are however present in the newly
synthesised data but below the selection threshold in the endogenous PC data.
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Figure 5.3: Molecular species percentage composition of d9PC for synchronised whole
cells. Data set 2. The error bars on this data represent the ﬁrst standard deviation over
three measurements and include biological variability in addition to systematic errors.
1775.2 Whole cell PC synthesis
The synchronised data was compared to that obtained for non-synchronised cells
as described in section 3.3.2. The results of this analysis are presented in Figures
5.4 to 5.7. As previously described, the error bars represent the combined stan-
dard deviation of the synchronised and non-synchronised results. This combined
standard deviation therefore includes the error of instrument instability from the
asynchronous data (see section 3.2.1) and the biological variability and systematic
errors from both data sets.
The saturated molecular species (Figure 5.4) generally show very little change rel-
ative to the non-synchronised control. The largest change is seen for the 12hr and
18hr time points of species 16:0/18:0 (m/z 771) in set 2 which are increased by
more than 2%. The other time points, within error, remain unchanged relative to
the control. The changes seen for this species in set 2 are not apparent in set 1
with all time points showing no signiﬁcant variation to the control.
Species 16:0/16:0 (m/z 743) shows an increase at the 9hr and 18hr time points in
set 1. This is not however repeated in set 2, rather a small reduction in the 3hr
and 18hr points occurs. When compared to the equivalent endogenous PC species
(Figure 3.14, m/z 734) it is clear that the results for set 1 are quite similar with
both showing the increase at 9hrs and 18hrs.
The 9hr time point of species 16:0a/16:0 (m/z 729) shows an increase relative to
the non-synchronised data in set 2 but this is not apparent in set 1. There is also
no increase at 9hrs in either data set of the equivalent endogenous PC species
(Figure 3.14, m/z 720). The very small increase in the 18hr time point of set 1
is, however, consistent with set 1 of the endogenous PC. The 14:0/16:0 (m/z 715)
species remains very similar to the control although the 3hr time point in set 1
and the 9hr and 18hr time points of set 2 show a very small decrease.
1785.2 Whole cell PC synthesis
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Figure 5.4: Difference between synchronised and non synchronised percentage compo-
sition for saturated d9PC species. Set 1 is shown at the top followed by set 2. The error
bars represent the combined standard deviation of sysnchronised and non-synchronised
data. This includes instrument instability from the asynchronous data and the biological
variability and systematic errors from both data sets.
Figure 5.5 shows the diﬀerence between the monounsaturated molecular species of
synchronised cells and non-synchronised cells. The most signiﬁcant change occurs
for species 16:0/18:1 (m/z 769). Unlike the equivalent endogenous PC species (Fig-
ure 3.15, m/z 760) the newly synthesised PC species shows a reduction, relative
to the asynchronous data, over most time points and in both data sets. There is
however a small increase for the 18hr time point of set 1 but this is not mirrored
in set 2.
The 3hr time point of set 1 species 18:0/18:1 (m/z 797) shows an increase which
is also seen in both data sets of the endogenous PC (Figure 3.15, m/z 788). This
is not however seen in set 2 and, unlike the endogenous PC, the other time points
1795.2 Whole cell PC synthesis
remain unchanged relative to the asynchronous control.
Species 16:0a/18:1 (m/z 755) shows an increase at the 9hr time point in set 2
but none of the time points show any change in set 1. This is in contrast to the
endogenous PC (Figure 3.15, m/z 746) which shows no change in set 2 but a small
decrease in the 9hr and 12hr time points of set 1. The increase in set 1 species
18:0a/18:1 (m/z 783), over all time points, is not apparent in set 2 or in the en-
dogenous PC.
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Figure 5.5: Difference between synchronised and non synchronised percentage com-
position for monounsaturated d9PC species. Set 1 is shown at the top followed by set
2
The di-monounsaturated species (Figure 5.6) show very little change relative to
the non-synchronised data. The most signiﬁcant change is observed in set 1 for
species 18:1/18:1 (m/z 795) in which the 9hr, 18hr and 21hr time points are re-
duced. No other changes are apparent which is quite diﬀerent to the ﬁnding for the
1805.2 Whole cell PC synthesis
endogenous PC which indicated a decrease in all di-monounsaturated molecular
species relative to the non-synchronised.
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Figure 5.6: Difference between synchronised and non synchronised percentage compo-
sition for di-monounsaturated d9PC species. Set 1 is shown at the top followed by set
2
The polyunsaturated species (Figure 5.7) generally remain very similar to the
asynchronous control, an observation that was also made for the endogenous PC.
There is however an increase of species 18:1a/20:4 (m/z 803) in set 2 over all time
points. It is interesting to note that this species contains an alkyl link, a property
which appeared to be linked to increases in DAG molecular species relative to the
non-synchronised (Figure 3.21). A decrease, relative to the non synchronised, of
species 16:0/18:2 (m/z 767) occurs at the 18hr time point in set 1 and the 15hr
and 21hrs time points of set 2. The decrease at 18hrs in set 1 is also seen for the
equivalent endogenous species.
1815.2 Whole cell PC synthesis
As mentioned in section 5.2, DAG is involved in the synthesis of PC. There does
not, however, appear to be an obvious correlation between the changes, relative
to the non-synchronised control, in DAG and newly synthesised PC. The species
which shows the greatest change, at one or more time points, in both data sets
is 16:0/18:1 (m/z 769). As described for endogenous PC, this species is also the
most abundant newly synthesised PC molecular species in the cell (Figure 5.3).
-3.0
-2.0
-1.0
0.0
1.0
2.0
3.0
D
9
P
C
1
6
:
0
/
1
8
:
2
D
9
P
C
1
6
:
0
/
2
0
:
4
D
9
P
C
1
8
:
1
/
1
8
:
2
D
9
P
C
1
8
:
1
a
/
2
0
:
4
D
9
P
C
1
6
:
0
/
2
2
:
6
D
9
P
C
1
8
:
1
/
2
0
:
4
D
9
P
C
1
8
:
0
/
2
0
:
4
767 791 793 803 815 817 819
3hrs
6hrs
9hrs
12hrs
15hrs
18hrs
21hrs
-3.0
-2.0
-1.0
0.0
1.0
2.0
3.0
D
9
P
C
1
6
:
0
/
1
8
:
2
D
9
P
C
1
6
:
0
/
2
0
:
4
D
9
P
C
1
8
:
1
/
1
8
:
2
D
9
P
C
1
8
:
1
a
/
2
0
:
4
D
9
P
C
1
6
:
0
/
2
2
:
6
D
9
P
C
1
8
:
1
/
2
0
:
4
D
9
P
C
1
8
:
0
/
2
0
:
4
767 791 793 803 815 817 819
3hrs
6hrs
9hrs
12hrs
15hrs
18hrs
21hrs
D
i
f
f
e
r
e
n
c
e
 
b
e
t
w
e
e
n
 
s
y
n
c
h
r
o
n
i
s
e
d
 
a
n
d
 
n
o
n
 
s
y
n
c
h
r
o
n
i
s
e
d
 
p
e
r
c
e
n
t
a
g
e
 
c
o
m
p
o
s
i
t
i
o
n
 
Molecular species and m/z 
Figure 5.7: Difference between synchronised and non synchronised percentage com-
position for highly unsaturated d9PC species. Set 1 is shown at the top followed by set
2
Figure 5.8 shows the total amount of newly synthesised PC per cell over the cell
cycle. As described above, the data presented for each time point is an average of
the results from three phospholipid samples. The error bars on this data represent
1825.2 Whole cell PC synthesis
the ﬁrst standard deviation of the three measurements. Each sample was obtained
from separate ﬂasks of cells, therefore, the reported standard deviation includes
biological variability in addition to systematic errors. As this is quantiﬁed data it
includes any error resulting from cell counting and internal standard addition.
In set 1 the amount per cell remains very stable at all time points except 3hrs which
is more than two times greater than the others. This is not however reﬂected in set
2 which shows the greatest amount per cell at the 18hr time point. The pattern
of results is almost identical to that of the endogenous PC shown in Figure 3.30.
The amount per cell of newly synthesised PC in cells from an asynchronous popu-
lation (Table 5.1) is, within error, very similar to the values of set 1 except at 3hrs.
0.0E+00
1.0E-05
2.0E-05
3.0E-05
4.0E-05
5.0E-05
6.0E-05
7.0E-05
3 6 9 12 15 18 21
Hours past G1/S boundary / hours
A
m
o
u
n
t
 
p
e
r
 
c
e
l
l
 
/
 
n
m
o
l
e
s
Set 1
Set 2
Figure 5.8: Absolute amount per cell of d9PC for synchronised whole cells
Newly synthesised PC as a percentage of the total PC per cell over the cell cycle is
shown in Figure 5.9. At most time points the value is very similar for both data-
sets and also, within error, very similar to the value found for non-synchronised
cells. The 3hr and 15hr time points of set 1 and the 18hr time point of set 2 show
the greatest diﬀerence to the non-synchronised value. A previous study of HeLa
cells suggested an increase in net PC synthesis, particularly of saturated molecular
species, associated with the M and early G1 phase of the cell cycle [6]. Although
there is no evidence of an increase in saturated species (Figure 5.4), the small in-
crease in the percentage of newly synthesised PC at 15hrs and 18hrs may indicate
such an increase in synthesis during the early G1 phase (see Table 3.1).
1835.3 Endonuclear PC synthesis
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Figure 5.9: Newly synthesised PC as a percentage of the total PC per cell.
5.3 Endonuclear PC synthesis
CTP cholinephosphate cytidyltransferase (CCT) is the regulatory enzyme for PC
biosynthesis via the Kennedy pathway and exists in three isoforms [7, 8]. The
CCTα isoform is located in the nucleus throughout the cell cycle and forms part
of an intact pathway for endonuclear PC synthesis, separate to that of the whole
cell [9, 2].
Previous studies have indicated that changes in nuclear PC synthesis can accom-
pany progression through the cell cycle [10, 6]. These studies were not conducted
on nuclear envelope free nuclei but they do suggest a variation in PC synthesis
which is speciﬁc to the nucleus. This section describes the extent to which endonu-
clear HeLa cell PC synthesis is cell cycle dependent and how it diﬀers from that
in the whole cell.
Figure 5.10 shows the molecular species composition of newly synthesised en-
donuclear PC. The molecular species composition of the nuclei extracted with
Triton-X-100 is an average of measurements obtained over four diﬀerent days.
For nuclei extracted with matopyranoside, the result presented is an average of
measurements taken over three diﬀerent days. On each day the composition of
phospholipid extracted from three separate ﬂasks of cells was measured. The error
bars on the data represent the ﬁrst standard deviation of all these measurements
(12 samples in total for Triton-X-100 and 9 for maltopyranoside). The reported
standard deviation therefore includes error resulting from both biological variabil-
1845.3 Endonuclear PC synthesis
ity and instrument instability.
As described for endogenous PC (section 4.2.1), the newly synthesised endonuclear
PC has a higher proportion of saturated species than the whole cell newly syn-
thesised PC. Disaturated molecular species total 37.7% in nuclei extracted with
Triton-X-100 and 32.5% in nuclei extracted with maltopyranoside. This contrasts
with a total of 11.7% in the whole cell. Species where both fatty acid chains are
unsaturated are, as also described for endogenous PC, found in a higher propor-
tion in the whole cell. Diunsaturated newly synthesised PC molecular species total
30.1% in the whole cell. In nuclei extracted with Triton-X-100 this value is 12.6%
and in nuclei extracted with maltopyranoside it is 17%. These values are very
similar to those for endogenous PC (section 4.2.1). Such similarity was not found
for a previous study on IMR-32 cells [2] which instead suggested a continuation
of endonuclear newly synthesised PC remodelling after the 3 hour d9-choline in-
cubation time.
As seen for the whole cells (section 5.2), the composition of newly synthesied en-
donuclear PC is similar to that of the endogenous endonuclear PC shown in Figure
4.1. In both cases, species 16:0/18:1 is the most abundant and species 16:0/16:0,
18:1/18:1 and 18:0/18:1 are present at more than 5%. Species 16:0a/18:1, however,
is above 5% of the endogenous PC but below 5% of the newly synthesised PC.
There is also a marked reduction in the number of molecular species containing an
alkyl link in the newly synthesised PC data with respect to the endogenous PC.
Species 16:0a/16:1, 16:1a/18:1, 16:0a/18:0, 18:1a/18:1 and 18:0a/18:1 are below
the selection threshold in the newly synthesised PC data (Figure 5.10) but not in
the endogenous PC data (Figure 4.1). Although the proportion of disaturated and
diunsaturated molecular species is similar to endogenous PC, this reduction in the
number of species containing an alkyl link may suggest that further remodelling
takes place after 3 hours.
Within error the results obtained with each detergent are the same. This suggests
that the type of detergent used is not eﬀecting the molecular species composition
of the newly synthesised PC.
1855.3 Endonuclear PC synthesis
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Figure 5.10: Molecular species percentage composition of d9PC in nuclei. The reported
standard deviation includes error resulting from both biological variability and instrument
instability.
1865.3 Endonuclear PC synthesis
The total amount of endogenous and newly synthesised PC per nucleus is shown in
Table 5.2. The reported standard deviation includes error arising from instrument
instability, biological variability, internal standard addition and cell counting. The
newly synthesised PC as a percentage of the total PC per nucleus (also shown in
Table 5.2) is higher than the 5.7% in the whole cell (Table 5.1). The error on this
data is, however, very large. Newly synthesised PC as a percentage of the total PC
is, within error, the same for nuclei extracted with each detergent. This suggests
that the type of detergent used for nuclei extraction does not inﬂuence the rate of
PC synthesis.
Total amount of PC per nucleus /nmoles
Detergent
used for nuclei
extraction
Type of PC Average Standard
deviation
Coeﬃcient
of Varia-
tion (%)
Maltopyranoside
Endogenous 5.6 × 10−6 5.6 × 10−6 99.5
Newly synthesised 6.7 × 10−7 3.9 × 10−7 58.8
Total 6.3 × 10−6 5.8 × 10−6 92.5
Triton-X-100
Endogenous 9.0 × 10−6 1.4 × 10−5 154.7
Newly synthesised 1.2 × 10−6 2.3 × 10−6 189.0
Total 1.0 × 10−5 1.6 × 10−5 158.3
Newly synthesised PC as percentage of total PC per nucleus
Maltopyranoside
nuclei
15.3 ±7.74
Triton-X-100
nuclei
11.7 ±5.32
Table 5.2: Amount of endogenous and newly synthesised PC per nucleus and newly
synthesised PC as a percentage of the total PC per nucleus
The molecular species composition of newly synthesised endonuclear PC over the
cell cycle is shown in Figures 5.11, 5.12 and 5.13. The data presented for each time
point is an average of the results from three phospholipid samples. The error bars
on this data represent the ﬁrst standard deviation of the three measurements.
1875.3 Endonuclear PC synthesis
Each sample was obtained from separate ﬂasks of cells, therefore, the reported
standard deviation includes biological variability in addition to systematic errors.
As found for endogenous endonuclear PC (Figures 4.9 to 4.11), species 16:0/16:0
and 16:0/18:1 are the most abundant.
1885.3 Endonuclear PC synthesis
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Figure 5.11: Molecular species percentage composition of newly synthesised PC for
synchronised nuclei extracted with Triton-X-100
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Figure 5.12: Molecular species percentage composition of newly synthesised PC for
synchronised nuclei extracted with Maltopyranoside
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Figure 5.13: Molecular species percentage composition of newly synthesised PC for
synchronised nuclei extracted with Maltopyranoside repeat
1915.3 Endonuclear PC synthesis
Figures 5.14 to 5.16 show the result of comparing this data from synchronised
cells to that of the non-synchronised cells. The error bars represent the combined
standard deviation of the synchronised and asynchronous results. This combined
standard deviation is determined by calculating the square root of the sum of
the squared standard deviations for each equivalent data point. This combined
standard deviation therefore includes the error of instrument instability from the
asynchronous data and the biological variability and systematic errors from both
data sets.
The saturated species (Figure 5.14) generally show no change or an increase rela-
tive to the non-synchronised control. The most signiﬁcant increases in each data
set are for species 16:0/16:0 (m/z 743). In sets 1 and 3 the greatest increase is in
the 15hr time point, however, this is not true for set 2 which instead shows no
change at 15hrs but a large increase at 18hrs. This variation between the data-
sets may represent a slight shift in the cell cycle position. At 15hrs to 18hrs post
cell cycle block removal, a high proportion of the cell population are undergoing
mitosis or entering the G1 phase (Figure 3.10). Species 16:0/18:0 (m/z 771) also
shows the greatest increase relative to the non-synchronised cells at either the 15hr
or 18hr time point. This suggests that the increase at these time points may be
related to the cell cycle position. These results are very similar to that of endoge-
nous nuclear PC (Figure 4.12). In both cases species 16:0/16:0 shows the greatest
increase particularly at the later time points.
The monounsaturated species generally show no change or a decrease relative to
the non-synchronised control. Species 16:0/18:1 (m/z 769) shows the largest de-
crease in all three data-sets, particularly at the 15hr time point in set 1 and 3 and
the 18hr time point in set 2. Again this may indicate a link to the cell cycle position.
Species 18:0/18:1 (m/z 797) shows a decrease in set 1 but this is not apparent in
the other data sets. This data is also similar to that of the endogenous PC (Figure
4.13), however species 16:0/18:1 showed the greatest decrease at 6hrs rather than
15/18hrs and species 16:0a/18:1 showed a more signiﬁcant decrease for endogenous
PC than newly synthesised. Species 16:0/16:1 (m/z 741) shows a decrease at 15hrs
and 18hrs in set 1 and 3 and at 18hrs and 21hrs in set 2. The endogenous PC data,
however, shows very little change relative to the non-synchronised control except a
small decrease at 6hrs and 15hrs in set 1, 6hrs and 18hrs in set 2 and 15hrs in set 3.
1925.3 Endonuclear PC synthesis
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Figure 5.14: Difference between synchronised and non-synchronised percentage com-
position for endonuclear saturated d9PC species. Set 1 (nuclei extracted with Triton-X-
100) is shown at the top followed by set 2 (nuclei extracted with maltopyranoside) and
set 3 (independent repeat of nuclei extracted with maltopyranoside)
1935.3 Endonuclear PC synthesis
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Figure 5.15: Difference between synchronised and non-synchronised percentage com-
position for endonuclear monounsaturated d9PC species. Set 1 (nuclei extracted with
Triton-X-100) is shown at the top followed by set 2 (nuclei extracted with maltopyra-
noside) and set 3 (independent repeat of nuclei extracted with maltopyranoside)
The di-monounsaturated and highly unsaturated species (Figure 5.16) show very
little change relative to the asynchronous control except for species 18:1/18:1 (m/z
1945.3 Endonuclear PC synthesis
795) which shows a signiﬁcant decrease in all three data sets. Species 18:1/18:2a
(m/z 722) shows a signiﬁcant increase relative to the asynchronous control at the
6hr time point in set 2. Although the equivalent endogenous species does not ap-
pear in the analysis presented in Figure 4.14, species 18:1/24:5a (m/z 848) is also
signiﬁcantly increased relative to the asynchronous control at the 6hr time point
in both set 1 and 2. This may indicate a link between highly unsaturated species
and the start of the S-phase of the cell cycle (Figure 3.10). As this increase is not
found in all data-sets the possibility that this is an artefact should also be noted.
As described for whole cells in section 5.2, there does not appear to be an obvi-
ous correlation between the changes in DAG relative to the asynchronous control
(Figure 4.25) and the changes in newly synthesised PC. The newly synthesised
PC molecular species which show the greatest change, in all three data sets, are
16:0/16:0 (m/z 743) and 16:0/18:1 (m/z 848). As noted for whole cells, these are
the most abundant endonuclear newly synthesised PC molecular species (Figures
5.11 to 5.13).
1955.3 Endonuclear PC synthesis
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Figure 5.16: Difference between synchronised and non-synchronised percentage com-
position for unsaturated endonuclear d9PC species. Set 1 (nuclei extracted with Triton-
X-100) is shown at the top followed by set 2 (nuclei extracted with maltopyranoside) and
set 3 (independent repeat of nuclei extracted with maltopyranoside)
Figure 5.17 shows the amount of newly synthesised PC per nucleus over the cell
cycle. The data presented for each time point is an average of the results from three
phospholipid samples. The error bars on this data represent the ﬁrst standard de-
1965.3 Endonuclear PC synthesis
viation of the three measurements. Each sample was obtained from separate ﬂasks
of cells, therefore, the reported standard deviation includes biological variability
in addition to systematic errors. This is quantiﬁed data and therefore also includes
any error resulting from cell counting and internal standard addition.
The values obtained for each data set are quite similar except for the 15hr and
21hr time points. At these time points the nuclei extracted with maltopyranoside
data set shows a value approximately three times greater than the other data sets.
This does not appear to be detergent related as the repeat does not show the same
trend. The newly synthesised PC is quantiﬁed from the same internal standard as
the endogenous PC however the endogenous PC (Figure 4.40) does not show an
equivalent result at these time points. This suggests that the result is not simply
due to incorrect internal standard addition, however, it is unclear why this increase
is only seen in one data set.
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Figure 5.17: Absolute amount per cell of d9PC for synchronised nuclei. The reported
standard deviation includes biological variability in addition to systematic errors. This is
quantiﬁed data and therefore also includes any error resulting from cell counting and
internal standard addition.
The newly synthesised PC as a percentage of the total endonuclear PC is shown
in Figure 5.18. There is a considerable variation between the data sets at some
time points (up to 20% at the 21hr time point), however, most of these values
fall within the error of the non-synchronised results. The 18hr time point has the
most consistently high percentage of newly synthesised PC although the variation
1975.4 Radiochemical study of PC synthesis
between the data sets prevents a more detailed analysis of any link between the
cell cycle position and proportion of newly synthesised PC.
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Figure 5.18: Newly synthesised PC as a percentage of the total PC per cell.
5.4 Radiochemical study of PC synthesis
Phosphatidylcholine synthesis can also be determined by monitoring the incorpo-
ration of radiolabelled choline [11, 12]. Figure 5.19 shows the amount of newly
synthesised PC in synchronised whole cells following a three hour incubation with
methyl-[14C]choline chloride. The data presented for each time point is an average
of measurements on three separate phospholipid samples. The error bars represent
the ﬁrst standard deviation of this data and therefore include biological variability
in addition to systematic errors. This data is directly comparable to that obtained
by mass spectrometry and provides an independent means of assessing trends in
PC biosynthesis.
1985.5 Phospholipid synthesis within naked nuclei
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Figure 5.19: Radiochemical study of PC synthesis. This ﬁgure shows the amount of
newly synthesised PC per whole cell at various cell cycle points following a three hour
incubation with methyl-[14C]choline chloride. The error bars represent the ﬁrst standard
deviation of this data and therefore include biological variability in addition to systematic
errors.
The amount of newly synthesised PC per cell determined by the radiochemical
method is less than that determined by mass spectrometry (Figure 5.8). There
is however a very similar trend over the cell cycle between set 2 of the mass
spectrometry results and the radiochemical results.
5.5 Phospholipid synthesis within naked nuclei
The results presented in section 5.3 show that the biosynthesis of endonuclear PC
occurs whilst the cell remains intact. A preliminary investigation was undertaken
to determine if PC biosynthesis could occur in naked nuclei. Naked nuclei were pre-
pared as previously described (section 7.3) and incubated with excess d9-choline
in D-MEM for 3 hours at 37◦C.
Figure 5.20C shows that newly synthesised PC was detected by ESI-MS in naked
nuclei prepared with n-Decyl β-D-Maltopyranoside. Newly synthesised PC was
also detected in nuclei prepared with Triton-X-100 (Figure 5.20B) although this
is diﬃcult to observe due to detergent contamination.
Figure 5.21 shows the molecular species composition of PC synthesised in naked
nuclei compared to that synthesised in nuclei whilst they remain part of the intact
1995.5 Phospholipid synthesis within naked nuclei
cell. It also shows PC synthesised in whole cells (see also Figure 5.10). The com-
position of PC synthesised within naked nuclei extracted with maltopyranoside
more closely resembles that of the whole cell than the nucleus and does not show
the enrichment of saturated species as described in section 5.3.
2005.5 Phospholipid synthesis within naked nuclei
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Figure 5.20: Synthesis of PC was detected in naked nuclei after isolation from the intact
cell. A; Typical P184 spectrum of naked nuclei. B; Example P193 spectrum (newly
synthesised PC) from nuclei extracted with Triton X-100. The peaks marked with arrows
arise from detergent contamination. C; Example P193 spectrum from nuclei extracted
with n-Decyl β-D-Maltopyranoside
2015.5 Phospholipid synthesis within naked nuclei
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Figure 5.21: Molecular species composition of PC synthesised in naked nuclei compared
to the composition of endonuclear PC synthesised whilst the cell remains intact and the
composition of newly synthesised PC in whole cells.
2025.5 Phospholipid synthesis within naked nuclei
The total amount of newly synthesised PC per cell is shown in Figure 5.22 and
summarised in Table 5.3. The phospholipid composition from three separate ﬂasks
of cells was measured. The error bars represent the ﬁrst standard deviation of this
data and therefore include biological variability in addition to systematic errors.
The amount of newly synthesised PC is less for nuclei extracted with Triton-X-100
than with maltopyranoside. This is most likely due to contamination of the ex-
tracted phospholipid by Triton-X-100 which is easily detected by ESI-MS (Figure
5.20B). The peak at m/z 767 for example is completely masked by a detergent
peak.
2035.5 Phospholipid synthesis within naked nuclei
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Figure 5.22: Total amount of newly synthesised PC per naked nucleus. Data is shown
for nuclei extracted with both Triton-X-100 and n-Decyl β-D-Maltopyranoside. The error
bars represent the ﬁrst standard deviation of this data and include biological variability in
addition to systematic errors.
The newly synthesised PC as a percentage of the total PC per nucleus is also
shown in Table 5.3. This is less than in intact cells (Table 5.2) however this prob-
ably reﬂects a loss of molecules such as ATP which would normally be present in
intact cells. It is possible that addition of molecules such as ATP to the naked
nuclei may result in greater synthesis.
2045.5 Phospholipid synthesis within naked nuclei
Total amount of PC per nucleus /nmoles
Detergent
used for nuclei
extraction
Type of PC Average Standard
deviation
Coeﬃcient
of Varia-
tion (%)
Maltopyranoside
Endogenous 8.2 × 10−5 2.8 × 10−5 34.3
Newly synthesised 4.1 × 10−6 3.8 × 10−6 91.9
Total 3.4 × 10−4 4.6 × 10−5 13.2
Triton-X-100
Endogenous 1.4 × 10−5 5.5 × 10−6 39.7
Newly synthesised 2.2 × 10−7 7.9 × 10−8 36.3
Total 4.2 × 10−5 8.3 × 10−6 19.5
Newly synthesised PC as percentage of total PC
Maltopyranoside
nuclei
1.2
Triton-X-100
nuclei
0.5
Table 5.3: Total amount of endogenous and newly syntheised PC in naked nuclei. The
newly synthesised PC as a percentage of the total PC is also shown.
These results strongly indicate that naked nuclei are indeed capable of PC biosyn-
thesis. It is however widely accepted that the catalytic activity of CCTα is medi-
ated by membrane interaction [13, 14, 15, 16]. Naked nuclei have been shown to
be free of nuclear envelope (NE) and endoplasmic reticulum (ER) contamination
(section 2.2.1 and a study on IMR-32 nuclei by Hunt et al [2]). These results ther-
fore indicate that the NE is not required for endonuclear CCTα activity.
It has been suggested that nuclei contain tubular membrane bound invaginations,
termed neoplasmic reticulum, which may provide a site for endonuclear PC biosyn-
thesis [17, 18, 19, 20]. The presence of membranous structures within naked nuclei,
however, has not yet been demonstrated [2, 21]. Endonuclear phospholipid may
form aggregate structures (such as liquid crystal phases) which are able to interact
with CCTα and mediate its activity.
These preliminary ﬁndings raise many interesting questions; What is the endonu-
clear phospholipid structure which could mediate CCTα activity? Could the pres-
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ence of detergent from the extraction procedure eﬀect CCTα activity and therefore
the rate of PC biosynthesis? Are there any substances present in intact cells which
would improve synthesis in naked nuclei? Are naked nuclei also capable of synthe-
sising other phospholipid species? What is the eﬀect of cell cycle phase?
5.6 Summary
This chapter describes the use of ESI-MS to analyse newly synthesised PC in
whole cells (section 5.2) and nuclei (section 5.3). The molecular species composi-
tion of newly synthesised PC in whole cells was found to be very similar to that
of endogenous whole cell PC. As also described for endogenous PC, the molecular
species composition was also similar to that of DAG. It was suggested that the
involvement of DAG in the synthesis of PC via the Kennedy pathway may explain
such a similarity. Whole cell newly synthesised PC was found to account for ap-
proximately 5.7% of the total PC per cell.
Unlike endogenous PC, the saturated molecular species of newly synthesised PC in
synchronised whole cells showed very little change relative to the non-synchronised
control. The monounsaturated molecular species 16:0/18:1 was decreased at most
time points. The other monounsaturated species, however, showed little consis-
tent change. This similarity to the non-synchronised data was also found for di-
monounsaturated and highly unsaturated molecular species. Several diﬀerences
between the endogenous and newly synthesised PC results were noted. As men-
tioned earlier DAG is involved in the synthesis of PC, however, no correlation
between the changes, relative to the non synchronised control, were found be-
tween DAG and the newly synthesised PC. As described for endogenous PC, the
species which showed the greatest change is also the most abundant molecular
species in the cell.
The amount of newly synthesised PC per whole cell was found to remain very
stable at all time points except 3hrs. Set 2, however, showed the largest amount
of newly synthesised PC at 18hrs. The pattern of these results over the time
points closely resembled that of the endogenous PC. Newly synthesised PC as a
percentage of the total PC per cell was generally found to be very similar to the
non-synchronised value in both data sets. The 3hr and 15hr time points of set 1 and
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the 18hr time point of set 2 show the greatest diﬀerence to the non synchronised
value. It was suggested that this may agree with a previous study that showed an
increase in PC synthesis associated with the M and early G1 phase of the cell cycle.
As found for endogenous PC, the proportion of saturated molecular species is
higher in newly synthesised endonuclear PC than in newly synthesised whole cell
PC. Disaturated molecular species were found to total 37.7% in nuclei extracted
with Triton-X-100 and and 32.5% in nuclei extracted with maltopyranoside. This
contrasts with only 11.7% in the whole cell. The composition of newly synthesised
PC in the nucleus was very similar to that of the endogenous PC for nuclei ex-
tracted with both detergents. Newly synthesised PC as a percentage of the total
PC per nucleus was approximatly 15% for nuclei extracted with maltopyranoside
and 12% for nuclei extracted with Triton-X-100. These results suggest that the
type of detergent does not inﬂuence the rate of PC synthesis or the composition
of newly synthesised PC.
The saturated molecular species of newly synthesised endonuclear PC show either
no change or an increase relative to the non-synchronised control. The monoun-
saturated species generally show a decrease or no change relative to the non-
synchronised control. The di-monounsaturated and highly unsaturated species
show very little change relative to the non-synchronised control, except species
18:1/18:1 which shows a signiﬁcant decrease in all three data sets. Unlike whole
cells, the results for newly synthesised endonuclear PC are very similar to that of
endogenous PC. As found for whole cells, there was no obvious correlation between
the changes in DAG, relative to the non-synchronised control, and the changes in
newly synthesised PC. The molecular species that showed the greatest change were
again those that were most abundant.
The total amount of newly synthesised PC per nucleus is quite similar for each
data set except at the 15hr and 21hr time points. At these time points, the mal-
topyranoside extracted nuclei data is approximately three times larger than the
other time points. The value of newly synthesised PC as a percentage of the total
endonuclear PC varies between the data sets at some time points. Most of the
values, however, fall within the standard deviation of the non-synchronised result.
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Section 5.4 describes the use of radiolabelled choline to monitor the synthesis of
PC. The amount of newly synthesised PC per cell was found to be less than that
determined by mass spectrometry. The trend over the cell cycle was, however,
similar to data set 2 of the whole cell mass spectrometry results.
Section 5.5 describes the results of a preliminary experiment to determine if PC
biosynthesis can occur in naked nuclei. Newly synthesised PC was detected by
ESI-MS in nuclei extracted with both maltopyranoside and Triton-X-100. The
composition of PC synthesised in naked nuclei extracted with maltopyranoside
more closely resembles that of the whole cell than the nucleus and does not show
an enrichment of saturated molecular species. The newly synthesised PC as a
percentage of the total PC per nucleus was 1.2% for nuclei extracted with mal-
topyranoside and 0.5% for nuclei extracted with Triton-X-100. This is less than in
the nuclei of intact cells and it was suggested that loss of molecules such as ATP
may cause this decrease in synthesis.
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211Chapter 6
Conclusions
6.1 Introduction
As described in section 1.1, the main aim of the neonuclei project was to produce
synthetic analogues of cell nuclei. To guide the preparation of these neonuclei it was
important to study and understand the components and processes of real nuclei.
Previous studies (see sction 1.2.1) indicated that nuclei from Human cells contain
a pool of endonuclear phospholipid, distinct from the nuclear membrane, which is
potentially involved in nuclear processes such as transcription [1, 2, 3]. The aim
of this study was to elucidate the composition and role of this endonuclear phos-
pholipid in eukaryotic cells. Tandem electrospray mass spectrometry was utilised
to determine the phospholipid content of cultured HeLa cells and their isolated
nuclei throughout the cell division cycle.
Section 6.2 gives a brief summary of the work undertaken and the main ﬁndings
that are detailed in each chapter of this thesis. This is followed in section 6.3 by
a discussion of the signiﬁcant ﬁndings which were observed for both whole cells
and nuclei and the conclusions that can be drawn from these. Finally, the future
perspectives for this work are presented in section 6.4.
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6.2 Summary of ﬁndings
6.2.1 Method development
Throughout this investigation several biological and instrumental protocols were
developed and optimised to best address the requirements of this study.
Analysis of endonuclear phospholipids requires the preparation of nuclei that are
free from nuclear envelope contamination. The detergent Triton-X-100 success-
fully removes nuclear envelope but residual detergent contamination of the nuclei
can lead to artefactual peaks in the P193 spectrum. Alternative detergents to
Triton-X-100 were therefore investigated. The non-ionic detergent n-Decyl β-D-
Maltopyranoside was found to be a suitable alternative to Triton-X-100 as it al-
lowed isolation of naked nuclei without causing detergent peaks when analysed by
mass spectrometry. TEM was used to conﬁrm that n-Decyl β-D-Maltopyranoside
eﬀectively removed the nuclear enverlope.
Phospholipid quantiﬁcation by mass spectrometry requires an accurate estimate
of the number of cells per sample. Haemocytometer counting is a simple and
quick method for such analysis. Naked nuclei, however, can occasionally become
clumped, making an accurate assessment of their number challenging by this
method. An alternative method based on using DNA content as an indicator of
cell number was therefore investigated. The preliminarly results did not show any
signiﬁcant improvement over the haemocytometer method. It is possible that fur-
ther development of the procedure may lead to a viable alternative although this
was beyond the scope of this study.
Using a carefully prepared mixture of phospholipids at known concentrations,
termed the standard mixture, the correction procedures applied to raw mass spec-
trometry data and instrument stability were assessed. It was determined that
intersession variability of mass spectrometry results can occur even when identical
samples are measured (standard mixture). This variability tends to be larger for
results obtained over longer time periods.
Several molecular species of a particular phospholipid class can have the same
mass. Q-TOF mass spectrometry was therfore used to determine the correct molec-
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ular species assignments for each phospholipid class.
6.2.2 Phospholipid composition of intact HeLa cells
The phospholipid composition of intact HeLa cells was determined to provide a
basis for comparison with the endonuclear phospholipid composition.
Asynchronous populations were found to contain a total phospholipid content of
1.17×10−4±7.72×10−5 nmoles per cell. The largest proportion of this phospholipid
was found to be PC and PE at 44% and 29% of the total respectively. PC, DAG and
PA/PG were found to be composed mainly of monounsaturated molecular species.
PE, PI and PS were composed of both monounsaturated and polyunsaturated
molecular species.
The relationship between cell cycle phase and phospholipid content was also inves-
tigated. HeLa cell populations were treated with mimosine to give a cell population
with a higher degree of cell cycle synchronicity than an untreated population. Flow
cytometry was used to assess the DNA replication cycle of these synchronised cell
populations. The application of mimosine resulted in cell cycle arrest prior to DNA
replication. On release of the cell cycle block, the synchronised HeLa cell popu-
lation was enriched by over 20% in the G1 phase relative to the asynchronous
population. The HeLa cell cycle was estimated to last for approximately 21 hours.
Using ESI-MS the phospholipid composition of synchronised HeLa cell populations
was determined at three hour intervals following release of the mimosine cell cycle
block. The data from asynchronous cell populations was used as a control to allow
direct comparison of diﬀerent data sets and a detailed analysis of the compositional
variation between time points.
• Saturated and monounsaturated PC molecular species showed either no
change or an increase relative to the non-synchronised data.
• Di-monounsaturated PC molecular species showed a reduction relative to
the non-synchronised data.
• Highly unsaturated PC molecular species, PE molecular species and PI
molecular species remained very similar, within error, to the non-synchronised
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results.
• DAG molecular species containing an alkyl link were increased relative to
the non-synchronised control.
• PS molecular species did not show a consistent trend across the data sets.
The total amount of each phospholipid class per cell was also determined at three
hour intervals following release of the mimosine cell cycle block. The proportion of
PC in synchronised cells was similar to that of non-synchronised cells in set 1 but
up to 30% greater in set 2. The proportions of DAG and PI were also higher but
only in data set 2. The proportion of PA/PG was the same as the value for non
synchronised cells in set 2 but more than twice this value in set 1. The proportion
of PE was, however, more than 10% less in synchronised cells than asynchronous
cells in both data sets. The total amount of phospholipid per cell did not double
as would be expected for the formation of two daughter cells, instead remaining
stable across the time points in set 1 and following a wave like pattern in set 2.
6.2.3 Endonuclear phospholipid composition
The endonuclear phospholipid content of HeLa cells was determined by ESI-MS
following isolation of the naked nuclei.
The molecular species composition was found to be the same, within error, for
nuclei extracted both with Triton-X-100 and maltopyranoside. Endonuclear PC,
DAG and PI was found to be enriched in saturated molecular species with respect
to the whole cell composition. Disaturated PC molecular species total 34.4% in
nuclei extracted with Triton-X-100 and 22% in nuclei extracted with maltopy-
ranoside. Such species total only 12.3% in the whole cell. The total amount of
endonuclear phospholipid was found be 12% of that in the whole cell for nuclei
extracted with maltopyranoside and 14% of that in the whole cell for nuclei ex-
tracted with Triton-X-100. The proportion of each phospholipid class within the
nucleus was the same as within the whole cell.
As found for whole cells, the molecular species composition of endonuclear phos-
pholipid was found to diﬀer between nuclei from asynchronous populations and
nuclei from synchronised populations.
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• Saturated PC molecular species showed an increase relative to the non-
synchronised control. The magnitude of these changes was up to 25% com-
pared to only 1.5% in whole cells.
• Monounsaturated PC molecular species showed either no change or a de-
crease relative to the non-synchronised control which contrasts with the
whole cell results.
• Di-monounsaturated PC molecular species showed either no change or a
decrease relative to the non-synchronised control.
• Saturated and highly unsaturated PE molecular species, PI molecular species
and PA molecular species showed little consistent change relative to the non-
synchronised control.
• Monounsaturated and di-monounsaturated PE molecular species showed no
change or a decrease which contrasts with the whole cell results.
• Data sets 1 and 2 show an increase in most saturated DAG species and a
decrease in unsaturated DAG species relative to the non-synchronised con-
trol.
• Set 3 only shows an increase in DAG species containing an alkyl link and
either no change or a decrease in the remaining species. This is similar to
the whole cell data.
• Most PS molecular species show little change relative to the non-synchronised
control. Species 18:0/18:1, however was decreased in all three data sets.
The total amount of phospholipid per nucleus, as found for whole cells, showed
no doubling as would be expected prior to mitosis. The proportion of DAG per
nucleus was higher in nuclei from synchronised cell populations than in nuclei from
asynchronous cell populations.
6.2.4 Phosphatidylcholine biosynthetic dynamics
Using a combination of stable isotope labeling and ESI-MS, the synthesis of PC
in whole cells and nuclei was determined.
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Whole cell newly synthesised PC was found to account for approximately 5.7% of
the total PC per cell after a three hour incubation with d9-choline. The molecular
species composition of this newly synthesised PC was found to be similar to that
of endogenous whole cell PC.
Unlike endogenous PC, most newly synthesised PC molecular species in synchro-
nised whole cells showed little consistent change relative to the non-synchronised
control. As a percentage of the total PC per cell, newly synthesised PC in syn-
chronised cells was very similar to that of non-synchronised cells.
As found for endogenous PC, the proportion of saturated molecular species in
endonuclear newly synthesised PC is higher than in whole cell newly synthesised
PC. Disaturated molecular species were found to total 37.7% in nuclei extracted
with Triton-X-100 and and 32.5% in nuclei extracted with maltopyranoside. This
contrasts with only 11.7% in the whole cell.
Newly synthesised PC as a percentage of the total PC per nucleus was approxi-
mately 15% for nuclei extracted with maltopyranoside and 12% for nuclei extracted
with Triton-X-100. The saturated molecular species of newly synthesised endonu-
clear PC show either no change or an increase relative to the non-synchronised
control. The monounsaturated species generally show a decrease or no change
relative to the non-synchronised control. The di-monounsaturated and highly un-
saturated species show very little change relative to the non synchronised control,
except species 18:1/18:1 which shows a signiﬁcant decrease in all three data sets.
The value of newly synthesised PC as a percentage of the total endonuclear PC
falls within the standard deviation of the non-synchronised result.
Biosynthesis of PC was found to continue in nuclei which had been removed from
the cell and stripped of their nuclear envelope. The molecular species composi-
tion of this newly synthesised PC in nuclei extracted with maltopyranoside more
closely resembled that of the whole cell than endonuclear newly synthesised PC
(endonuclear synthesis whilst the cell is intact). The newly synthesised PC as a
percentage of the total PC was 1.2% for nuclei extracted with maltopyranoside
and 0.5% for nuclei extracted with Triton-X-100. This is less than in nuclei of
intact cells but loss of molecules such as ATP may account for this.
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6.3 Key ﬁndings and conclusions
6.3.1 Endonuclear and whole cell phospholipid composition
The detergent n-Decyl β-D-Maltopyranoside was found to be a suitable alternative
to Triton-X-100 as it allowed isolation of naked nuclei without causing artefactual
detergent peaks in mass spectrometry analysis. Throughout this study, no sig-
niﬁcant diﬀerence was observed between results from nuclei extracted with each
detergent. This indicates that the endonuclear phospholipid composition deter-
mined by ESI-MS is not an artefact of the detergent used to strip the nuclear
envelope.
Endonuclear PC was found to be enriched in disaturated molecular species with
respect to whole cell PC. In contrast, diunsaturated PC molecular species were
found in a higher proportion in the whole cell than the nucleus. The ﬁnding that
endonuclear PC is enriched in saturated molecular species agrees with previous
study of IMR-32 cells [3] and gives further evidence that this is a generalised
phenomenon across a variety of Human cell lines [4]. An increase in disaturated
molecular species was also observed for DAG and PI. DAG and PI are known to
be involved in cell signalling [5, 6, 7], indicating that this increase in saturated
molecular species may play a role in endonuclear phospholipid signalling.
6.3.2 Eﬀects of synchronisation
The molecular species composition of both whole cells and nuclei from cell pop-
ulations that have been treated with mimosine diﬀers to those which have not.
These diﬀerences were particularly apparent for PC and DAG molecular species
and appeared to be related to the saturation level of the molecular species. There
were indications of similar, saturation dependent, changes in other phospholipid
classes. These were not always consistent in all data sets, however, probably due to
the larger error on these results. DAG molecular species with an alkyl link showed
an increase relative to the non-synchronised control in whole cells and one set of
the endonuclear data.
As discussed in section 3.3.2 it possible that these changes are an artefact of
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treatment with mimosine. Mimosine can cause cellular changes that correlate with
the apoptotic process [8, 9]. A study of the neuronal cell line HN2-5 found an
increase in saturated fatty acid containing phospholipids associated with apoptosis.
This increase in saturated species was attributed to the changes in membrane
morphology such as shrinkage and ﬂuidity that occur during apoptosis [10, 11].
It was also found that redistribution of arachidonate containing molecular species
could lead to cellular changes associated with apoptosis [12]. In whole cells (section
3.3.2) the arachidonate containing species PE16:0/20:4 and PE20:4/22:5 are visible
in the synchronised data but not in the non-synchronised data.
Certain molecular species show a greater change, relative to the non synchronised
control, than other species of the same saturation level. These molecular species
tend to also be those which are most abundant in the cell. It seems plausible that
these species are preferentially remodelled due to their high abundance.
It was observed that the increase in certain DAG molecular species may correlate
with the decrease in other DAG molecular species. This would suggest that the
molecular species that are decreased, relative to the control, are remodelled into
the species that increase, relative to the control. There is, however, an increase in
species containing the 16:0a fatty acid but no decrease in species containing this.
There is also no obvious correlation between the molecular species that show an
increase and those that decrease for other phospholipid classes. This indicates that
several remodelling mechanisms may be involved in this process.
A distinction between the compositional changes of certain molecular species in the
whole cell and nucleus was observed (section 4.3.1). It is possible that endonuclear
lipid may be aﬀected in a diﬀerent way to whole cell phospholipid during apoptosis.
Previous studies indicated that endonuclear phospholipids may interact with DNA
and be involved with DNA synthesis [13, 14]. Mimosine may interfere with this
lipid-DNA interaction and thus lead to alterations in endonuclear phospholipid
composition that are diﬀerent to the whole cell.
Several diﬀerences were noted between the compositional changes of newly syn-
thesised PC and endogenous PC in the whole cell (section 5.2). For example, all
endogenous PC di-monounsaturated species were reduced, relative to the non-
synchronised control, but little change was observed for newly synthesised PC
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molecular species. The results for newly synthesised and endogenous PC, how-
ever, were very similar in the nucleus. It is possible that the eﬀects of mimosine
are longer lasting in the nucleus than the whole cell.
It has been shown that the biophysical characteristics of a membrane, its cur-
vature elastic stress, could regulate CTP:phosphocholine cytidyltransferase and
thus PC synthesis [15]. This curvature elastic stress is determined by the phos-
pholipid composition of that membrane. It is possible that changes in molecular
species composition following synchronisation might alter the value of curvature
elastic stress and thus alter PC synthesis. Newly synthesised PC as a percentage
of the total PC was not, however, signiﬁcantly diﬀerent in synchronised cells than
non-synchronised cells.
There were some indications that the position of the cell in the cell cycle, following
release from the cell cycle block, may inﬂuence the magnitude of changes relative to
the non-synchronised control. In section 4.3.1 for instance, the 18 hour time point
of species PC16:0/16:0 consistently shows the greatest increase over all three data
sets. Apoptosis has been linked to the cell cycle, with certain cell cycle regulators
inﬂuencing both proliferation and cell death [16, 17]. If addition of mimosine is
causing an apopotopic response this may provide an explanation for these results.
In both whole cells and nuclei the total phospholipid content was not found to
double, as would be expected prior to mitosis, at any time point after release of
the cell cycle block. As discussed in section 3.3.3 this may be because phospholipids
are not fully synchronised with DNA following treatment with the cell cycle block
[18, 19, 20, 21]. The cell population is not 100% synchronised following treatment
with mimosine (section 3.3.1). A proportion of the cell population may therfore be
halving their mass whilst others are doubling leading to only a small net increase
in the total phospholipid.
6.3.3 Variation between data sets
The molecular species composition and amount per cell of each phospholipid class
was often found to vary between independent data sets. Curvature elastic stress,
or torque tension, of a membrane is likely to be under homeostatic control as it
is intrinsically linked to properties such as membrane ﬂuidity and permiability
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[22]. As discussed in section 3.3.3 the variations between data sets may represent
diﬀerent phospholipid compositions that maintain a similar value of torque tension.
6.3.4 PC biosynthesis
Biosynthesis of PC was found to continue in nuclei which had been removed from
the cell and stripped of their nuclear envelope. This gives compelling evidence
of a separate PC synthesis pathway within the nucleus. The newly synthesised
PC as a percentage of the total PC was less than in the nuclei of intact cells,
however, this may be due to the loss of molecules such as ATP. The composition
of PC synthesised in naked nuclei extracted with maltopyranoside did not show
an enrichment in saturated molecular species like PC synthesised in the nuclei of
intact cells. It is possible that there is also a loss of substances such as acyl-CoA,
preventing the remodelling of newly synthesised PC.
6.3.5 Summary of key ﬁndings
• Intersession variability of mass spectrometry results should be taken into
account when comparing samples measured on diﬀerent occasions.
• Endonuclear phospholipid composition is not an artefact of the detergent
used to strip the nuclear envelope.
• Endonuclear PC, DAG and PI are enriched in saturated molecular species
with respect to the whole cell.
• The molecular species composition of cells treated with mimosine diﬀers to
untreated cells. It appears that many of these diﬀerences are related to the
saturation level of the species.
• Treatment with mimosine does not lead to a doubling of phopsholipid con-
tent prior to mitosis. Phopspholipids may not be synchronised with DNA
following treatment with a cell block such as mimosine.
• The molecular species composition was found to vary between independent
data sets. This may be due to similar values of membrane torque tension
resulting from diﬀerent phospholipid compositions.
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• Biosynthesis of PC was found to continue in naked nuclei after removal from
the cell.
6.4 Perspectives
This study has raised many interesting questions which could form the basis of
further studies into this area.
6.4.1 Continuation of the current study
The work presented in this report has highlighted some important questions re-
garding cell cycle analysis following synchronisation using methods such as cell cy-
cle inhibitors and serum starvation (section 3.3.3). If the synchronisation method
causes changes in the molecular species compostion, it can become diﬃcult to dis-
tinguish those changes that arise due to position in the cell cycle from those that
are artefacts of the synchronisation method.
The next step in determining the eﬀect of cell cycle position on phospholipid com-
position therefore relies on the assessment of suitable synchronisation techniques.
Ideally the synchronisation technique should not perturb the natural cellular phys-
iology and should produce a highly synchronous population. It is possible that a
technique that relies on selecting cells from an asynchronous population based on
their phase, rather than arresting the whole population in a certain phase, may
oﬀer results which better reﬂect real cellular events. Methods which select cells of
a certain phase based on their size have been reported [23] however these could
result in a small sample size and poor synchronisation.
The current study provides a comparison of the endonuclear phospholipid com-
position with that of the whole cell. This work could be extended by determining
the composition of the nuclear envelope and comparing this to the endonuclear
composition.
The molecular species composition of cell populations that have been treated with
mimosine diﬀers to those which have not. It may be possible to design a computer
based approach to assess the increase or decrease of molecular species, follow-
ing treatment with mimosine, and the resulting eﬀect on predicted stored elastic
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stress. This would allow further investigation into the apparent diﬀerences between
certain data sets.
Preliminary results suggested that naked nuclei were capable of PC biosynthesis.
The eﬀect of adding molecules such as ATP should be investigated as these may
increase the rate of synthesis. The rate of synthesis could also be assessed with re-
spect to the cell cycle. An important extension to this work would be to determine
the biosynthesis of phospholipids other than PC in both the naked nuclei and also
in the endonuclear compartment whilst the cell remains intact.
Section 2.3.5 highlighted the issue of intersession reproducibility for mass spec-
trometry analysis [24]. As with all lipidomic studies, a large amount of data is gen-
erated, however this can lead to extremely complicated data analysis [25, 26, 27].
This work could be extended to fully explore the variability of results and design
experiments that are appropriate for a detailed statistical analysis.
6.4.2 Future work
This thesis has described the composition of endonuclear phospholipids. The nu-
cleus is not however a homogenous compartment containing a mixture of nucleic
acids, proteins and lipids. Although not separated by membrane structures, the
nucleus contains several distinct structures such as the nucleolus [28, 29]. Some
studies using gold-conjugated phospholipases indicated that endonuclear phospho-
lipids are mainly localised in the interchromatin spaces and the nucleolus [1, 30]. A
study of the composition and biosynthetic dynamics of these diﬀerentially located
endonuclear phospholipids would provide a challenging area for future research.
Such a study could potentially give a more detailed insight into the roles of en-
donuclear phospholipid.
The current study has focused on the phospholipid content of the nucleus. The
same techniques could, however, be applied to other organelles such as the mito-
chondria.
Some diﬃculties regarding the design of reproducible and accurate mass spec-
trometry studies were highlighted in this work. A vital area for future research
is therefore the investigation of new approaches to the design and analysis of
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lipidomic studies. Such studies have the potential to open up many exciting av-
enues of research in this ﬁeld. They may also provide novel methods for the analysis
of current data.
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228Chapter 7
Experimental
7.1 Cell culture
HeLa-GFP cells were obtained from Dr D. Zink (LMU Munich) [1]. Cells were cul-
tured at 37 ◦C and 5% CO2 in 50mL D-MEM (Dulbecos modiﬁed Eagles medium,
Gibco) containing 4 mM L-glutamine and HEPES buﬀer but no pyruvate. It was
supplemented with 10% foetal calf serum (Gibco, Heat inactivated South Ameri-
can origin) and 5% antibiotic/ antimycotic (Gibco).
A cell conﬂuence of approximately 70% was maintained by regular splitting. To
detach cells from the side of the ﬂask, Trypsin-EDTA, 5 mL (0.25%, Gibco) was
added to the ﬂask following removal of medium, and incubated at 37 ◦C for 5 min-
utes. Further action of the trypsin was prevented by addition of 10 mL D-MEM.
Cells were then removed from the resulting suspension.
7.2 Cell synchronisation
A stock solution of 200 mM L-mimosine (Sigma) in 1 M NH4OH was prepared.
For each 1 mL of medium, 1 µL of stock solution was added (ﬁnal concentration
200 µM). Cells were incubated with the mimosine for 16hrs causing the population
to remain near the G1/S boundary of the cell cycle. The mimosine cell cycle block
was removed by washing with PBS and supplementing with fresh medium. [1]
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Extraction buﬀer containing 0.5% (w/v) detergent and 4 mM EDTA in HBSS
(without Ca2+ or Mg2+) was prepared. A solution of 30% sucrose in the extrac-
tion buﬀer was also prepared. Cells were removed from the side of the ﬂask by
tripsinisation and washed with D-PBS (Gibco, without Ca2+ or Mg2+). The D-
PBS was removed and the cells re-suspended in 500 µL of extraction buﬀer. This
was kept on ice for 15 minutes with occasional mixing. The cells were then care-
fully layered over 400 µL 30% sucrose in extraction buﬀer. This was centrifuged
at 9000g for 3 minutes. Cell debris was removed from the sucrose solution with a
tissue. The supernatant was removed and the nuclear pellet (found at the bottom
of the tube) washed with HBSS [2].
7.4 Preparation of samples for phospholipid analysis
by Mass Spectrometry
7.4.1 Deuterated PC
An excess of deuterated phosphocholine was added to the cells to assess the rate of
PC synthesis by mass spectrometry. Deuterated phosphocholine (d9-PC, HD Iso-
topes) in HBSS (2 mg/mL), 500 µL, was added to the ﬂask of cells and incubated
at 37 ◦C for three hours.
7.4.2 Cell counting
Cells were counted on a haemocytometer by the dye exclusion method using 0.4%
Trypan blue solution (Sigma) [3]. The cell pellet was suspended in 5 mL of HBSS
and a 10 µL sample removed for counting. To this, 40 µL of trypan blue was added,
mixed by pipetting and loaded onto the haemocytometer. The number of cells in
the original sample was estimated using the following formula:
(number of cells counted/number of squares) × dilution factor × dilution factor
of volume
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7.4.3 Phospholipid extraction and internal standards
Phospholipid was extracted from whole cell and nuclear samples using a chloro-
form/methanol extraction protocol ﬁrst described by Bligh and Dyer [4]. Each
sample was made up to 800 µL with saline (0.9% NaCl) and transferred to a glass
centrifuge tube. A known volume of each internal standard was added (see section
7.4.4). 1 mL of chloroform was added followed by 2 mL of methanol, 1 mL of chlo-
roform and ﬁnally 1 mL of water. After each addition the sample was vortexed.
The sample was then centrifuged for 10 minutes at 1500 rpm. The lower organic
layer containing the phospholipid was removed and dried under nitrogen. Samples
were stored at -20 ◦C until analysis by mass spectrometry.
7.4.4 Internal standards
Known concentrations of non-physiological phospholipids (internal standards) were
used to allow sample quantiﬁcation by mass spectrometry. A known amount of each
internal standard species was accurately measured from the stock (for stock so-
lutions in chloroform, the concentration given by the manufacturer (Avanti Polar
Lipids) was assumed to be correct). This was made up to a known volume with
chloroform and aliquoted into several vials. The vials were dried under nitrogen
and stored at - 20 ◦C until needed. Internal standards were made up to a known
concentration with chloroform before use. The amount of internal standard added
to each sample was chosen to give a peak height similar to that of the other species
when measured by mass spectrometry.
7.4.5 Standard mixture preparation
A mixture of phospholipids (purchased from Avanti Polar Lipids) was prepared to
give a number of identical samples for the assessment of mass spectrometry pro-
tocols. The appropriate amount of each molecular species was carefully prepared
from stock (Table 7.1) to give enough for 200 identical samples each containing 10
nmoles of PC molecular species and 2 nmoles of all other molecular species (Table
2.2). This mixture was made up to 5 mL with chloroform to give a single stock
from which 25 µL aliquots were transferred into 2 mL brown glass screw cap vials.
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All solutions were prepared as accurately as possible using volumetric glassware
and Drummond positive displacement microdispensers, taking care to minimise
evaporation of chloroform. The samples were dried under nitrogen and stored in
the freezer until use.
Phospholipid Original stock Method of preparation
PC 18:1/18:1 solution in chloroform aliquoted from stock
PC 16:0/16:0 stock from G.Koster made up to 1 ml in chloroform
and aliqoted
PC 16:0/14:0 stock from G.Koster made up to 1 ml in chloroform
and aliqoted
PC 20:0/20:0 stock from G.Koster made up to 1 ml in chloroform
and aliqoted
DG 16:0/18:1 solution in chloroform aliquoted from stock
DG 12:0/12:0 solution in chloroform aliquoted from stock
PS 16:0/16:0 solution in chloroform aliquoted from stock
PS 18:1/18:1 powder weighed accurately to make solu-
tion in chloroform
PS 14:0/14:0 stock from G.Koster made up to 1 ml in chloroform
and aliqoted
PA 18:1/18:1 solution in chloroform aliquoted from stock
PA 16:0/16:0 solution in chloroform aliquoted from stock
PA 14:0/14:0 stock from G.Koster made up to 1 ml in chloroform
and aliqoted
PE 18:1/18:1 powder weighed accurately to make solu-
tion in chloroform
PE 14:0/14:0 stock from G.Koster made up to 1 ml in chloroform
and aliqoted
Table 7.1: Standard mixture compostition and preparation. This mixture was prepared as
accurately as possible to give many identical samples. All phospholipids were purchased
from Avanti Polar Lipids. Some phospholipid species were obtained from G. Koster -
these had been aliquoted from chloroform solution and dried down.
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Ferric chloride (27g, FeCl36H2O) and ammonium thiocyanate (30g, NH4SCN) were
made up to 1 Litre in water. Phospholipid samples were dissolved in 2 mL chlo-
roform and 1 mL of ammonium ferrothiocyanate reagent was added. This was
vortexed for 1 minute and then centrifuged at low speed. The lower layer was
removed and the absorbance of this solution measured at 488 nm. A calibration
curve was constructed by measuring the absorbance of known phospholipid con-
centrations and the absorbance of internal standard solutions compared to this
[5].
7.6 Mass Spectrometry
ESI-MS of phospholipids extracted from whole cells or nuclei was performed on
a Micromass Quatro Ultima triple quadrupole mass spectrometer (Micromass,
Wythenshaw, UK) equipped with an electrospray ionisation interface. Samples
were dissolved in butanol:methanol:water:ammonia (conc) (2:6:1.6:0.4) and intro-
duced into the mass spectrometer by syringe pump at a ﬂow rate of 5 µL/min.
Nitrogen was used as the cone and desolvation gas and argon as the collision gas
(3.5 x 10−3 mbar). Table 7.2 shows the scan settings used for each phospholipid
species. Data was acquired and processed using MassLynx NT software. An Excel
Visual Basic macro written by Dr Grielof Koster was used for the correction of
13C isotope eﬀects and subsequent analysis.
2337.7 TOF mass spec
Phospholipid
species
Fragment Ionisation
mode
Collision
energy (eV)
Cone volt-
age (V)
PC P184 positive 32 90
d9PC P193 negative 32 90
PE NL141 positive 28 90
PS NL87 negative 22 80
PA P153 negative 34 90
DAG NL35 positive 15 50
PI P241 negative 39 100
Table 7.2: ESI-MS settings for the analysis of phospholipid composition. Following frag-
mentation with argon gas, sequential scans of the appropriate fragment permit deter-
mination of each phospholipid species present. ‘P’ represents parent scans and ‘NL’ a
constant neutral loss scan.
7.7 TOF mass spec
The PC, PE, acidic and neutral phospholipid fractions were separated on Bond
Elute solid phase extraction columns as described in section 7.7.1. TOF-MS was
performed on a Micromass Q-TOF spectrometer.
The neutral, acidic and PE sampes were dissolved in MeOH:CHCl3:H2O:NH3(conc),
70:20:80:20 (v/v) for introduction into the mass spectrometer. The PC fraction
was dissolved in MeOH:NH3:H2O:CHCl3:CH3COOH, 70:2:8:20:0.2 (v,v) to allow
it to be run under negative ionisation. Data was aquired using Mass-Lynx software
and analysed using an Excel macro designed by Dr. G. Koster.
7.7.1 Bond-elute
Bond Elute NH2 disposable solid phase extraction columns (Varian) were equili-
brated with 1 mL chloroform under gravity. Dried phospholipid samples were dis-
solved in 1 mL of chloroform and applied to the columns. The columns were washed
with chloroform (2 x 1 mL) under low pressure nitrogen. This neutral fragment was
collected. The PC fraction was collected using 1 mL chloroform:methanol (60:40)
under low pressure nitrogen. The PE fraction was eluted with 1 mL methanol un-
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der low pressure nitrogen. The acidic fraction was collected after washing with 3 x
1 mL of methanol: water: phosphoric acid (96:4:1). The acidic fraction was dried
under nitrogen and back extracted by adding 100 µl of water, 200 µl methanol
and 200 µl chloroform and collecting the lower chloroform layer.
7.8 Flow cytometry
Cells were washed with 5-10 ml of PBS and resuspended in 500 µL of cold PBS
containing 0.1% glucose. 5 mL of 70% ethanol (kept at -20 ◦C) was added and the
sample left overnight at 4 ◦C. The cells were then spun down and washed with 10
mL of PBS. Residual PBS was removed following centrifugation. The sample was
incubated at 37 ◦C for 30-45 minutes with 20 µL of PI solution (69 µM propidium
iodide in 3.8 mM Sodium Citrate, pH 7.4) and 20µL of 10 mg/mL RNAse before
analysis by FACS. Measurements were obtained with a BD FACS Aria ﬂow cy-
tometer using a 585/42 nm bandpass ﬁlter for peak emission. Data collection and
analysis was performed using BD FACS Diva software. The percentage of the cell
population in each phase of the cell cycle was determined by estimating the area
under each part of the curve corresponding to each phase.
7.9 Electron microsopy
Cell samples were ﬁxed overnight in ﬁxative (3% gluteraldehyde and 4% formalde-
hyde in 0.1M PIPES buﬀer at pH 7.2). The ﬁxed samples were then embedded
in 5% sodium alginate. Approximately 0.75 mL of post ﬁxative (2 mL OsO4 and
2 mL of 0.2 M PIPES) was added to the sample and placed in a rotator for 1
hour. Post ﬁxative was removed and the sample washed twice with 0.1 M PIPES
and once with water. The sample was stained with 1 mL of 2% uranyl acetate
for 20 minutes. Following removal of the stain the sample was dehydrated in a
graded ethanol series (use a series of ethanol concentrations from 30% to abso-
lute). The ethanol was removed from the sample and replaced with acetonitrile for
10 minutes. Following inﬁltration of 50:50 acetonitrile:resin overnight the sample
was left in resin for 6 hours. Finally the sample was embedded in fresh resin and
polymerised at 60 ◦C. Thin sections were cut with a glass knife using an ultrami-
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crotome and collected on metal grids. Sample grids were stained using Reynolds
lead stain. Electron micrographs were obtained using a Hitachi H7000 TEM at 75
kV [6].
7.10 DNA extraction and quantiﬁcation
Aqueous and solid fractions from Bligh Dyer phospholipid extraction were dried
under nitrogen before use. DNA was isolated using a Promega Wizard SV kit.
The sample was suspended in lysis buﬀer and transferred to minicolumn. DNA
was bound to the column using centrifugation and washed four times with wash
solution. The DNA was eluted from the column with nuclease free water. Detailed
instructions included with the Wizard SV kit were followed. DNA concentration
was quantiﬁed by measuring absorbance at 260 nm with a Thermo scientiﬁc nan-
odrop 1000 spectrophotometer using the DNA-50 setting. The nucleic acid con-
centration in ng/microlitre is calculated using the Beer-Lambert equation with an
extinction coeﬃcient of 50 mg-cm/µL. This calculation is performed automatically
by the nanodrop 1000 software.
7.11 Radiochemical assessment of newly synthesised
PC
An appropriate volume of methyl 14C choline was added to each ﬂask of cells
to give an isotopic diultion of 5% and incubated at 37 ◦C for three hours. The
phospholipid was extracted by the Bligh and Dyer method and the chloroform
layer dried under nitrogen. The activity in counts per minute was measured by
liquid scintillation counting on a Beckman LS 6500 scintillation counter.
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Figure A.1: Coefﬁcient of variance for the standard mixture PE percentage composition
results
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Figure A.2: Coefﬁcient of variance for the standard mixture PS percentage composition
results
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Figure A.3: Coefﬁcient of variance for the standard mixture DAG percentage composition
results
239mass Originally assigned species
716 PE16:0/18:2 16:1/18:1 16:0/18:2 18:1/16:1 16:0/18:2
718 PE16:0/18:1 16:0/18:1 18:0/16:1 16:0/18:1 18:0/16:1
740 PE16:0/20:4 20:4/16:0 16:0/20:4
742 PE18:1/18:2 18:1/18:2 18:0/18:3 18:1/18:2 18:0/18:3
744 PE18:0/18:2 18:1/18:1 18:0/18:2 18:1/18:1 18:0/18:2 16:0/20:2
746 PE18:0/18:1 18:0/18:1 18:0/18:1
764 PE16:0/22:6 18:1/20:5 22:6/16:0 18:1/20:5 22:6/16:0
766 PE18:1/20:4 18:1/20:4 22:5/16:0 18:1/20:4 20:5/18:0 16:0/22:5
768 PE18:0/20:4 18:0/20:4 20:3/18:1 18:0/20:4 20:3/18:1
770 PE18:0/20:3 18:0/20:3 18:1/20:2 18:0/20:3 18:2/20:1
772 PE18:0/20:2 20:1/18:1 18:0/20:2 18:0/20:2 18:1/20:1 16:0/22:2
774 PE18:0/20:1 20:0/18:1 20:1/18:0 18:1/20:0 18:0/20:1
788 PE18:0a/22:1 22:0a/18:1 22:0a/18:1
790 PE18:0a/22:0 24:0a/16:0 18:0/22:0a
792 PE18:0/22:6 18:0/22:6 18:0/22:6 18:2/22:5
794 PE18:0/22:5 18:0/22:5 18:0/22:5 18:1/22:4
796 PE18:0/22:4 22:3/18:1 18:1/22:3 18:0/22:4
798 PE18:0/22:3 22:2/18:1 18:1/22:2
800 PE18:0/22:2 18:1/22:1 18:1/22:1 18:2/22:0 18:0/22:2
whole cells nuclei
Species found to be present by TOF analysis. In order of intensity
Figure A.4: The NL141 (PE) molecular species composition for whole cells and nuclei.
The species are presented in the order of decreasing intensity. The proportion of each
species for a particular mass can not be quantiﬁed.
mass Originally assigned species
572 AG16:0a/16:0
584 AG16:0/16:1 16:0/16:1
586 AG16:0/16:0 16:0/16:0 16:0/16:0
598 AG16:0a/18:1
600 AG16:0a/18:0
610 AG16:0/18:2 16:1/18:1 16:0/18:2 16:1/18:1
612 AG16:0/18:1 16:0/18:1 16:0/18:1
614 AG16:0/18:0 16:0/18:0 16:0/18:0
626 AG18:0a/18:1 18:0a/18:1
636 AG18:1/18:2 18:1/18:2
638 AG18:0/18:2 18:1/18:1 16:0/20:2 18:1/18:1 16:0/20:2
640 AG18:0/18:1 18:0/18:1 16:0/20:1 18:0/18:1
642 AG18:0/18:0 18:0/18:0 20:0/16:0 18:0/18:0
664 AG18:0/20:3
666 AG18:0/20:2
668 AG18:0/20:1 LCH18:1 16:0/22:1
694 AG18:0/22:2 18:0/22:2
whole cells nuclei
Species found to be present by TOF analysis. In order of intensity
Figure A.5: The NL35 (DAG) molecular species composition for whole cells and nuclei.
The species are presented in the order of decreasing intensity. The proportion of each
species for a particular mass can not be quantiﬁed.
mass Originally assigned species
647 PA16:0/16:0 16:0/16:0 16:0/16:0 14:0/18:0
673 PA16:0/18:1 16:0/18:1 16:0/18:1
675 PA16:0/18:0 16:0/18:0 16:0/18:0
695 PA16:0/20:4 18:1/18:3
699 PA18:0/18:2 18:1/18:1 16:1/20:1 16:0/20:2 18:1/18:1 18:0/18:2
701 PA18:0/18:1 18:0/18:1 16:0/20:1 18:1/18:0 16:0/20:1
747 PA18:0/22:6 PG16:0.18:1 PG16:0/18:1
759 PA18:0/22:0 PG18:1a/18:1 PG18:1a/18:1 PG18:0a/18:2
773 PA20:0a/22:0 PG18:1/18:1 PG18:018:2 PG18:1/18:1 PG16:0/20:2 18:0/24:0a
775 PA20:0/22:6 PG18:0/18:1 PG18:0/18:1 PG16:0/20:1 PG16:1/20:0
781 PA20:3/22:0 PG16:0/22:5a
789 PA22:0a/22:6 PG20:1a/18:0 26:6a/18:0 PG20:0a/18:1
809 PA22:0/22:3 18:1/26:2 18:1/26:2
whole cells nuclei
Species found to be present by TOF analysis. In order of intensity
Figure A.6: The P153 (PA) molecular species composition for whole cells and nuclei.
The species are presented in the order of decreasing intensity. The proportion of each
species for a particular mass can not be quantiﬁed.
240mass Originally assigned species
760 PS16:0/18:1 18:1/16:0 16:1/18:0 16:0/18:1 16:1/18:0
774 PS18:0a/18:1 18:0a/18:1 18:0a/18:1 16:0/20:1a
784 PS18:1/18:2 18:2/18:1 18:1/18:2 18:0/18:3
786 PS18:0/18:2 18:1/18:1 18:0/18:2 18:1/18:1 18:2/18:0
788 PS18:0/18:1 18:1/18:0 18:1/18:0
802 PS18:0a/20:1 20:1a/18:0 18:0a/20:1 18:0/20:1a 18:1/20:0a 18:0a/20:1
810 PS18:0/20:4 20:4/18:0 20:3/18:1 18:0/20:4
812 PS18:0/20:3 20:3/18:0 20:2/18:1 18:2/20:1 18:0/20:3
814 PS18:0/20:2 18:1/20:1 18:0/20:2 22:2/16:0 18:1/20:1 18:0/20:2
816 PS18:0/20:1 20:1/18:0 20:0/18:1 18:0/20:1 18:1/20:0
828 PS18:0a/22:2 22:1a/18:1 22:2a/18:0 18:1/22:1a 20:0a/20:2 20:1a/20:1 22:2a/18:0
834 PS18:0/22:6 22:6/18:0 18:0/22:6
836 PS18:0/22:5 22:5/18:0 18:0/22:5
838 PS18:0/22:4 22:4/18:0 20:0/20:4
840 PS18:0/22:3 22:2/18:1 22:1/18:2 18:1/22:2 18:0/22:3 18:2/22:1 20:1/20:2
842 PS18:0/22:2 22:2/18:0 18:1/22:1 22:2/18:0 22:1/18:1 20:0/20:2 20:1/20:1
844 PS18:0/22:1 18:1/22:0 18:1/22:0 18:0/22:1
Species found to be present by TOF analysis. In order of intensity
whole cells nuclei
Figure A.7: The NL87 (PS) molecular species composition for whole cells and nuclei.
The species are presented in the order of decreasing intensity. The proportion of each
species for a particular mass can not be quantiﬁed.
mass Originally assigned species
833 PI16:0/18:2 16:1/18:1 18:2/16:0 16:1/18:1
835 PI16:0/18:1 16:0/18:1 16:1/18:0 16:0/18:1 16:1/18:0
837 PI16:0/18:0 16:0/18:0 16:0/18:0
849 PI18:0a/18:1 18:1a/18:0 18:0a/18:1 18:0a/18:1 18:1a/18:0
859 PI18:1/18:2 18:2/18:1 16:0/20:3 18:2/18:1 18:3/18:0
861 PI18:0/18:2 18:1/18:1 18:2/18:0 20:2/16:0 18:1/18:1 18:2/18:0
863 PI18:0/18:1 18:1/18:0 18:0/18:1
865 PI18:0/18:0 18:0/18:0 18:0/18:0
875 PI18:0a/20:2 20:1a/18:1 20:2a/18:0 18:0a/20:2 20:1a/18:1 20:2a/18:0
883 PI18:1/20:4 20:4/18:1 20:5/18:0 18:1/20:4 22:5/16:0
885 PI18:0/20:4 18:0/20:4 20:3/18:1
887 PI18:0/20:3 18:1/20:2 20:3/18:0 20:2/18:1 20:3/18:0
889 PI18:0/20:2 18:0/20:2 20:1/18:1 18:0/20:2 20:1/18:1
891 PI18:0/20:1 20:1/18:0 20:0/18:0 20:1/18:0
whole cells nuclei
Species found to be present by TOF analysis. In order of intensity
Figure A.8: The P241 (PI) molecular species composition for whole cells and nuclei.
The species are presented in the order of decreasing intensity. The proportion of each
species for a particular mass can not be quantiﬁed.
2412 
Figure A.9: Phospholipid biosynthetic pathways. (Diagram by G.S Attard, Sept 96 and
redrawn by J. Beard, Nov 01)
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Figure A.10: Typical FACS plots at time points following synchronisation with mimosine
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Mass spectrometry data
2440 5 10 15 20 25 30 35
PC14:0/16:0
PC16:0a/16:1
PC16:0a/16:0
PC16:0/16:1
PC16:0/16:0
PC16:1a/18:1
PC16:0a/18:1
PC16:0/18:0a
PC16:0/18:2
PC16:0/18:1
PC18:1a/18:1
PC18:0a/18:1
PC16:0/20:4
PC18:1/18:2
PC18:1/18:1
PC18:0/18:1
PC18:1/20:4
PC18:0/20:4
PC18:1/20:1
7
0
6
7
1
8
7
2
0
7
3
2
7
3
4
7
4
4
7
4
6
7
4
8
7
5
8
7
6
0
7
7
2
7
7
4
7
8
2
7
8
4
7
8
6
7
8
8
8
0
8
8
1
0
8
1
4
M
o
l
e
c
u
l
a
r
 
s
p
e
c
i
e
s
 
a
n
d
 
m
/
z
Percentage composition %
21hrs
18hrs
15hrs
12hrs
9hrs
6hrs
3hrs
Figure B.1: Molecular species percentage composition of PC for synchronised whole
cells (data set 1)
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Figure B.2: Molecular species percentage composition of PE for synchronised whole
cells (data set 1)
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Figure B.3: Molecular species percentage composition of DAG for synchronised whole
cells (data set 1)
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Figure B.4: Molecular species percentage composition of PI for synchronised whole cells
(data set 1)
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Figure B.5: Molecular species percentage composition of PS for synchronised whole
cells (data set 1)
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Figure B.6: Molecular species percentage composition of PA for synchronised whole
cells (data set 1)
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Figure B.7: Molecular species percentage composition of d9PC for synchronised whole
cells (data set 1)
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Figure B.8: Difference between synchronised and non synchronised percentage compo-
sition PE. Data set 2
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